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ABSTRACT 
 
MOTOR PROTEIN REGULATION IN MAMMALIAN MITOSIS 
MAY 2018 
BARBARA JENKINS MANN, B.S. ROGER WILLIAMS UNIVERSITY 
PhD., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Patricia Wadsworth 
Developing and maintaining a multicellular organism relies on the fundamental 
biological process of cell division, which ensures that genetic material is equally 
segregated between daughter cells. During mitosis, cells completely rearrange their 
cytoskeleton into a bipolar spindle through the concerted efforts of microtubules, motor 
proteins, and microtubule-associated proteins, which cells must regulate spatially and 
temporally to prevent errors such as chromosomal missegregation: a major cause of 
cancer. Although the mitotic spindle is a validated target for chemotherapy drug 
resistance and redundant pathways have highlighted the need for new targets. It is 
therefore important to understand how proteins that help build and/or maintain the 
spindle are regulated. Consequently, this dissertation focuses on the regulation of two 
separate but somewhat redundant mitotic kinesin motor proteins, Eg5 and Kif15, in vitro 
and in vivo.  
In general, proteins are regulated several ways, including protein-protein 
interactions and post-translational modifications. My data show that the C-terminal 37 
amino acids of the microtubule-associated protein, TPX2, which were known to regulate 
Eg5 localization, are also responsible for Kif15 localization. TPX2 inhibits Eg5 walking 
on single microtubules by acting as both a brake and a roadblock but only inhibits Kif15 
 vii 
as a brake. In vivo, dynamic microtubules are also involved in Kif15 behavior. These 
results highlight the differences in the mechanisms that govern the regulation of these 
motors. To further demonstrate this, I found that Eg5 activity is also regulated motor 
domain phosphorylation by Src kinase. Eg5 phosphomimic mutations produce monopolar 
spindles due to reduced Eg5 activity while non-phosphorylatable mutants result in 
disorganized spindles. Together, these data suggest that phosphorylation of Eg5 must be 
temporally regulated. Finally, using CRISPR/Cas9, I endogenously tagged Eg5 and 
TPX2 with EGFP in HeLa cells and quantified protein distribution. My results differed 
from reports using non-endogenous tags and reveal that Eg5 and TPX2 have distinct 
spindle localization throughout mitosis with TPX2 absent in areas where Eg5 activity is 
required. Additionally, I correlated fluorescence to protein concentration both locally and 
globally in mammalian cells, which is the first step in developing models to understand 
this complex biological process. 
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 1 
CHAPTER 1 
 
FUNCTION AND REGULATION OF KINESIN-5 
1.1 Introduction 
The main structural elements of the mitotic spindle are microtubules, hollow polar 
filaments built from dimers of α/β tubulin.  Spindle formation and function requires 
numerous motor and non-motor microtubule-associated proteins (MAPs) that regulate the 
nucleation, dynamics, and crosslinking of microtubules. In nearly every organism that has 
been studied, a member of the Kinesin-5 family of motor proteins localizes to the spindle 
(Fig. 1.1 A, B) and is required for spindle assembly (Blangy et al., 1995; Enos and 
Morris, 1990; Ferenz et al., 2010; Goshima and Vale, 2003; Hagan and Yanagida, 1990; 
Hoyt et al., 1992). Kinesin-5s function as bipolar homotetramers (Acar et al., 2013; 
Gordon and Roof, 1999; Hildebrandt et al., 2006; Kashina et al., 1997; Sharp et al., 
1999a), and this structural organization allows the motor to crosslink and slide 
antiparallel microtubules. Inhibition of kinesin-5 activity by genetic or chemical 
perturbations results in monopolar spindles that fail to establish bipolarity, demonstrating 
the critical role that this protein plays in cell division (Kapoor et al., 2000; Mayer et al., 
1999).   
In many cell types, Kinesin-5 also contributes to spindle elongation in anaphase. 
Anaphase is typically divided into two temporally overlapping sub-phases, anaphase A 
and B (Fig. 1.1 E).  In anaphase A, the distance between the kinetochores and the spindle 
pole decreases as kinetochore fiber microtubules shorten by microtubule disassembly at 
 2 
kinetochores and/or spindle poles (McIntosh et al., 2012; Roostalu et al., 2010). During 
anaphase B the distance between the two spindle poles increases as the spindle elongates 
(Roostalu et al., 2010; Scholey et al., 2016). In many cells, spindle elongation occurs 
when antiparallel microtubules slide relative to each other driven by kinesin-5. In some 
cases, this sliding is accompanied by microtubule polymerization. In other cells, kinesin-
5 motors oppose outward pulling forces, acting as frictional brakes (Hu et al., 2011; 
McIntosh et al., 2012; Scholey et al., 2016) (see section 1.4.4). Thus, despite variation 
among different cells, kinesin-5 force production plays a key role. 
Although Kinesin-5 has been studied for decades, new features of motor behavior 
and regulation continue to be discovered. These studies provide insight into how the 
motor is spatially and temporally regulated during mitosis, and how various properties of 
the motor contribute to mitosis in diverse cells. 
1.2 Kinesin-5 motile behavior 
1.2.1 Kinesin-5 Motility  
 Kinesins with the motor domain located at the N-terminus of the protein, like 
Kinesin-5, were originally shown to move toward microtubule plus-ends (Miki et al., 
2005; Sawin et al., 1992). Consistent with this, purified vertebrate Kinesin-5s walk 
processively toward the plus-ends of microtubules with relatively short run lengths (~8 
steps) (Fig. 1.1 C) (Kapitein et al., 2005; Valentine et al., 2006; Valentine and Gilbert, 
2007). Additionally, because they are bipolar homotetramers, Kinesin-5s use both their 
motor domains and non-motor tail domains to crosslink and simultaneous walk on two 
microtubules, showing a preference for microtubules in the antiparallel configuration 
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(Kapitein et al., 2008; Kapitein et al., 2005; van den Wildenberg et al., 2008; Weinger et 
al., 2011) resulting in microtubules sliding. The ability to move microtubules relative to 
each other is thought to be the key feature of kinesin-5 motors that enables bipolar 
spindle formation and elongation. This feature also distinguishes kinesin-5 from other 
kinesins, which typically transport vesicular cargos along the microtubule lattice.  For 
kinesin-5, the microtubule is both the cargo and track.  
Despite the evidence that kinesin-5 is a plus-end directed motor, several groups 
recently made the surprising discovery that kinesin-5s from budding and fission yeast 
(Cin8, Kip1, Cut7) can move toward microtubule plus or minus ends using the same 
motility mechanism; differences in motor concentration or ionic strength dictate their 
directionality on microtubules (Britto et al., 2016; Edamatsu, 2014; Fallesen et al., 2017; 
Fridman et al., 2013; Gerson-Gurwitz et al., 2011; Roostalu et al., 2011; Shapira and 
Gheber, 2016; Shapira et al., 2017).  For example, in vitro assays show that when 
individual Cin8, Kip1, and/or Cut7 motors are observed either walking on or gliding 
individual microtubules in vitro, they move in a fast (up to 360 nm/s), processive, minus-
end directed manner (Britto et al., 2016; Edamatsu, 2014; Fridman et al., 2013; Gerson-
Gurwitz et al., 2011; Roostalu et al., 2011; Thiede et al., 2012).  As the concentration of 
motors is increased, motor direction changes to the more canonical plus-end directed 
(Figure 1.2 B). This result suggests that kinesin-5s work in mechanically coupled teams 
(Fallesen et al., 2017; Roostalu et al., 2011; Shimamoto et al., 2015), although the 
mechanism by which this behavior is controlled is not yet established. 
In addition to motor number, ionic strength also affects directionality of Cin8, 
Kip1 and Cut7.  Minus end directed motility is observed under relatively high, close to 
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physiological, ionic conditions (~200-300mM NaCl) (Thiede et al., 2012). As ionic 
strength is lowered, plus-end directed motility is observed.  Further, when engaged by 
two antiparallel microtubules, motors switch direction and become less processive but the 
net overall movement is plus-end directed, regardless of ionic strength. These data show 
that when kinesin-5 is engaged between two antiparallel microtubules plus-end directed 
motility is triggered (Thiede et al., 2012).     
The Saccharomyces cerevisiae kinesin-5, Cin8, is unique because it has an extra 
loop (Loop 8, 99 amino acids long) that is lacking in other kinesin-5 motors. When Loop 
8 is deleted, Cin8 becomes unidirectional towards the minus end and can no longer 
switch direction as ionic strength is lowered (Gerson-Gurwitz et al., 2011). Expression of 
this mutant construct in yeast reduces both motility toward the spindle midzone, where 
microtubule plus-ends are located and spindle elongation suggesting a role for directional 
switching in anaphase (Gerson-Gurwitz et al., 2011). Further, this loop facilitates unique 
binding of the motor to microtubules, which promotes clustering (Bell et al., 2017). 
Sequence comparisons of kinesin-5 proteins from diverse organisms have identified 
several domains unique to the yeast bi-directional kinesin-5 motors (Singh et al., 2018). 
Future studies will likely reveal how these domains contribute to motor bi-directionality 
and function in vivo and in vitro (Singh et al., 2018). 
 
1.2.2 Tip-Tracking  
The association of molecules with the plus-ends of microtubules is called tip 
tracking; some proteins track microtubule tips autonomously while others bind to other 
tip tracking proteins (e.g. EB family members) for tracking activity (Akhmanova and 
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Steinmetz, 2008; Akhmanova and Steinmetz, 2010). Kinesins from several different 
families can tip track including members of the kinesin-13, -8 and -14 families 
(Akhmanova and Steinmetz, 2008; Honnappa et al., 2009). In vitro vertebrate kinesin-5s 
are observed to move toward the plus-ends where they can remain attached (Fig. 1.1 C), 
although these microtubules are non dynamic and are not thought to have the same 
structural features as dynamic MTs (Balchand et al., 2015; Kapitein et al., 2005). The 
Saccharomyces cerevisiae kinesin-5, Kip1, is one of the only kinesin-5 proteins that has 
been shown to autonomously tip track (Fridman et al., 2013).  Kip1 localizes to the 
midzone in anaphase where it remains associated with the plus-ends of depolymerizing 
microtubules eventually translocating to the spindle poles. 
Kinesin-5 tip tracking has also been demonstrated using a dimeric Eg5-Kinesin-1 
chimera composed of the kinesin-5 motor fused to the Kinesin-1 tail (Chen and Hancock, 
2015). In in vitro assays, this chimeric motor protein was shown to both prevent 
microtubule catastrophes and track growing ends. This result is in contrast to prior work 
showing that in cells the yeast kinesin-5, Cin8, promotes catastrophes at plus-ends 
(Gardner et al., 2008). Thus, kinesin-5 may act at microtubule plus-ends, but additional 
work is needed to define this activity. 
1.3 Kinesin-5 Phosphoregulation 
Like many mitotic proteins, kinesin-5 localization and activation are controlled by 
cell cycle regulated phosphorylation. Although kinesin-5 phospho-regulation is common 
across organisms, the kinases and phosphatases, the phosphorylation sites, timing and 
consequences of phosphorylation vary (Table 1.1).  
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1.3.1. Tail Domain Phosphorylation 
As mentioned, kinesin-5s are important for establishing spindle bipolarity and 
therefore must localize to the spindle microtubules and spindle poles early in mitosis. 
Kinesin-5s are generally not found on interphase microtubules (Blangy et al., 1995; 
Sawin and Mitchison, 1995) except in certain specialized cell types such as neurons 
where they contribute to microtubule organization (Falnikar et al., 2011; Kahn et al., 
2015; Myers and Baas, 2007). Kinesin-5 also localizes to interphase microtubules in 
plants, but the function is unknown (Bannigan et al., 2007).  
In dividing cells, kinesin-5s bind to mitotic microtubules for spindle formation 
and this is regulated by phosphorylation within the tail domain. A conserved region 
within the C-terminal tail, known as the ‘BimC box’, originally identified kinesin-5 
family members (Ferenz et al., 2010). This BimC box contains a consensus Cdk1 
phosphorylation site (Blangy et al., 1995) (Table 1.1). In H. sapiens, X. laevis and D. 
melanogaster, phosphorylation of kinesin-5s tail domain by Cdk1 is required to localize 
the motors to centrosomes and spindle microtubules early in mitosis (Blangy et al., 1997; 
Blangy et al., 1995; Cahu et al., 2008; Goshima and Vale, 2005; Heck et al., 1993; Sawin 
and Mitchison, 1995; Sharp et al., 1999a). Not only does Cdk1 phosphorylation regulate 
microtubule interaction of kinesin-5s, but also facilitates interactions with other proteins. 
For example, when Cdk1 phosphorylates HsEg5 early in mitosis it localizes to 
centrosomes where it co-localizes and associates with the dynactin subunit p150 (Blangy 
et al., 1997; Blangy et al., 1995). In C. elegans, Aurora B (AIR-2) kinase, not Cdk1, is 
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responsible for phosphorylating the BMK-1 tail resulting in its localization to both the 
mitotic and meiotic spindle microtubules (Bishop et al., 2005).  
Interestingly, in fission yeast, the kinesin-5 Cut7 also contains the Cdk1 
consensus site (T1011), however it is not required for spindle localization suggesting 
divergent regulation (Drummond and Hagan, 1998). Neither of the budding yeast 
kinesin-5s (Kip1, Cin8) contain the conserved Cdk1 site (Chee and Haase, 2010) that is 
required for localization in other organisms; however, mass spectrometry analysis of in 
vivo phosphorylation by Cdk1 identified alternate sites within the tail domain of Kip1 and 
Cin8 (Table 1.1) (Chee and Haase, 2010). These sites do not affect protein localization; 
however, phosphorylation is essential for protein function as corresponding non-
phosphorylatable alanine mutations result in defects in spindle pole body (SPB) 
separation (Chee and Haase, 2010).  
The tail domain of HsEg5 is also phosphorylated by Nek6/Nek7 (Table 1.1) and 
this is necessary for HsEg5 motor function and to establish spindle bipolarity (Bertran et 
al., 2011; Rapley et al., 2008). Plk1 phosphorylates Nek9, which then activates 
Nek6/Nek7, ultimately resulting in phosphorylation of kinesin-5 at S1033 specifically at 
centrosomes (Bertran et al., 2011; Fry et al., 2017). Unlike the Cdk1 site, Nek6/Nek7 
phosphorylation does not affect the ability of HsEg5 to bind microtubules, but regulates 
spindle pole localization where phosphorylation is needed for motor activity specifically 
to separate centrosomes (Rapley et al., 2008). The proposed model is that in prophase, 
Cdk1 phosphorylation first localizes HsEg5 to the centrosome microtubules where it 
accumulates. Then, Nek6/Nek7 can then phosphorylate the motor initiating centrosome 
separation and ultimately spindle bipolarity (Bertran et al., 2011; Fry et al., 2017). Not 
 8 
only does Nek6/Nek7 phosphorylation regulate HsEg5 activity at poles but was also 
recently found to facilitate interaction with the microtubule associated protein, TPX2, 
(Eibes et al., 2017). Although TPX2 is predominantly nuclear in prophase, a centrosomal 
pool is required for Eg5 localization and centrosome separation. 
 
1.3.2. Motor Domain Phosphorylation 
Once motors have been localized to the mitotic spindle, their activity must be 
regulated and several studies have shown that phosphorylation of the motor head, near 
the ATP binding pocket contributes to this regulation. 
Motor domain phosphorylation was first demonstrated in D. melanogaster 
kinesin-5, KLP61F, in which three tyrosine residues within the motor head are 
phosphorylated by Wee1 (dWee1) Kinase (Table 1.1) (Garcia et al., 2009). 
Phosphorylation at these sites is required for motor function and normal spindle 
morphology.  Embryos expressing a homozygous loss of function allele (klp61f3) have 
spindle defects including monopolar spindles that could only be rescued by expressing 
wild-type KLP61F (KLP61FWT), not a non-phosphorylatable (KLP61F3YF) mutant. These 
embryos also showed dominant effects including extra microtubule organizing centers 
(MTOCs) and abnormal microtubules.  
One of the three tyrosine residues phosphorylated in D. melanogaster, Y207, is 
conserved in mammalian cells (Y211) where it is also essential for normal spindle 
formation (Bickel et al., 2017) (Chapter IV). However, in vitro kinase reactions show that 
Src, not Wee1, is the kinase responsible for this phosphorylation (Table 1.1) (Bickel et 
al., 2017) (Chapter IV). Although phosphorylation of these sites does not affect the 
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motors ability to bind to microtubules, motor activity is altered. When phosphorylation is 
mimicked at Y211 (Y211E), ATP hydrolysis and motor driven microtubule gliding both 
significantly decrease. In cells, the same mutation results in monopolar spindles. Taken 
together, this suggests phosphorylation renders the motor less active and thus unable to 
produce sufficient outward force necessary for bipolarity. Conversely, a non-
phosphorylatable mutation (Y211F) increases the prevalence of disorganized spindles 
similar to those seen when Src specific inhibitors are used (Bickel et al., 2017) (Chapter 
IV). These results suggest that motor activity is regulated by temporally specific 
phosphorylation and dephosphorylation at this site. 
In yeast, a different set of sites in the motor domain regulates activity and spindle 
localization. Cdk1 phosphorylates Cin8 and Kip1 at several sites within the motor head 
(Table 1.1) (Avunie-Masala et al., 2011; Chee and Haase, 2010; Gerson-Gurwitz et al., 
2011; Goldstein et al., 2017). One of these sites is a conserved consensus site between 
Cin8 and Kip1 (S455 and S388 respectively) and is essential for proper spindle pole body 
separation and cell proliferation. In Cin8, phosphorylation of S455 in combination with 
two other sites in the motor head specific to Loop 8, regulate localization to the spindle 
midzone in anaphase (Avunie-Masala et al., 2011). Non-phosphorylatable mutants fail to 
localize to the midzone due to a weakened intereraction of Cin8 with the microtubule 
resulting in faster minus-end directed motion (Gerson-Gurwitz et al., 2011).  
Differential timing of Cdk1 phosphorylation at 3 different sites within the motor 
head (Table 1.1) also regulates Cin8 localization to the anaphase spindle (Goldstein et 
al., 2017). In early anaphase, phosphorylation of S277 causes Cin8 to detach from the 
spindle pole bodies (SPBs) and move to the midzone. As anaphase progresses, S493 also 
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becomes phosphorylated and further moves Cin8 from the SPBs to the midzone where it 
helps regulate the rate of spindle elongation. Finally, as the cell enters late anaphase, 
T285 phosphorylation occurs detaching Cin8 from the spindle because all 3 sites are 
phosphorylated. This detachment was also observed in vitro, where a phosphomimic (3D) 
mutant motor increased minus end directed motility, increased velocity and had a weaker 
interaction with the microtubule (Shapira and Gheber, 2016). This is the only evidence of 
phosphorylation regulating localization of a Kinesin-5 late in mitosis but further 
investigations are needed in other systems to see if there is conservation. 
 
1.3.3. Stalk Domain Phosphorylation 
Aurora Kinase has been shown to phosphorylate Xenopus laevis Eg5 (XlEg5) in 
the Stalk region (Giet et al., 1999) at S543 (Cahu et al., 2008). Though it was initially 
suggested that this phosphorylation was essential, when the site was mutated to a non-
phosphorylatable alanine, spindles were normal suggesting the opposite (Cahu et al., 
2008). There is a (putative) Aurora kinase consensus site in HsEg5 (S511) but no studies 
have been done to investigate a potential role in mammalian mitosis. 
 
1.3.4. Kinesin-5 De-Phosphorylation 
Although phosphorylation sites and the kinases involved have been well studied 
in kinesin-5s, less is known about the corresponding phosphatases. Two recent studies 
looked at the phosphatase responsible for removing the phosphate at the HsEg5 Cdk1 tail 
domain consensus site (T926) (He et al., 2016; Liu et al., 2017). The first identified was 
PTEN phosphatase which interacts with HsEg5 in mitosis and regulates its 
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dephosphorylation at T926 (He et al., 2016). Alternately, PP2A is also implicated in 
removing the phosphate from T926, which then removes HsEg5 from the spindle later in 
mitosis (Liu et al., 2017). In either case, cells fail to progress through mitosis when a 
phosphomimic is expressed or when either phosphatase is depleted. Investigators have 
just started looking into phosphatases and their role in kinesin-5 regulation. 
 
1.3.5. Other Post-Translational Modifications 
While the role of phosphorylation in localization and activity of kinesin-5 has 
been well studied, other post-translational modifications are beginning to be explored. Of 
note, a recent study found an acetylation site in the motor domain of Eg5 (L146) (Muretta 
et al., 2018). This site forms a salt bridge with D91 which when disrupted using an 
acetylation mimic (L146Q) results in coupling of the neck-linker with the catalytic 
domain and causes Eg5 to act as a brake. Instead of the short run lengths seen under low 
load (Valentine et al., 2006), the motor becomes dissociation resistant with an increase in 
stalling. In vivo, this modification results in slower spindle pole separation due to this 
braking ability. Further investigations might establish other post-translational 
modifications that also result in changes to the motor behavior. 
1.4 Physiological Roles 
1.4.1. Bipolar Spindle Formation 
As noted in section 1.1, perhaps the most conserved role of kinesin-5 family 
members is to establish spindle bipolarity in early mitosis (Fig. 1.1 D).  Although some 
organisms do not require kinesin-5s for building a bipolar spindle (i.e. C. elegans, 
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Dictyostelium), mitotic spindles fail to form when kinesin-5 is mutated or inhibited across 
most organisms that have been studied (Bishop et al., 2005; Kapoor et al., 2000; Mayer et 
al., 1999; Sawin and Mitchison, 1995; Tikhonenko et al., 2008).  Accumulating evidence 
suggests that regulation of kinesin-5 localization and activity as described above, is 
responsible for this key function. 
For example, although the discovery of minus end directed motility in yeast 
kinesin-5 was surprising at first, several studies suggest that this behavior contributes to 
spindle formation.  Motor accumulation at spindle poles may increase the probability that 
antiparallel microtubules from the opposite pole are captured, initiating sliding and 
generation of the outward forces required for bipolarity (Saunders et al., 1997). Motor 
clustering, like that seen by Cin8 (Bell et al., 2017), at minus ends could also contribute 
to plus-end directed motility, allowing Cin8 to redistribute along the microtubules, 
further indicating that motor directionality and reversal is important for establishing 
bipolarity (Blackwell et al., 2017; Shapira et al., 2017).  
Bi-directional motility has only been described for yeast kinesin-5 motors, but 
kinesin-5 is enriched at spindle poles in other cells (Cheerambathur et al., 2008; Gable et 
al., 2012; Sawin et al., 1992; Sawin and Mitchison, 1995; Uteng et al., 2008) (Chapter 
V). Previous work showed that both X. laevis and Human Eg5 are transported toward 
spindle poles (microtubule minus-ends) in a dynein/dynactin dependent manner (Gable et 
al., 2012; Uteng et al., 2008), although the mechanism is not fully understood. In 
mammalian cells, the microtubule associated protein, TPX2, regulates HsEg5 motor 
stepping and localization to the spindle, and potentially couples Eg5 to dynein/dynactin 
for minus end directed transport (Balchand et al., 2015; Eckerdt et al., 2008; Gable et al., 
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2012; Ma et al., 2011) (Chapter II). A link between Eg5 and dynein/dynactin was 
previously shown (Blangy et al., 1997) and an interaction between Dynein and TPX2 as 
was previously suggested (Gable et al., 2012; Wittmann et al., 1998) but more work is 
needed to establish a relationship and/or mechanism between these oppositely directed 
motors. Recently, it was shown that TPX2 plays a role in localizing HsEg5 to 
centrosomes in prophase (Eibes et al., 2017) via an importin-independent cytoplasmic 
pool of TPX2 that localizes HsEg5 in a Nek6/Nek7 dependent manner (Table 1.1). Thus 
in mammalian cells both transport and interactions with specific binding partners 
contribute to kinesin-5 enrichment toward microtubule minus ends.  Despite differences 
in the mechanism of localization, we speculate that poleward accumulation in prophase 
may serve to initiate microtubule sliding when antiparallel microtubules are encountered 
(Fig. 1.1 D, D’), as in yeast spindles (Blackwell et al., 2017; Shapira et al., 2017). 
   A recent computation model has achieved bipolar spindle formation from an 
initially monopolar configuration, using parameters from fission yeast (Blackwell et al., 
2017). In the model, bidirectional behavior of kinesin-5 motors was required for bipolar 
spindle formation.  Removing minus end motion entirely or including it for only single 
heads bound to a microtubule prevented bipolar spindle formation (Blackwell et al., 
2017).  These results support the idea that motor bidirectionality plays an essential 
physiological role in spindle formation in this organism and potentially highlights the 
need for a mechanism for pole localization/minus-end directed movement during bipolar 
establishment in diverse cells (Fig. 2 A, B). 
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1.4.2. Maintenance of Spindle Bipolarity 
Although much of the work on kinesin-5 has focused on its essential role in 
spindle formation, kinesin-5 is also needed to maintain spindle bipolarity in some 
organisms (Hoyt, 1994; Kapoor et al., 2000; Saunders and Hoyt, 1992; Sharp et al., 
2000b; Sharp et al., 1999b). In vertebrate cells, spindles remain bipolar following 
treatment with Eg5 inhibitors (Cameron et al., 2006; Ferenz et al., 2009b; Kapoor et al., 
2000) due to the action of kinesin-12 (Sturgill et al., 2016; Sturgill and Ohi, 2013; 
Tanenbaum et al., 2009; Vanneste et al., 2009). In cells depleted of kinesin-12, a short 
spindle phenotype is observed, demonstrating that the motor also contributes to outward 
force production. Additionally, overexpression of kinesin-12 (Kif15) can drive spindle 
formation in the absence of kinesin-5, although an alternate pathway for spindle 
formation is used (Sturgill et al., 2016; Sturgill and Ohi, 2013). Interestingly, both 
kinesin-12 and kinesin-5 are regulated by TPX2 suggesting redundancy in motor 
regulation (Balchand et al., 2015; Drechsler et al., 2014; Ma et al., 2011; Mann et al., 
2017; Vanneste et al., 2009) (Chapters II &III). Kinesin-12 has been reported to exist as a 
tetramer, although a dimeric form may also be functional (Drechsler and McAinsh, 2016; 
Drechsler et al., 2014; Mann et al., 2017; Sturgill et al., 2014) (Chapter III). However, 
kinesin-12 tetramers crosslink only parallel microtubules, aligning them into bundles 
(Drechsler and McAinsh, 2016). Consistent with a conserved role for kinesin-12 in 
establishment and maintenance of spindle bipolarity, kinesin-12 contributes to meiotic 
spindle formation in C. elegans by sorting microtubules into an acentrosomal spindle 
(Wolff et al., 2016). 
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1.4.3. Kinesin-5s on Parallel Microtubules 
As noted in section 1.2.1, although kinesin-5s act on antiparallel microtubules, 
they can also crosslink parallel microtubules (Kapitein et al., 2005; Shimamoto et al., 
2015). Recent in vitro experiments showed that Eg5 can crosslink parallel microtubules 
and generate braking forces that scale with motor number and microtubule overlap length 
(Shimamoto et al., 2015). This idea of crosslinking parallel microtubules was also 
suggested to be important for ensuring proper chromosome segregation in budding yeast.  
Cin8 and Kip1 localize to kinetochore microtubules (kMTs) where they cluster the 
kinetochores (Tytell and Sorger, 2006). Cin8 specifically crosslinks these parallel 
microtubules creating bundles that help establish and maintain normal metaphase 
spindles. Though kinesin-5 is enriched at the spindle poles in metaphase, where parallel 
microtubules are located, (Mastronarde et al., 1993; Sharp et al., 1999a) evidence for a 
specific role on these microtubules is lacking. 
 
1.4.4. Kinesin-5s in Anaphase 
Kinesin-5 motors also contribute to spindle elongation in anaphase in a cell type 
specific manner. Anaphase cells are characterized by an array of overlapping antiparallel 
microtubules in the interpolar region between the separating chromosomes (Ding et al., 
1993; Mastronarde et al., 1993; McIntosh and Landis, 1971; Winey et al., 1995) which is 
established by antiparallel crosslinking microtubule associated proteins (i.e. Ase1/PRC1) 
(Scholey et al., 2016). These antiparallel microtubules serve as a scaffold on which 
kinesin-5s can act (Fig. 1.1 E). 
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In some cells, kinesin-5 motors generate the force for spindle elongation. For 
example, in budding yeast, Cin8 and Kip1 drive antiparallel microtubule sliding and the 
contribution of each to anaphase is distinct. Kip1 plays a greater role in later anaphase 
events than Cin8 ultimately allowing the spindle to increase up to 5 times its initial length 
(Straight et al., 1998).  Similarly, in D. melanogaster, KLP61F is required to generate the 
sliding forces for anaphase B and spindle pole separation (Brust-Mascher et al., 2009; 
Scholey et al., 2016).   
In other cells, kinesin-5 activity is dispensable for anaphase B and in some cases 
contributes antagonistic braking forces. In C. elegans, cells lacking the kinesin-5 
homolog, BMK1, show faster elongation than wild type cells (Saunders et al., 2007). This 
is also observed in pig epithelial cells, where acute treatment with kinesin-5 inhibitors at 
anaphase onset results in faster spindle elongation (Collins et al., 2014). Finally, in 
Dictyostelium discoideum, deletion of the kinesin-5 homolog, Kif13, causes premature 
spindle pole separation and more extensive elongation (Tikhonenko et al., 2008). Thus 
kinesin-5 in these systems is thought to act as a frictional brake, limiting the rate and 
extent of spindle elongation (Shimamoto et al., 2015).  
In some spindles, forces external to the midzone generate pulling forces to 
elongate the spindle; in these cases, braking forces may be required to limit the extent of 
elongation (Saunders et al., 2007; Tikhonenko et al., 2008). This is also the case in yeast, 
where the Chromosome Passenger Complex (CPC) causes Kip1 and Cin8 to switch from 
sliding to braking forces on the spindle countering pulling forces from astral microtubules 
(Rozelle et al., 2011). Conversely, astral microtubules are not present or play only a 
minor role in elongation and in these cells, active pushing forces from the midzone may 
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be critical to achieve chromosome segregation (Brust-Mascher et al., 2009; Scholey et al., 
2016).   
Thus, the contribution of kinesin-5 to spindle elongation varies with cell type. 
There are several established roles for kinesin-5s in anaphase; however, in almost all cells 
that have been examined, redundant mechanisms contribute to spindle elongation. This 
redundancy is most evident in anaphase B where different motors, different mechanisms 
and different regulation by maps have been described (reviewed (Scholey et al., 2016)). 
1.5 Future Directions 
Prior work has shown that outward forces generated by kinesin-5 are opposed by 
inward forces generated by minus end directed motors (Saunders et al., 1997; She and 
Yang, 2017). Disrupting the balance of forces by eliminating the activity of Eg5 leads to 
dynein dependent spindle collapse (Ferenz et al., 2009b; Tanenbaum et al., 2008; van 
Heesbeen et al., 2014). Interestingly, when both inward and outward motor dependent 
forces are eliminated, bipolar spindles form (Mitchison et al., 2005; Sharp et al., 1999b). 
Recent work demonstrated that in fission yeast this required the microtubule crosslinker 
Ase1 (PRC1) suggesting that forces from crosslinked and growing microtubules are 
sufficient for bipolar spindle formation in the absence of motors (Rincon et al., 2017). 
However, precisely how the balance of inward and outward forces is achieved is not clear 
in any system.  Recent work, which directly measured force production by multiple 
kinesin-5s, showed that both sliding and braking forces scale with motor number and 
overlap length (Fallesen et al., 2017; Shimamoto et al., 2015). Further investigations are 
required to understand how these parameters are regulated in vivo. 
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Table 1.1 Phosphorylation of Kinesin-5 
 
  
Region Organism Kinesin-5 Kinase Site(s) Function Reference(s) 
Tail 
Homo sapiens Kif11/HsEg5 Cdk1 T926 
Localization to Spindle 
MTs 
 (Blangy et al., 
1997; Blangy et al., 
1995) 
Homo sapiens Kif11/HsEg5 Nek6/Nek7 S1033 
Interaction with TPX2, 
Localization to 
Centrosomes & Motor 
Activity 
 (Bertran et al., 
2011; Eibes et al., 
2017; Rapley et al., 
2008) 
Xenopus laevis XlEg5 Cdk1 T937 
Localization to Spindle 
MTs 
 (Cahu et al., 2008; 
Sawin and 
Mitchison, 1995) 
Drosophila 
melanogaster 
KLP61F Cdk1 T933 
Localization to Spindle 
MTs 
 (Goshima and 
Vale, 2005; Heck et 
al., 1993; Sharp et 
al., 1999a) 
Caenorhabditis 
elegans 
BMK-1 Aurora B 
T921,  
T922 & 
T928 
Localization to Spindle 
MTs 
 (Bishop et al., 
2005) 
Saccharomyces 
cerevisiae 
Cin8 Cdk1 S972 SPB separation defects 
 (Chee and Haase, 
2010) 
Saccharomyces 
cerevisiae 
Kip1 Cdk1 
S1037 & 
T1040 
SPB separation defects 
(Chee and Haase, 
2010)  
Motor 
Homo sapiens Kif11/HsEg5 Src 
Y125, 
Y211,  
Y231 
Phosphorylation results in 
loss of MT gliding, reduced 
ATPase activity, 
monopolar spindles; No 
phosphorylation results in 
disorganized spindles 
 (Bickel et al., 2017) 
Drosophila 
melanogaster 
KLP61F dWee1 
Y23, 
Y152,  
Y207 
Monopolar Spindles 
 (Garcia et al., 
2009) 
Saccharomyces 
cerevisiae 
Cin8 Cdk1 
S277, 
T285,  
S493 
Re-Localization from SPBs 
to Midzone of Anaphase 
Spindle followed by 
detachment 
 (Goldstein et al., 
2017) 
Saccharomyces 
cerevisiae 
Cin8 Cdk1 
S239, 
S247 
Located in Loop 8, 
Localization in anaphase, 
pole-directed movements 
(Avunie-Masala et 
al., 2011; Gerson-
Gurwitz et al., 
2011) 
Saccharomyces 
cerevisiae 
Cin8 Cdk1 S455 
SPB separation defects, 
failure to divide, cell death 
(Avunie-Masala et 
al., 2011; Chee and 
Haase, 2010)  
Saccharomyces 
cerevisiae 
Kip1 Cdk1 S388 
SPB separation defects, 
failure to divide, cell death 
(Chee and Haase, 
2010)  
Stalk Xenopus laevis XlEg5 Aurora A S543 
Direct interaction but 
spindles appear normal 
when not phosphorylated 
 (Cahu et al., 2008; 
Giet et al., 1999) 
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Figure 1.1 Kinesin-5 Localization and where it is acting. (A) Max projected images of 
LLC-Pk1 cells immunostained for Eg5 (green) and MTs (red) through the stages of 
mitosis. (B) Max projected images of live, HeLa cells stably expressing endogenously 
tagged Eg5-EGFP (green) and labeled MTs (SiR Tubulin; magenta). (C) TIRF images of 
Eg5-EGFP accumulating at microtubule plus ends. (D) Schematic of centrosome 
separation in prophase. (D’) Zoom of Eg5 accumulation at spindle poles during prophase; 
transported by Dynein/dynactin to microtubule minus ends at the pole. (E) Schematic of 
anaphase. Scale bars in A and B = 10 μm. Scale bar in C = 1 μm. 
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Figure 1.2 Kinesin-5 Motility and Engagement. Mammalian (A) and yeast spindle (B) 
diagrams. Boxes highlight areas where Kinesin-5 motors are engaged and/or moving 
within each respective spindle. 
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CHAPTER 2 
 
TPX2 INHIBITS EG5 BY INTERACTIONS WITH BOTH MOTOR AND 
MICROTUBULE 
 
This chapter is adapted from Balchand et al. 2015 and was completed with the guidance 
of Patricia Wadsworth in collaboration with Sai K. Balchand, Janel Titus and Jennifer L. 
Ross. JT cloned the TPX2 constructs expressed in Sf9 cells. Microtubule gliding, 
microtubule-microtubule sliding assays, pelleting assays, and Mean Squared 
Displacement (MSD) experiments were performed by SKB. Single-molecule TIRF 
experiments and data analysis were performed in collaboration with SKB and JLR. 
2.1 Introduction 
Accurate chromosome segregation during cell division requires the assembly and 
function of the mitotic spindle.  The spindle is composed of a bipolar array of dynamic 
microtubules that are required for chromosome alignment and segregation.  Mitotic motor 
proteins play important roles in regulating microtubule organization and dynamics and in 
generating the forces required for spindle formation and chromosome motion. Despite the 
characterization of many mitotic motor proteins, how their activity is regulated both 
spatially and temporally in the spindle remains incompletely understood (Walczak and 
Heald, 2008).  
 TPX2 is a conserved mitotic microtubule-associated protein (MAP) that was 
originally identified as a protein required for the dynein-dependent targeting of the 
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Xenopus kinesin Xklp2 to mitotic spindle poles (Wittmann et al., 1998).  In mammalian 
cells, TPX2 localizes to the nucleus in interphase and to the spindle in mitosis with an 
enrichment near spindle poles (Garrett et al., 2002; Gruss et al., 2002).  Depletion of 
TPX2 using siRNA results in short bipolar or multipolar spindles that fail to progress 
through mitosis (Garrett et al., 2002; Gruss et al., 2002). The N-terminus of TPX2 binds 
and activates the mitotic kinase Aurora A, and is required to localize the kinase to spindle 
microtubules (Bayliss et al., 2003; Eyers and Maller, 2004; Kufer et al., 2002). During 
spindle formation, TPX2 is required for microtubule formation near kinetochores, an 
activity that requires GTP bound Ran, which relieves the inhibitory action of importin 
 on TPX2 (Tulu et al., 2006).  In addition, it has been demonstrated that the C-
terminus of TPX2 binds to the bipolar kinesin Eg5 and targets the motor to spindle 
microtubules (Eckerdt et al., 2008; Ma et al., 2010). Expression of TPX2 lacking the C-
terminal 35 amino acids, which contribute to Eg5 binding, results in defective spindles 
with greatly reduced Eg5 on spindle microtubules, unfocussed spindle poles and bent and 
buckled microtubules (Ma et al., 2011).   
 Because Eg5 plays a critical and conserved function in establishing spindle 
bipolarity, it is important to understand how this motor is regulated in the spindle. 
Previous in vitro experiments have shown that purified TPX2 reduces the velocity of 
Eg5-dependent microtubule gliding and microtubule-microtubule dependent sliding (Ma 
et al., 2011).  Eg5 accumulation on microtubules is enhanced in the presence of full 
length TPX2, but less in the presence of TPX2 lacking the Eg5 binding domain (Ma et 
al., 2011).  These results directly demonstrate that TPX2 inhibits the ability of Eg5 to 
translocate microtubules, but the mechanism of inhibition is not established. Here we use 
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in vitro assays and single molecule TIRF microscopy to characterize the interaction of 
TPX2 with microtubules and to examine the behavior of Eg5 in the presence of TPX2.  
Our results demonstrate that TPX2 blocks Eg5 motility by both a direct interaction with 
Eg5 and by binding to microtubules and acting as a roadblock.  Using microtubule 
gliding assays, we further show that dimeric, but not monomeric, Eg5 is differentially 
inhibited by full-length and truncated TPX2.  Our experiments provide new insight into 
the microtubule-associated protein TPX2 and its regulation of the mitotic kinesin Eg5. 
2.2 Results  
2.2.1 TPX2 binding to microtubules  
 To examine the regulation of mammalian Eg5 by TPX2, we expressed and 
purified full-length TPX2 and a truncated version lacking the C-terminal 35 amino acids 
(referred to as TPX2-710) that mediate the interaction with Eg5 (Eckerdt et al., 2008; Ma 
et al., 2011) (Fig. 2.1A).  To characterize the microtubule binding of these proteins, we 
performed microtubule co-sedimentation experiments.  Both full-length TPX2 and TPX2-
710 co-sedimented with microtubules with apparent dissociation constants of 125 and 
240 nM, respectively (Fig. 2.1B,C).  Both full length and truncated TPX2 could be 
released from the microtubule lattice by adding KCl to the buffer, with negligible binding 
at 250 mM KCl.  This demonstrates that, like other microtubule-associated proteins, 
TPX2 makes ionic interactions with the microtubule lattice (Fig. 2.2A).  
 Microtubule-associated proteins are thought to make electrostatic interactions 
specifically with the negatively-charged C-terminal E-hooks of tubulin, named for the 
abundance of glutamic acid residues (Paschal et al., 1989). To determine whether the E-
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hooks are either a requirement for or facilitate TPX2 binding to microtubules, 
polymerized microtubules were digested with the enzyme Subtilisin A to cleave off the 
E-hooks and binding of TPX2 and TPX2-710 to control and digested microtubules was 
measured.  The results show that binding of full length or truncated TPX2 to 
microtubules was not different for untreated, compared to Subtilisin digested, 
microtubules (Fig. 2.2B).  
 To examine the interaction of individual molecules of TPX2 with the microtubule 
we performed single molecule TIRF microscopy of Halo-tagged TPX2 full length and 
TPX2-710.  Individual molecules were stationary on the microtubule lattice and, at the 
concentration examined, no enrichment at either end of the microtubule was observed. 
The average dwell time of full length TPX2-Halo, measured from image sequences 
acquired at 2 s intervals for 15 min, was 60.1 sec (Fig. 2.2C).   The average dwell time of 
Halo tagged TPX2-710 was 46.6 sec and was not statistically different from the Halo 
tagged full length TPX2. 
 Together these results demonstrate that TPX2 binds to the microtubule lattice 
with high affinity, and that the C-terminal 35 amino acids do not contribute significantly 
to this interaction. Additionally, TPX2 does not require the tubulin E-hook for 
microtubule binding, suggesting that other tubulin residues are responsible for the 
interaction. 
2.2.2 Functional Eg5 from mammalian cell extracts  
 We prepared cytoplasmic extracts (Cai et al., 2009) from a mammalian cell line 
stably expressing full length, localization and affinity purification (LAP)-tagged Eg5 
(hereafter Eg5-EGFP) expressed from a bacterial artificial chromosome under control of 
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the native promoter (Cheeseman and Desai, 2005; Gable et al., 2012) (see Methods).  The 
concentration of Eg5-EGFP in the cell extracts was determined using Western blotting; 
values of 20-60 nM were obtained depending on the extract (Fig. 2.3A). The 
concentration of TPX2 in these cytoplasmic extracts was less than ~1 nM, consistent with 
the localization of TPX2 to the nucleus during interphase (data not shown).     
 To analyze Eg5-EGFP motors in cell extracts, the extract was diluted into motility 
buffer (Methods) to achieve a final motor concentration of ~ 1 nM. Diluted extract was 
added to flow chambers containing rhodamine-labeled, taxol-stabilized microtubules 
immobilized to the surface using anti-tubulin antibodies (Methods).  Using TIRF 
microscopy, bright puncta were observed to bind to the microtubules in the absence of 
ATP.  Upon addition of ATP, robust motility of nearly all puncta was observed (Fig. 
2.3B).  We observed an accumulation of motors at one end of most microtubules in the 
field of view (Fig. 2.3B) indicating that motors remain associated with the microtubule 
plus-end after motion.  This is consistent with the previously observed tethering of 
microtubules near the microtubule end in sliding assays using Xenopus Eg5 (see below) 
(Kapitein et al., 2005). At higher motor concentration, microtubules were uniformly 
coated with fluorescence, and individual puncta could not be resolved. The average 
velocity of individual puncta was 14.7 ± 0.9 nm/s, (SEM, N = 205) similar to the velocity 
of purified Xenopus and Drosophila Eg5 motors (Kapitein et al., 2008; Kwok et al., 2006; 
van den Wildenberg et al., 2008) (Fig. 2.3D). The average association time of Eg5 with 
the microtubules was not determined because motors rarely dissociated over the course of 
a 10 min movie and longer movies resulted in photobleaching of individual puncta.  
Finally, motor behavior was not altered following storage in liquid nitrogen for several 
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weeks, so a single extract could be used for multiple experiments, making this a robust 
and versatile method for studying motor behavior (see Discussion). 
 To determine the directionality of motor motion, Kinesin-1-EGFP, a plus-end 
directed motor, was added to the chamber and the direction of motion observed.  Next, 
the chamber was washed with 5 chamber volumes of ATP containing motility buffer, to 
remove the Kinesin-1-EGFP, and Eg5-EGFP was added to the same chamber and motor 
behavior was followed in the same field of view.  In all cases, both Kinesin-1-EGFP and 
Eg5-EGFP moved to the same end of the microtubule (Fig. 2.3C) demonstrating that the 
motile puncta in the mammalian extract walk to the microtubule plus-end. 
 Next, we wished to determine if the Eg5-EGFP motors in the extract were present 
as tetramers.  Because the cells expressing Eg5-EGFP also express endogenous Eg5, the 
motile motors could be composed of between 1 and 4 EGFP molecules. In this cell line, 
the Eg5-EGFP is not resistant to the siRNA designed to deplete endogenous Eg5 (Gable 
et al., 2012). Therefore, to estimate the number of labeled Eg5 motors in the motile 
puncta, we depleted endogenous Eg5 from parental cells co-transfected with siRNA 
resistant Eg5-mEmerald, and prepared cell extracts.  The average fluorescence intensity 
of Eg5-mEmerald puncta was measured and compared with the fluorescence intensity of 
bacterially expressed Kinesin-1-EGFP dimers imaged under identical conditions (Fig. 
2.3E). On average, the Eg5-mEmerald puncta were twice as bright as the Kinesin-1-
EGFP dimers indicating that Eg5 was predominately tetrameric. The increase in quantum 
fluorescence yield of mEmerald alone is not sufficient to explain the nearly two-fold 
increase in fluorescence intensity (Day and Davidson, 2009).  Additionally, the siRNA 
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may not deplete 100% of the endogenous Eg5, which could form tetramers with the Eg5-
mEmerald, resulting in decreased fluorescence of some puncta. 
 To determine if the Eg5-EGFP molecules function as tetramers, we examined the 
ability of Eg5-EGFP from extracts to crosslink two microtubules. To do this we added 
Eg5-EGFP to immobilized microtubules in a flow chamber and then added additional 
microtubules. The added microtubules bound to the immobilized microtubules and were 
translocated upon addition of ATP demonstrating that Eg5-EGFP was capable of 
crosslinking and sliding microtubules (Fig. 2.3F). In addition, the moving microtubule 
remained associated with the tip of the track microtubule, consistent with previous 
observations (Kapitein et al., 2005).  Together, these experiments demonstrate that Eg5-
EGFP from extracts is tetrameric (Fig. 2.3 E,F). 
  Next, we performed size exclusion chromatography on the extracts from LLC-
Pk1 cells. Owing to the low abundance of Eg5-EGFP in our extracts, we used cells 
overexpressing Eg5-mEmerald to aid in the detection. The western blots of the fractions 
obtained show that Eg5-mEmerald elutes around the same fractions as the Eg5-EGFP 
molecules, which are purified from SF9 insect cells, suggesting that the Eg5 molecules 
obtained from cell extracts are tetramers (Fig. 2.3G) 
 To demonstrate that the bright motile puncta derived from the cell extract are Eg5 
molecules, we added S-trityl-L-cysteine (STLC) or 2-[1-(4-fluorophenyl)cyclopropyl]-4-
(pyridin-4-yl)thiazole (FCPT) which specifically inhibit Eg5 (Groen et al., 2008; 
Skoufias et al., 2006b). Each inhibitor completely stopped the motion of motile puncta 
(Fig. 2.3H); in the presence of FCPT, motors remained bound to the microtubule lattice, 
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whereas in the presence of STLC, motors stopped walking and in many cases were 
released from the microtubule (Kwok et al., 2006) (Fig. 2.3H).  
 Eg5 has been shown to exhibit diffusive behavior on microtubules at 
physiological salt concentration (Kwok et al., 2006; Weinger et al., 2011).  To determine 
if mammalian Eg5 present in diluted cell extracts showed similar diffusive behavior, we 
added increasing concentrations of KCl to the motility buffer, and examined motor 
behavior.  At 20 mM KCl, the velocity of Eg5 was 12.1 nm/s, similar to that observed in 
0 mM KCl, and the diffusion coefficient, D, obtained from plots of MSD over time, was 
1588 nm2/s.  At 50 mM KCl, motor velocity dropped to 3 nm/s and the value of D was 
4556 nm2/s (Fig. 2.3I).  These results demonstrate that motor processivity is dependent on 
the ionic conditions, consistent with previous results using Xenopus Eg5 (Kapitein et al., 
2008; Weinger et al., 2011). 
 Together, our results show that Eg5-EGFP motors in mammalian cell extracts 
behave in a manner similar to purified Xenopus and Drosophila Eg5 tetramers. 
Specifically, the velocity, directionality, sensitivity to STLC and FCPT and diffusive 
behavior in higher ionic strength buffer are all consistent with previously reported 
properties of purified Xenopus and Drosophila Kinesin-5 motors. Somewhat surprisingly, 
the behavior of mammalian Eg5 motors has not been previously examined.  Our data 
show that these motors are similar to insect and other vertebrate Eg5 motors and distinct 
from kinesin-5 motors from yeast that show directional switching (Gerson-Gurwitz et al., 
2011; Roostalu et al., 2011).  Importantly, the similar properties of the mammalian 
motors strongly suggests that components that are present in the cell extract do not have a 
major effect on motor behavior.   
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2.2.3 Interactions of TPX2 with the microtubule and with Eg5 both contribute to 
inhibition of motility  
 Previous work demonstrated that the gliding of microtubules by surface attached 
Eg5 dimers is inhibited by TPX2 full length and to a lesser extent by TPX2-710 (Ma et 
al., 2011).  Full length TPX2 also inhibits Eg5 mediated microtubule-microtubule sliding 
(Ma et al., 2011).  In both of these assays, however, the behavior of populations of 
motors is examined, so how individual Eg5 molecules are regulated by TPX2 was not 
revealed.  To gain a better understanding of the mechanism of inhibition of Eg5 by 
TPX2, we performed single molecule experiments.   
 To determine the effect of TPX2 on Eg5 behavior, the cytoplasmic extract 
containing Eg5-EGFP was diluted in motility buffer, added to chambers of immobilized 
microtubules, and motors were imaged.  Next, TPX2 was added to the chamber during 
image acquisition (Fig. 2.4A).  For these experiments, the velocity of motors following 
addition of TPX2 is expressed as a percentage of the velocity prior to addition of TPX2.  
The data show that full-length TPX2 is a potent inhibitor of the velocity of individual 
Eg5 motors: at 250 nM, TPX2 reduced Eg5 velocity by 83% and at 50 nM Eg5 velocity 
was reduced by 32% (Fig. 2.4B). To understand how the interaction of TPX2 with Eg5 
contributes to motor inhibition, we repeated the experiment using TPX2-710.  Addition 
of TPX2-710 also substantially reduced the velocity of Eg5-EGFP indicating that 
microtubule binding by TPX2 contributes to the reduction in motor velocity.  At low 
concentrations (50 nM) both TPX2 and TPX2-710 showed similar inhibition of Eg5 
(32% and 24% respectively. However, at higher concentrations (250 nM) TPX2-710 was 
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a less effective inhibitor of Eg5-EGFP than TPX2 full length (inhibition of 53% and 
83%, respectively) (Fig. 2.4B).   
 The results further show that TPX2 reduces the velocity of Eg5-EGFP motors 
without inducing dissociation of most motors from the microtubule (Fig. 2.4A) consistent 
with the established role of TPX2 in targeting Eg5 to spindle microtubules (Ma et al., 
2011). In the presence of TPX2-710, more motors appeared to dissociate from the 
microtubule, although photobleaching precluded accurate quantification.  In some cases, 
we saw that following addition of TPX2 to the motility chamber, motors from solution 
associated with the microtubule, and these motors also moved with reduced velocity (Fig. 
2.4A).   
 To confirm the specificity of the Eg5-TPX2 interaction, we added full length 
TPX2-Halo covalently tagged with an Alexa 660 ligand to Kinesin-1-EGFP dimers in a 
single molecule assay (Fig. 2.4C).  Consistent with prior results from microtubule gliding 
assays, TPX2 addition did not alter the motility of Kinesin-1-EGFP (11).   
 To visualize the interaction between Eg5 and TPX2 in the single molecule 
experiments, we used TPX2-Halo covalently tagged with an Alexa 660 ligand (Fig. 
2.4D).  In this experiment, addition of TPX2-Halo (at 20 nM) reduced the velocity of 
Eg5-EGFP.  Analysis of kymographs showed that individual motors that encountered 
TPX2-Halo walked at reduced velocity.  In some cases a motor that has reduced velocity 
can resume motion when it encounters an area of the microtubule that is relatively free of 
TPX2 (Fig. 2.4D, right panels).  Note that in this experiment, a lower concentration of 
TPX2 was used because at higher concentration, fluorescent TPX2 coated the entire 
microtubule surface. 
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 We also performed experiments in which 50 nM TPX2 or TPX2-710 was pre-
mixed with the motor in motility buffer before addition to the chamber.  This method 
allows Eg5 and TPX2 to potentially interact, and both molecules are introduced to the 
chamber simultaneously (Fig. 2.4E,F).  This experiment also showed greater inhibition of 
Eg5-EGFP by the full-length compared to the truncated TPX2 (Fig. 2.4E,F).  
Interestingly, pre-mixing full-length TPX2 with Eg5-EGFP resulted in greater inhibition 
than when the same concentration of TPX2 was added to motors pre-bound to 
microtubules (60% vs. 32% inhibition, Fig. 2.4B, F).  This result indicates that when the 
motor and TPX2 bind to the microtubule at the same time, stronger inhibition results.  In 
contrast, when TPX2 is added to motors already bound to microtubules, TPX2 can bind 
to the microtubule at sites distant from the motors, and thus not immediately impact 
motor velocity.  Interestingly, in the case of TPX2-710, inhibition of Eg5-EGFP was 
similar regardless of whether the motors were premixed or added sequentially (Fig. 2.4B, 
F). 
Finally, to exclude the possibility that adding a Halo tag to TPX2 affected the 
TPX2-Eg5 interaction, we compared inhibition of Eg5 by untagged and Halo tagged 
TPX2.  As seen in Fig. 2.4F, inhibition of Eg5-EGFP by TPX2 was not changed by the 
presence of the Halo tag demonstrating that the Halo tag was not detectably affecting 
TPX2-Eg5 interaction (Fig. 2.4F). 
 Together, the results of these experiments demonstrate that Eg5 in cytoplasmic 
extracts is inhibited by TPX2.  Full length TPX2, which can interact with Eg5 and with 
the microtubule, is a more potent inhibitor than TPX2-710, which lacks the Eg5 
 40 
interaction domain.  However, by binding to the microtubule lattice, TPX2-710 also 
substantially reduces the velocity of individual Eg5 puncta.  
 
2.2.4 TPX2 differentially inhibits Microtubule gliding by Eg5 dimers, but not 
monomers 
 To determine how Eg5-EGFP motors are inhibited by TPX2, we performed 
microtubule gliding assays using Eg5 dimers and Eg5 monomers (Methods).  Dimers 
supported microtubule gliding at an average rate of ~20 nm/s.  The velocity of gliding 
was reduced to ~6 nm/s by 250 nM full length TPX2; addition of the same concentration 
of TPX2-710 reduced the velocity of gliding to ~15 nm/s, demonstrating that TPX2-710 
was a less effective inhibitor than the full length protein (Fig. 2.5A).  This result 
demonstrates that dimeric Eg5 retains the ability to interact with TPX2, consistent with 
previous in vitro binding assays (Ma et al., 2011).  In contrast, the velocity of 
microtubule gliding driven by monomeric Eg5 was inhibited to a similar extent by either 
full length or truncated TPX2 (Fig. 2.5B).  It should be noted that the velocity of 
microtubule gliding driven by monomeric Eg5 is approximately half the rate of the 
dimeric construct, presumably due to the uncoordinated action of monomers.  Further, 
our results also show that monomer-driven microtubule gliding is inhibited at lower 
concentrations of TPX2 or TPX2-710 (Fig. 2.5B).  For example, addition of 25 nM TPX2 
or TPX2-710 nearly completely halted microtubule gliding by monomeric Eg5 whereas a 
20-fold greater concentration of TPX2 is required to result in a similar reduction in the 
velocity of microtubule gliding by Eg5 dimers.  The reason for this increased sensitivity 
is not known, but may relate to the presence of a single motor head.  These results 
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suggest that the stalk region in the dimeric construct, or the dimer conformation, is 
required for differential inhibition by TPX2 and TPX2-710. 
2.3 Discussion  
2.3.1 TPX2 binding to microtubules  
 The results of our experiments provide insight into the interaction of TPX2 with 
the microtubule lattice.  Our data show that TPX2 and TPX2-710 bind with relatively 
high apparent affinity to microtubules; these results are similar to the previously reported 
KD of 0.5 M for full length Xenopus TPX2 (Wittmann et al., 2000). The similar binding 
of TPX2 and TPX2-710 suggests that the C-terminal region is not a major contributor to 
microtubule binding, and instead interacts with the motor.  The apparent affinity of TPX2 
for microtubules is similar to other MAPs, including the dynein regulator, She1, MAP2 
and Cep170 (Illenberger et al., 1996; Markus et al., 2012; Welburn and Cheeseman, 
2012).  The relatively strong interaction of TPX2 with the microtubule lattice is also 
reflected in the long dwell time measured for individual TPX2 puncta using microscopy 
(~60 s).  Our experiments did not reveal a diffusive component to TPX2 behavior under 
the conditions used.  Under physiological ionic conditions, however, we expect that 
TPX2 would bind less strongly to the microtubule lattice and could exhibit 1-D diffusive 
behavior that is characteristic of many MAPs. 
  Somewhat surprisingly, our results show that the C-terminal tails of tubulin, the 
E-hooks, do not contribute to TPX2 interaction with the microtubule.  Other MAPs, 
including Tau, She1, and XMAP215 require the tubulin E-hooks for microtubule binding 
(Brouhard et al., 2008; Hinrichs et al., 2012; Markus et al., 2012).   Additionally, the 
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processivity of Kinesin-1 and dynein motors, and the diffusive end targeting of MCAK, 
are enhanced by the E-hooks (Helenius et al., 2006; Thorn et al., 2000; Wang and Sheetz, 
2000).  The observation that the interaction of TPX2 with microtubules does not require 
the E-hooks indicates that TPX2 binds to tubulin residues that are located between 
protofilaments, as opposed to along the ridge where the E-hooks are located.  This is 
consistent with the observation that TPX2 does not inhibit single molecule motion of 
Kinesin-1-EGFP dimers on microtubules (Fig. 2.4C) and previous work demonstrating 
that TPX2 does not inhibit Kinesin-1 in a gliding assay (Ma et al., 2011).  In contrast, 
Tau, which binds along the outer ridge and requires the E-hook for lattice diffusion 
(Hinrichs et al., 2012), induces the release of kinesin motors, including both Kinesin-1 
and Eg5, from the microtubule.  This suggests that the location of MAP binding to the 
microtubule lattice results in differential effects on motor behavior (e.g. inhibition of 
motility vs. release) (Ma et al., 2011). 
 The high affinity interaction of TPX2 with microtubules is consistent with its 
established role in promoting microtubule assembly near kinetochores (Tulu et al., 2006) 
and branched microtubules in the spindle (Petry et al., 2013). However, the interaction of 
TPX2 with microtubules in cells is dynamic, as evidenced by its poleward motion in the 
spindle (Ma et al., 2010). One possibility that can account for these differences is that 
modifications, such as phosphorylation, or interactions with other binding partners, such 
as dynein, regulate TPX2 dynamic behavior in cells. 
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2.3.2 Functional Eg5 from mammalian cell extracts  
 Previous work showed that the behavior of motors present in extracts of cultured 
mammalian or budding yeast cells is comparable to the behavior of the purified motor 
(Cai et al., 2007; Gerson-Gurwitz et al., 2011).  We found that the rate of Eg5-EGFP 
stepping along the microtubule was ~14 nm/s in the plus-end direction, which is similar 
to the values obtained for purified Xenopus or Drosophila Eg5. To our knowledge, our 
results are the first report of single molecule data on the behavior of Eg5-EGFP tetramers 
from a mammalian source, although the behavior of human Eg5 dimers has been 
previously measured (Valentine et al., 2006). Mammalian Eg5-EGFP showed exclusively 
plus-end directed motion at low salt and diffusive behavior at higher salt concentrations.  
At the highest salt concentration that we examined, no processive minus-end directed 
motion was detected, indicating that mammalian Eg5 does not show directional switching 
like the yeast homolog, Cin8 (Gerson-Gurwitz et al., 2011; Roostalu et al., 2011).  
  There are several potential advantages to using motors present in mammalian 
extracts for biophysical experiments.  For example, the contribution of specific domains 
or potential phosphorylation sites can be determined using extracts prepared from cells 
transfected with fluorescent constructs encoding mutant versions of the protein of 
interest.  Similarly, to eliminate binding partners, or accessory subunits implicated in 
motor regulation or function, cells can be treated with siRNA prior to preparation of the 
extract.  In addition, cells can be arrested at particular stages of the cell cycle prior to 
preparation of the extract to determine how cell cycle-dependent modifications may 
impact motor function.  Finally, the ease of preparation and robust motile behavior 
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demonstrate that biophysical measurements of motors from cell extracts is a powerful 
tool for future experiments.   
 
2.3.3 TPX2 inhibits Eg5 by interactions with both the motor and microtubule  
 The single molecule data presented here demonstrate that TPX2 has two modes of 
inhibition for Eg5.  Truncated TPX2 that cannot interact directly with Eg5, still bound to 
the microtubule lattice and substantially reduced the velocity of Eg5.  Full-length TPX2, 
which binds to both the microtubule and the motor, was an even more potent inhibitor of 
Eg5.  These results show that both binding to the microtubule and to Eg5 contribute to 
inhibition of the motor.   
 Our work is consistent with previous work demonstrating that MAPs can regulate 
motor behavior.  For example, Tau results in differential regulation of Kinesin-1 and 
dynein; upon encountering a Tau patch, Kinesin-1 motors frequently detach from the 
microtubule, whereas dynein motors are likely to reverse direction or pause (Dixit et al., 
2008).  However, a direct interaction of either Kinesin-1 or dynein with Tau has not been 
reported.  Other MAPs function to target motors to microtubules.  For example, Cep170, 
is important for targeting the kinesin-13, Kif2b, to the spindle (Welburn and Cheeseman, 
2012) and the yeast microtubule associated protein She-1 prolongs the attachment of 
dynein to the microtubule in a stalled state in addition to inhibiting dynein motility 
(Markus et al., 2012).  In contrast, the MAP ensconsin recruits and activates Kinesin-1 
(Sung et al., 2008) independent of microtubule binding by ensconsin (Barlan et al., 2013).   
 Recent in vitro experiments show that TPX2 inhibits the stepping behavior of the 
kinesin-12, Kif15, the human homolog of Xklp2 (Drechsler et al., 2014).  TPX2 enhances 
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the binding of Kif15 to microtubules in pelleting assays and increases motor binding to 
the microtubule under load in optical trapping experiments (Drechsler et al., 2014).  
Purified Eg5 has been shown to detach from the microtubule before stalling (Korneev et 
al., 2007), suggesting that TPX2 may function to increase Eg5 binding to the microtubule 
under load, as is the case for Kif15.  In mitotic cells, Eg5 and Kif15 act redundantly to 
establish and maintain spindle bipolarity.  Furthermore, minus-end directed forces 
generated by cytoplasmic dynein antagonize force generated by these plus-end directed 
motors. Though TPX2 slows Eg5 and Kif15 motion on microtubules, by increasing the 
force generating capacity of these motors, it may play a key role in regulating forces 
needed for spindle bipolarity. 
   
2.3.4 Model for Regulation of Eg5 by TPX2 
 The data presented here are consistent with the following model for the regulation 
of Eg5 by TPX2 (Fig. 2.5C):  Eg5 motors step along the microtubule protofilament and 
encounter TPX2, resulting in reduced velocity without inducing motor detachment from 
the microtubule.  Our data showing that TPX2 does not require the E-hooks for 
microtubule binding suggest that TPX2 and Eg5 do not compete with each other for 
microtubule binding.  The differential slowing of the motor by full length and truncated 
TPX2 demonstrates that binding of TPX2-710 to the microtubule is sufficient to reduce 
motor velocity but that the C-terminus of TPX2, which interacts with Eg5, results in 
stronger inhibition (Fig. 2.5C).  This suggests that TPX2-710 acts as a slowing agent, 
reducing velocity when encountered by Eg5 motors.  Additionally, our data suggest that 
the C-terminal domain may contribute to the retention of the motor on the microtubule 
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(Ma et al., 2011).  Although our experiments, and those of others (Drechsler et al., 2014), 
clearly demonstrate that TPX2 greatly reduces motor stepping on the microtubule, the 
TPX2-motor interaction must be regulated in live cells so that the motor can generate 
sliding forces to establish and maintain spindle bipolarity.  Discovering precisely how 
this MAP-motor interaction is regulated spatially and temporally will provide important 
insight into spindle function in vivo.   
2.4 Materials and Methods 
2.4.1 Materials 
 All chemicals, unless otherwise specified, were purchased from Sigma-Aldrich. 
 
2.4.2 Cell culture 
LLC-Pk1 cells were cultured in a 1:1 mixture of F10 Hams and Opti-MEM (Life 
Technologies, Grand Island, N.Y.) containing 7.5% fetal bovine serum and antibiotics at 
1X and 5% CO2. Cell extracts were made from LLC-Pk1 cells stably expressing LAP-
tagged Eg5 from a bacterial artificial chromosome (Gable et al., 2012). To prepare the 
extract, a confluent 100 mm diameter cell culture dish was washed twice with 5 ml of 
room temperature PBS. Then, 300 μl of extraction buffer containing 40 mM 
HEPES/KOH pH 7.6, 100 mM NaCl, 1 mM EDTA, 1 mM PMSF, 10 μg/ml Leupeptin, 1 
mg/ml pepstatin, 0.5% Triton X 100 and 1 mM ATP (Cai et al., 2007) was added 
dropwise to the dish and incubated for approximately 2 min, without disrupting the 
monolayer. The cell extract was transferred to a microcentrifuge tube and centrifuged at 
14,500 RPM at 4°C for 10 min in a tabletop centrifuge. The supernatant was recovered 
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and aliquoted into small tubes, flash frozen and stored in liquid nitrogen. Protein 
concentration was determined using the method of Lowry (Lowry et al., 1951). For 
fluorescent intensity measurement experiments with Eg5-mEmerald, an siRNA resistant 
Eg5-mEmerald construct was transiently co-transfected into LLC-Pk1 cells with siRNA 
directed against endogenous Eg5 (target sequence CUGAAGACCUGAAGACAAU). 
The extract was made 48 hours post transfection as described. For the extracts used in 
size exclusion chromatography, siRNA treatment against endogenous Eg5 was omitted. 
 
2.4.3 Construction of plasmids 
For bacterial expression, desired nucleotide sequences of human TPX2 constructs 
(full length or truncated at amino acid 710) were cloned into a pGEX vector following an 
N-terminal GST tag and a ULP1 protease cleavage site (Markus et al., 2012). At the C-
terminus of TPX2, the stop codon was removed and the Halo tag sequence was 
introduced. Constructs were verified by sequencing.  For expression in SF9 insect cells, 
nucleotides coding for full length or the first 710 amino acids of human TPX2 were 
cloned into the pFast Bac A vector after an N terminal 6X His tag and the constructs were 
verified by sequencing.  The virus for infecting the cells was obtained following the Bac-
to-Bac protocol (Invitrogen, Grand Island, NY).  The plasmid for monomeric Eg5-367 
containing the first 367 amino acids of human Eg5 was a kind gift from the laboratory of 
Dr. Sarah Rice. The plasmid for the expression of dimeric Eg5-513 containing the first 
513 amino acids of Eg5 was the kind gift from the laboratory of Dr. Susan Gilbert.  
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2.4.4 Protein purification 
Full length TPX2 and TPX2-710 were expressed and purified from Sf9 cells using 
the Bac-to-Bac expression system (Invitrogen, Grand Island, NY). Infected cells were 
harvested, washed with ice-cold water and resuspended in lysis buffer (50 mM potassium 
phosphate pH 8, 250 mM KCl, 40 mM imidazole, 1% NP-40, 10 mM beta 
mercaptoethanol, and a protease inhibitor tablet (Roche, Indianapolis, IN) on ice. The 
lysate was spun at 125,000 x g for 45 min at 4°C. The supernatant was loaded onto pre-
equilibrated Ni NTA agarose beads (Qiagen, Valencia, CA) and incubated for 90 min at 
4°C with end-over-end shaking. The flow through was removed and beads were washed 
with wash buffer (same as lysis buffer with 10% glycerol and 0.01% NP-40). The protein 
was eluted with elution buffer (50 mM potassium phosphate pH 7, 150 mM KCl, 250 
mM imidazole, 10% Glycerol, 10 mM beta mercaptoethanol, and 0.01% NP-40) and 
dialyzed in a buffer containing 25 mM HEPES, pH 7.6, 10 mM KCl, 2 mM MgCl2, 10% 
Glycerol, 0.01% NP-40 and 1 mM DTT for 4 hours at 4°C. Aliquots were flash frozen in 
liquid nitrogen and stored at -80°C. 
Full length TPX2-Halo and TPX2-710-Halo were expressed and purified from 
E.coli Rosetta DE3 pLysS cells. In short, 500 ml of culture was grown to an optical 
density of 0.5-0.8, induced with 0.1 mM IPTG at 18°C for 16 hours.  The bacteria were 
harvested and washed with ice-cold distilled water. The cell pellet was resuspended in 2X 
lysis buffer (60 mM HEPES pH 7.4, 0.4 mM EGTA, 2 mM DTT, 1.4 μg/ml pepstatin, 1.0 
mM Pefabloc, 4 μg/ml leupeptin, and 2 μg/ml Aprotinin), diluted to 1X with cold dH2O, 
sonicated on ice (3X 30 s at maximum setting), and clarified at 15,000 x g for 20 min at 
4°C. The supernatant was incubated for 1 hour at 4°C with Glutathione sepharose beads 
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that were pre-equilibrated in lysis buffer.  The beads were then washed 3X in wash buffer 
(10% glycerol, 300 mM KCl, 0.1% Triton X-100, 1 mM DTT, 0.7 μg/ml pepstatin and 
0.5 mM Pefabloc) and twice in TEV buffer (5 mM Tris pH 8.0, 150 mM KCl, 10% 
glycerol, 0.1% Triton X-100, 1 mM DTT and 0.5 mM Pefabloc). The beads were 
resuspended in TEV buffer and incubated with 23 μM Halo tag Alexa fluor 660 
(Promega, Madison, WI) for 15-20 min at room temperature and then washed to remove 
unbound ligand. The beads were then resuspended in TEV buffer containing Ulp1 
protease and incubated at 16°C for 1 hr to cleave protein off the beads.  The supernatant 
containing the protein was collected by centrifugation and aliquots were flash frozen and 
stored in liquid nitrogen. 
Monomeric Eg5-367 was purified from E.coli as described in (Larson et al., 
2010). Briefly, 500 ml of bacteria was grown and induced at an OD of 0.5-0.8 with 0.1 
mM IPTG and incubated at 16°C for 16 hours. The bacteria were pelleted and washed 
with ice-cold water. The pellet was resuspended in lysis buffer (10 mM sodium 
phosphate buffer pH 7.2, 20 mM NaCl, 2 mM MgCl2, 1 mM EGTA, 1 mM DTT, and 0.1 
mM ATP with protease inhibitor tablet) and lysed by sonication. The lysate was clarified 
by centrifuging at 15,000 x g for 30 min at 4°C. The supernatant was incubated with pre-
equilibrated Ni NTA agarose beads for 90 min at 4°C. The beads were then washed in 
wash buffer (same as lysis buffer containing 20 mM imidazole) and eluted in elution 
buffer (same as lysis buffer with 300 mM imidazole). The eluate was then dialyzed 
against buffer containing 20 mM HEPES pH 7.2, 5 mM magnesium acetate, 0.1 mM 
EDTA, 0.1mM EGTA, 50 mM potassium acetate, 1 mM DTT, and 5% sucrose for 4 
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hours at 4°C. Aliquots were flash frozen in liquid nitrogen and stored at -80°C. Dimeric 
Eg5-513 was expressed and purified from E.coli exactly as described (Ma et al., 2011).   
 
2.4.5 TPX2 co-sedimentation with microtubules  
Unlabeled tubulin prepared from porcine brains (Hyman et al., 1991b) was 
polymerized and resuspended in PEM 100 buffer containing 50 μM Taxol. 500 nM full 
length TPX2 or TPX2-710 was incubated with indicated concentration of unlabeled 
polymerized microtubules at room temperature for 10 min. The mixture was centrifuged 
for 10 min at room temperature in a tabletop centrifuge at maximum speed. The 
supernatant and pellet fractions were carefully separated. Samples for SDS 
electrophoresis were prepared by boiling the samples with SDS protein sample buffer and 
run on an 8% polyacrylamide gel. The proteins were then transferred to a PVDF 
membrane and probed using antibodies against TPX2 (Novus Biologicals, Littleton, CO) 
and tubulin (DM1A, Sigma-Aldrich). The blots were developed by chemiluminescence 
and captured on a Biorad (Hercules, CA) imaging station.  Analysis of band intensities 
were performed using ImageJ.  Data were plotted using KaleidaGraph and fit with a 
quadratic equation (Markus et al., 2012). Subtilisin A treated microtubules were prepared 
as described (Markus et al., 2012).  
 
2.4.6 TPX2-Halo Microtubule Binding Assays 
 For TPX2-Halo binding experiments, first 10 μL of 10% Rat YL ½ (0.1 mg/ml) 
anti-tubulin antibody (Accurate Chemical, Westbury, N.Y.) was added to the flow 
chamber and incubated for 2 min.  Second, 0.1 mg/ml Rhodamine-microtubules 
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(untreated or treated with Subtilisin A) were flowed in and incubated for 2 min.  Third, 
the surface was blocked by adding 5 % Pluronic F-127 and incubated for 2 min.  For 
assays done in epifluorescence, the chamber was incubated with the indicated 
concentration of TPX2-Halo for 2 min in PEM 100, [100 mM K-Pipes, pH 6.8, 2 mM 
MgSO4, and 2 mM EGTA] plus 0.5% Pluronic F-127, 50 μM taxol, 5 mM DTT, 15 
mg/ml glucose, 1.23 mg/ml glucose oxidase and 0.375 mg/ml catalase).  Salt (KCl) from 
a 10 X stock of the working concentration was added directly to the buffer.  Wide field 
images were acquired with a constant exposure time. To measure dwell times of TPX2-
Halo and TPX2-710-Halo, experiments were performed using TIRF microscopy. 
 
2.4.7 Eg5 single molecule experiments 
The concentrations of Eg5 in the extracts were measured by quantitative Western 
blots. For the single molecule experiments, the perfusion chambers were made from glass 
slides, silanized coverslips and double stick tape. 10 μL of 10% Rat YL ½ anti-tubulin 
antibody (Accurate Chemical, Westbury, N.Y.) was flowed into the chamber and 
incubated for 3 min. Then, the chamber was blocked by flowing in 5% Pluronic F127 for 
3 min. Diluted Cy5 labeled microtubules (composed of a mixture of Cy5 tubulin 
(Cytoskeleton, Inc, Denver, CO) and unlabeled brain tubulin) were flowed into the 
chamber and incubated for 3 min followed by a second block of 5% pluronic F127. Eg5 
was diluted to 1 or 1.5 nM in motility buffer containing PEM 50 (50 mM Pipes pH 6.9, 2 
mM EGTA, 2 mM MgSO4), 0.5% F127, 5 mM ATP, 1 mM DTT, 25 μM Taxol 
supplemented with oxygen scavenging system (15 mg/ml glucose, 1.23 mg/ml glucose 
oxidase and 0.375 mg/ml catalase) and flowed into the chamber and imaged. For pre-
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incubation experiments with TPX2, the indicated concentrations of TPX2 were added to 
the motility buffer along with Eg5 in extract and incubated on ice for 2 min before 
flowing into the chamber. 
 
2.4.8 Kinesin-1 single molecule experiments 
Perfusion chambers were made as described above. 10 μL of 10% Rat YL ½ anti-
tubulin antibody, 5% pluronic F127, and diluted Cy5 labeled microtubules were added 
sequentially and incubated for 5 min each. The chamber was washed with PEM 100 plus 
Taxol. Kinesin-1 was diluted in PEM 100 with 10 mM DTT. This was then added to the 
motility buffer (PEM100, 25 μM Taxol, 0.5% F127, 0.5 mg/mL BSA, oxygen scavenging 
system, and 0.5 mM ATP) and flowed into the chamber and imaged. For experiments 
with TPX2 addition, TPX2-Halo was diluted into the motility buffer (without Kinesin-1) 
and flowed into the chamber during image acquisition. 
 
2.4.9 Microtubule-microtubule gliding assays 
Biotinylated, Cy5 labelled microtubules were immobilized on silanized coverslips 
using anti-Biotin antibody (Sigma-Aldrich). The chamber was blocked using 5% F127. 
Eg5-EGFP from extracts was preincubated with rhodamine labelled microtubules for 3 
min and the mixture was flowed into the chamber. Finally, motility buffer was added 
followed by acquisition on a TIRF microscope. 
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2.4.10 Size Exclusion Chromatography 
 Eg5-EGFP was purified from SF9 insect cells as per manufacturer’s instructions 
(Bac to Bac, Invitrogen, Grand Island, NY). The extract from LLC-Pk1 cells was 
prepared as mentioned before. The Superose 6 10/300 GL column (GE Healthcare, 
Pittsburgh, PA) was pre equilibrated with 10mM HEPES, pH7.6, 0.05% triton X100, 
100mM NaCl, 1mM ATP before use. 100μL of the purified protein was loaded onto the 
column and run at a constant flow rate of 0.2ml/min. The Elution profile of Eg5-EGFP 
was directly followed by measuring absorbance at 488nm. For the size exclusion of LLC-
Pk1 cell extracts, 175μL of cell extract was loaded on the column and run under identical 
conditions. The collected fractions were separated by SDS PAGE, transferred to a PVDF 
membrane and were probed for the presence of Eg5 using western blot.   
 
2.4.11 Microtubule surface gliding assays 
Perfusion chambers of approximately 10 μL volume were made using glass slides 
and coverslips with a double stick tape spacer.  For gliding assays with the Eg5-367 
monomer, the chamber was incubated with anti-His antibody and 2 mg/ml BSA for 3 min 
followed by two washes with motility buffer (80 mM PIPES pH 6.8, 2 mM MgCl2, 1 
mM EGTA, 0.2 mg/ml BSA, and 150 mM sucrose). Then, the chamber was incubated 
with Eg5-367 for 3 min and washed again with motility buffer. Finally, the activation 
mix, consisting of motility buffer containing oxygen scavenging system, ATP, Taxol and 
diluted Cy5 labeled microtubules was added and imaged on a Nikon TiE microscope 
using epifluorescence. Surface gliding experiments with the dimeric Eg5-513 were 
performed exactly as described in Ma et al (2011). For TPX2 addition experiments, the 
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TPX2 constructs were added to the activation mix, incubated for 2 min on ice and the 
flowed into the chamber. 
 
2.4.12 Microscope Imaging and Analysis 
 TIRF microscopy was performed using a microscope (Ti-E; Nikon Instruments, 
Melville, N.Y.) equipped with a 60X 1.4 NA objective lens.  The system was run by 
Elements software (Nikon Instruments, Melville, N.Y.).  Images were acquired using a 
512 x 512–pixel camera (Cascade II; Photometrics, Tuscon, AZ).  A 4X image expansion 
telescope in front of the camera was used.  The micron-to-pixel ratio was 68.5 nm/px.  A 
blue diode laser (488 nm, 50 mW) was used. Images were acquired every 2 or 3 seconds 
for 10 min.  For two color TIRF, a 488 nm argon laser and a 647 nm diode laser were 
used on a custom built TIRF system on a Nikon TiE stand, run by Elements software.  A 
60X objective lens was used; exposure times for both red and green illumination were 50-
100 ms. Wide field Imaging for Eg5-513 gliding assays, and for binding of TPX2-Halo to 
microtubules, was performed using epifluorescence illumination.   
 
2.4.13 Quantification of gliding velocity, single molecule velocity and MSD 
 The velocity of Eg5-513- and Eg5-367-dependent microtubule gliding movement 
was calculated using the MTrackJ plugin in ImageJ.  To calculate the velocity of Eg5-
EGFP single molecules from TIRF images, ImageJ was used to generate a kymograph of 
moving molecules.  Velocities were calculated by manually tracking individual puncta. 
The data were ported to excel and a polynomial 2 trendline was added to the MSD vs 
time plot to determine D.  
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Figure 2.1 Binding of TPX2 and TPX2-710 to microtubules.  (A) Schematic diagram 
of the TPX2 constructs (left) and Commassie Brilliant Blue stained gel of the purified 
proteins (right).  (B) Co-sedimentation of TPX2 with microtubules; S-supernatant; P-
pellet.  Concentration of microtubules in each pair of lanes is noted above. Western blots 
stained for TPX2 or tubulin. (C) Quantification of apparent affinity was performed using 
a quadratic fit. Experiment was performed twice and the values averaged; Error Bars =  
standard deviation. 
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Figure 2.2 Binding Dynamics of TPX2 and TPX2-710.  (A) Box plot showing release 
of TPX2 and TPX2-710 from microtubules in the presence of the indicated concentration 
of KCl added to the buffer. TPX2 fluorescence reported as AU = arbitrary units. 
Whiskers define the range, boxes encompass 25th to 75th quartiles, lines depict the 
medians.  (B) TPX2 and TPX2-710 binding to untreated and Subtilisin A digested 
microtubules; (upper panels) fluorescence images of TPX2-Halo or TPX2-710-Halo 
bound to untreated and Subtilisin A digested microtubules; (middle) quantification of 
TPX2 fluorescence; (lower) polyacrylamide gel showing digested and control 
microtubules.  TPX2 fluorescence measured for at least 60 microtubules for each of two 
independent experiments; error bars = SD. (C) Kymograph of TPX2-Halo and TPX2-
710-Halo on microtubules. Vertical scale (time) is 60 s; horizontal scale bar is 2 μm. 
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Figure 2.3 Characterization of Eg5 in mammalian cell extracts. (A) Western blot of 
cell extract and purified Eg5. (B) Schematic diagram of the single molecule TIRF 
experiments (left) and TIRF images of Eg5-EGFP accumulating at the microtubule plus-
end (right). (C) Kymographs of Kinesin-1 EGFP dimers and Eg5-EGFP from extracts on 
the same microtubule. Note the different time scale. Plus and minus ends of the 
microtubules are indicated. (D) Histogram of Eg5-EGFP motor velocity. (E) Histogram 
of the fluorescence of Kinesin-1 dimers (light gray) and Eg5 molecules (dark gray) in the 
extract.  (F) Schematic diagram (left) and fluorescence images (right) showing 
microtubule-microtubule sliding by Eg5. Arrowhead marks the end of the sliding 
microtubule.  (G) Coomassie Brilliant Blue stained gel of Eg5-EGFP purified from insect 
cells and the trace of absorbance at 488nm on the size exclusion column for the purified 
protein. The western blot shown is for the fractions obtained from size exclusion 
chromatography of Eg5-mEmerald from LLC-Pk1 extract probed for Eg5.  (H) 
Quantification of the velocity of Eg5-EGFP after addition of DMSO, STLC or FCPT 
(right). Error bars = SEM. (I) Directional and diffusive motility of Eg5-EGFP in the 
presence of 0, 20 or 50 mM KCl added to the motility buffer.  Kymographs (upper) and 
mean squared displacement (lower).  Horizontal scale bar in B, C, F, I is 1 μm; vertical 
scale bar in I is 60 s. Vertical scale in C is provided on the image. 
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Figure 2.4 Inhibition of Eg5 by TPX2 requires both binding to the microtubule and 
an interaction between TPX2 and Eg5.  (A) Kymographs of Eg5-EGFP before and 
following addition of TPX2 or TPX2-710; arrowhead marks time of TPX2 addition. (B) 
Quantification of Eg5-EGFP velocity; error bars = SD. (C) Kymograph of Kinesin-1 
EGFP dimers walking on microtubules before and after addition of TPX2 (arrowhead). 1 
nM Kinesin-1 EGFP (green) and 500 nM TPX2-Halo (red) were used. (D) Kymographs 
of Eg5-EGFP (green) before and following addition of 20 nM TPX2-Halo (red). Right 
panels show enlarged view.  (E) Kymographs of Eg5-EGFP that was pre-mixed with 
TPX2-Halo or TPX2-710-Halo. (F) Quantification of Eg5-EGFP velocity in the presence 
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of 50 nM TPX2 that was Halo tagged (left) or untagged (right).  Error bars = SEM. 
Horizontal scale bars in A, C, E are 1 μm; horizontal scale bar in D is 2 μm; vertical scale 
bar in A,D,E is 60 s and is 5 s in C. 
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Figure 2.5 Differential regulation of Eg5 dimers, but not monomers, by full length 
and truncated TPX2.  Velocity of microtubule gliding driven by (A) Eg5 dimers or (B) 
Eg5 monomers.  Error bars show SEM.  (C). Model for inhibition of Eg5 by TPX2.  Top 
shows inhibition of motor stepping by full length (left, stop symbol) and truncated TPX2 
(right, slow symbol) in single molecule assays.  Lower panels show inhibition of 
microtubule gliding by Eg5 dimers (top) and Eg5 monomers (bottom).  Eg5 - green; 
TPX2 - orange. 
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CHAPTER 3 
 
REGULATION OF KIF15 LOCALIZATION AND MOTILITY BY THE C-
TERMINUS OF TPX2 AND MICROTUBULE DYNAMICS 
 
This chapter is adapted from Mann et al. 2017 and was completed with the 
guidance of Patricia Wadsworth and in collaboration with Sai K. Balchand. PW 
generated the GFP-Kif15 LLC-Pk1 cell line used for live cell experiments and extracts 
for single-molecule TIRF microscopy. Live cell imaging and analysis were performed in 
collaboration with SKB and PW. 
3.1 Introduction 
During mitosis, microtubules are nucleated and organized into a dynamic 
structure called the mitotic spindle, which mediates chromosome segregation into two 
daughter cells.  In mammalian cells, microtubule nucleation at centrosomes, near 
chromatin and from pre-existing microtubules all contribute to spindle formation 
(Meunier and Vernos, 2016). Microtubule formation near chromatin and at kinetochores 
is regulated by nuclear localization sequence containing spindle assembly factors that are 
inactive when bound to importins α/β (Gruss and Vernos, 2004). The small GTPase 
Ran, which is locally activated near chromatin (Kalab et al., 2006), binds to importin β 
and relieves this inhibitory effect, thus promoting microtubule formation.  A well-studied 
Ran-regulated spindle assembly factor is TPX2, which stimulates microtubule formation 
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at kinetochores and in the chromatin region and is required for spindle assembly and 
completion of mitosis (O'Connell et al., 2009; Tulu et al., 2006).     
  During spindle formation the duplicated centrosomes separate to establish spindle 
bipolarity.  Centrosome separation is driven by the Kinesin-5, Eg5, a bipolar, tetrameric 
motor which crosslinks and slides antiparallel microtubules (Ferenz et al., 2010; Kapitein 
et al., 2005).  More recently it has been shown that following bipolar spindle formation 
the action of Eg5 is dispensable and spindle bipolarity is maintained by a Kinesin-12, 
Kif15 (Tanenbaum et al., 2009; Vanneste et al., 2009).  Spindles in cells depleted of 
Kif15 are shorter than spindles in control cells, consistent with a model in which Kif15, 
like Eg5, generates outward force in the spindle (Sturgill and Ohi, 2013).  However, in 
contrast to Eg5, Kif15 preferentially associates with kinetochore fiber microtubules.  
Cells overexpressing Kif15 can form a bipolar spindle in the absence of Eg5 activity 
(Raaijmakers et al., 2012; Sturgill and Ohi, 2013; Tanenbaum et al., 2009). The existence 
of two mitotic motors that can each power bipolar spindle formation may contribute to 
the lack of efficacy of Eg5 inhibitors in clinical trials and understanding how these 
motors are regulated may therefore be of clinical significance (Waitzman and Rice, 
2014). 
Localization of Kinesin-12 and Kinesin-5 motors to spindle microtubules requires 
TPX2 (Ma et al., 2011; Tanenbaum et al., 2009; Vanneste et al., 2009).  In fact, TPX2 
was initially discovered as a factor required for the dynein-dependent targeting of the 
Xenopus Kinesin-12, Xklp2 to spindle poles (Wittmann et al., 1998). The C-terminal 37 
amino acids of TPX2 are required to target Eg5 to the spindle; targeting of Kif15 requires 
the C-terminal leucine zipper of the motor (Wittmann et al., 1998).  The C-terminal half 
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of TPX2 is required to localize Kif15 to the spindle (Brunet et al., 2004) but if a specific 
domain of the protein is necessary is not yet known. 
These initial studies on TPX2 and Kif15 were consistent with the idea that dimers 
of Kif15 walked along one microtubule while tethered to a second microtubule via TPX2, 
thus generating force for spindle formation (Vanneste et al., 2009).  Subsequently, 
Sturgill et al. provided biochemical data showing that the motor was an autoinhibited 
dimer and identified a second, non-motor microtubule binding site in the coil 1 region of 
Kif15 (Sturgill et al., 2014).  These data led to a model in which autoinhibited Kif15 
dimers were first unmasked and then bound to microtubule bundles via motor and non-
motor binding sites (Sturgill et al., 2014).  More recent work, however, has shown that 
Kif15 exists as a tetramer which displays processive motility along individual 
microtubules in vitro (Drechsler et al., 2014; Dreschler and McAinsh, 2016). Thus, the 
oligomeric state of Kif15, and how it contributes to mitotic spindle formation remain 
unresolved. Finally, experiments using dynamic microtubules in vitro show that Kif15 
accumulates at microtubule plus-ends and suppresses catastrophe events, can crosslink 
microtubules and move them relative to one another, promoting the formation of parallel 
microtubule arrays (Dreschler and McAinsh, 2016). Thus, both Eg5 and Kif15 contribute 
to spindle bipolarity and are regulated by TPX2, but their mechanism of action is distinct.  
To gain insight into the cellular function and regulation of the Kinesin-12, Kif15, 
we investigated the behavior of the motor and its regulation by TPX2 in vitro and in vivo.  
Our data show that Kif15 motors, present in diluted mammalian cell extracts, are 
processive, track-switching tetramers and that the C-terminal region of TPX2 is required 
to inhibit Kif15 motor stepping.  Using a knockdown rescue approach in mammalian 
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cells, we further demonstrate that the C-terminal region of TPX2 contributes to targeting 
the motor to the mitotic spindle and that Eg5-independent bipolar spindle formation by 
overexpressed Kif15 requires the TPX2 C-terminal region.  In live cells, GFP-Kif15 
displays robust, plus-end directed motility at a rate similar to that of microtubule growth, 
and this behavior is suppressed by Paclitaxel. Together these results document the 
behavior of Kif15 in cells and demonstrate the importance of TPX2 and its C-terminal 
region for motor localization and activity. 
3.2 Results  
3.2.1 TPX2 C-terminus is required for Kif15 targeting to spindle microtubules 
The C-terminal 37 amino acids of TPX2 contribute to the targeting of the 
Kinesin-5, Eg5, to spindle microtubules (Ma et al., 2011), but if this domain contributes 
to the targeting of the Kinesin-12, Kif15, to the spindle is not known (Brunet et al., 2004; 
Tanenbaum et al., 2009; Vanneste et al., 2009; Wittmann et al., 1998). To address this, 
we first examined the distribution of endogenous Kif15 in LLC-Pk1 cells expressing full-
length TPX2 or TPX2-710, which lacks the C-terminal 37 amino acids, from bacterial 
artificial chromosomes (BAC), and depleted of the endogenous protein using siRNA (Ma 
et al., 2011). Cells were fixed and stained for microtubules and Kif15 at 40 hours 
following nucleofection with TPX2 siRNA, a time when the majority of TPX2 is 
depleted (Fig. 3.5A) (Ma et al., 2011).  Kif15 was present along spindle microtubules in 
parental LLC-Pk1 cells, but not in parental cells depleted of TPX2 (Fig. 3.1A). In LLC-
Pk1 cells expressing full-length TPX2 or TPX2-710 from a BAC, and depleted of 
endogenous TPX2, Kif15 was detected on spindle microtubules when full-length TPX2 
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was present and was reduced when TPX2-710 was expressed (Fig. 3.1A).  Quantification 
of the ratio of Kif15 to microtubules at the spindle pole and in the spindle, midway 
between the chromosomes and pole, shows a statistically significant reduction at both 
locations in cells expressing TPX2-710, as compared with cells expressing full-length 
TPX2 (Fig. 3.1C).  As previously reported (Ma et al., 2011), expression of TPX2-710 in 
cells depleted of TPX2 resulted in aberrant spindle morphology (Fig. 3.1B). These results 
demonstrate that for both Eg5 and Kif15, the C-terminal domain of TPX2 contributes to 
spindle targeting. 
 
3.2.2 Full-length TPX2 inhibits Kif15 motor velocity 
 Next, we wished to determine if the C-terminal domain of TPX2 was required to 
regulate Kif15 motor stepping in vitro.  To do this, we transfected LLC-Pk1 cells with 
full-length Kif15 tagged with EGFP (hereafter GFP-Kif15) (Vanneste et al., 2009) and 
used these cells to prepare cytoplasmic extracts for use in single molecule total internal 
reflection fluorescence (TIRF) microscopy experiments (Fig. 3.2A) (Balchand et al., 
2015; Cai et al., 2007).  Rhodamine-labeled, Paclitaxel stabilized microtubules were 
attached to the surface of a microscope flow chamber and cell extract, diluted in motility 
buffer, was added (Methods). Fluorescent puncta were observed to bind to microtubules 
and processively move upon addition of ATP (Fig. 3.2B, C, G). Notably, nearly every 
GFP-Kif15 puncta that bound a microtubule was motile, demonstrating that Kif15 from 
mammalian cells is not autoinhibited (Sturgill et al., 2014), but displays robust motility. 
TPX2 is undetectable in these cytoplasmic extracts because they are prepared from 
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asynchronous cells, >95% of which are in interphase, a time when TPX2 is located in the 
nucleus (Balchand et al., 2015).  
  GFP-Kif15 was observed to move predominantly in a plus-end directed manner 
(86% of events) with a smaller percentage of events toward the minus-end (see Methods) 
(14% of events) (Drechsler et al., 2014) (Fig. 3.2B).  The average velocity of plus-end 
directed motion was 128.7 nm/sec while the velocity of minus-end directed motion was 
slower, 86.6 nm/sec.  Motility was processive with average run lengths of 1.9 and 0.9 
microns in the plus- and minus-end directions, respectively (Fig. 3.2B).  In addition to 
directional reversals, Kif15 motors moving on one microtubule could switch to a 
neighboring microtubule and continue processive motility (Fig. 3.2C). In extracts 
prepared from LLC-Pk1 cells arrested in mitosis with a low concentration of nocodazole 
(Methods), motor velocity (151 nm/sec, n = 54, 53 plus- and 1 minus-end directed) was 
not different from that measured in interphase, with the caveat that TPX2 is present in 
these extracts.  Interestingly, minus-end directed motility was reduced in the mitotic 
compared with interphase extract. This data suggests that in in vitro assays motor 
microtubule affinity is sufficiently strong to overcome any potential mitotic regulation 
(vanHeesbeen et al., 2016).  This possibility is consistent with the observation that Eg5 
prepared from interphase extracts, and thus lacking the mitosis specific phosphorylation 
that is required for spindle microtubule binding (Blangy et al., 1995) shows robust 
motility in vitro (Balchand et al., 2015).   
Kif15 has been previously reported to exist as a tetramer or dimer using purified 
motors (Drechsler et al., 2014; Sturgill et al., 2014), or motors in mammalian cell extracts 
(Dreschler and McAinsh, 2016; Sturgill et al., 2016).  Understanding the quaternary 
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structure of the molecule is significant because tetramers can potentially interact with 
more than one microtubule simultaneously, and because formation of tetramers could 
potentially alter the availability of a second microtubule binding site in the motor tail 
(Sturgill et al., 2014).  To determine the oligomeric state of GFP-Kif15 in our 
experiments, we acquired images of purified Kinesin-1-GFP, which is known to be a 
dimer, and GFP-Kif15 using identical imaging conditions and using only motors that 
bound to microtubules.  For this experiment, endogenous Kif15 was depleted from the 
cells prior to preparation of the extract, so that the motors would be composed 
predominantly of the expressed GFP-tagged protein (Fig. 3.5B).  As shown in the 
histogram in Fig. 3.2D, bottom), Kif15 puncta showed a range of fluorescence intensities 
with an average intensity that was 1.6X the average fluorescence intensity of Kinesin-1-
GFP (Fig. 3.2D, top) (average fluorescence of 220.5 and 141.0 A.U.). The reason that the 
average value was not twice the intensity of Kinesin-1-GFP may result from incomplete 
depletion of endogenous Kif15 by siRNA (Fig. 3.5B), resulting in a mixture of motors 
containing two, three or four GFP-tagged motors.  Additionally, some motors may 
dissociate into dimers during preparation (Drechsler et al., 2014; Sturgill et al., 2014; 
Sturgill et al., 2016). We also imaged GFP-Kif15 in the absence of ATP and counted 
bleach steps.  We observed at least three discreet bleach events for approximately half of 
the particles (Fig. 3.2E) consistent with at least some of the GFP-Kif15 existing as a 
tetramer under these conditions.  To determine if Kif15 exists as a tetramer in mitosis, 
mitotic extract was added to microtubules in chambers without ATP and the number of 
bleach steps counted.  In this experiment, we observed particles with greater than three 
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bleach steps for more than half of the particles (Fig. 3.2E) demonstrating that in both 
interphase and mitotic extracts some of the Kif15 motors exist as tetramers. 
In summary, these data show that GFP-Kif15, prepared from mammalian cells, 
moves rapidly and processively toward microtubule plus-ends and can both switch 
microtubule tracks and reverse direction.  The motile parameters of Kif15 prepared from 
mammalian cells are strikingly similar to motors prepared from Sf9 cells and indicate that 
the native state of Kif15 in interphase and mitotic mammalian cells is likely a tetramer 
(Drechsler et al., 2014) that can dissociate into dimers depending on the experimental 
conditions (Drechsler et al., 2014; Dreschler and McAinsh, 2016; Sturgill et al., 2014; 
Sturgill et al., 2016).  
To identify the region, or regions, of TPX2 that regulate Kif15 motility in vitro, 
TPX2 was incubated with diluted extract containing GFP-Kif15, and then introduced into 
the motility chamber.  When full-length TPX2 was present in the reaction, motor velocity 
was reduced to ~65% of controls (Fig. 3.2F and G).  Next, we added TPX2-710 which 
binds microtubules (Balchand et al., 2015) and contributes to motor targeting (Figure 1) 
to determine if it also regulates motility in vitro. Incubation of TPX2-710 with GFP-
Kif15 prior to addition to the motility chamber did not result in a statistically significant 
reduction in motor velocity (Fig. 3.2F and G) demonstrating that full-length TPX2 is 
required for motor inhibition.  Two additional constructs, one lacking a larger C-terminal 
region (TPX2-657) and one containing a deletion of a conserved PFAM domain near the 
C-terminus (TPX2 ΔPFAM) (Fig. 3.5C) also failed to inhibit Kif15 (Fig. 3.2F and G). 
The lack of inhibition with the ΔPFAM construct, which is missing only part of the 
region deleted in TPX2-710, indicates that these nine amino acids may play a role in 
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motor inhibition.  Both TPX2-657 and TPX2 ΔPFAM bound microtubules following 
expression in mammalian cells that were depleted of endogenous TPX2 (Fig. 3.5D) 
demonstrating that failure to inhibit Kif15 did not result from failure of these proteins to 
bind microtubules. In summary, these experiments show that full-length TPX2 is required 
to inhibit Kif15 motor stepping in vitro.   
 
3.2.3 TPX2 is required for bipolar spindle formation in cells overexpressing Kif15 
Previous work has shown that bipolar spindle formation can proceed in cells 
lacking Eg5 activity and overexpressing Kif15, demonstrating that Kif15 can generate 
force for spindle formation in vivo (Sturgill and Ohi, 2013; Tanenbaum et al., 2009). To 
understand how TPX2 contributes to Kif15-dependent spindle formation in vivo, we 
examined spindle formation in LLC-Pk1 cells overexpressing GFP-Kif15.  In these cells, 
the distribution of GFP-Kif15 on spindle microtubules was similar to the distribution of 
Kif15 in the parental cells, showing a punctate staining pattern with enrichment along 
kinetochore fiber microtubules and near spindle poles (Fig. 3.3A). This distribution is 
equivalent to that observed in Xenopus cultured cell spindles (Wittmann et al., 2000) and 
similar to the distribution in other cultured mammalian cells (Sturgill and Ohi, 2013; 
Tanenbaum et al., 2009; Vanneste et al., 2009). Western blots of an extract of GFP-Kif15 
cells show that GFP-Kif15 is present at approximately 10X the level of endogenous 
Kif15 in the parental cells (Methods) (Fig. 3.3B).  
First, we asked if TPX2 is required for Kif15 localization in the overexpressing 
cells. Treatment with siRNA targeting TPX2 resulted in a dramatic reduction in GFP-
Kif15 on spindle microtubules and an ensuing increase in the level of cytoplasmic 
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fluorescence (Fig. 3.3C).  In some cells, residual GFP-Kif15 was detected near spindle 
poles (Fig. 3.3C). These results demonstrate that TPX2 contributes to the localization of 
GFP-Kif15 to spindle microtubules, even when high levels of the motor are present.    
In control cells, Kif15 is enriched on kinetochore fiber microtubules (Sturgill and Ohi, 
2013) and when overexpressed Kif15 binds and stabilizes non-kinetochore microtubules 
as well, where it is thought to play a key role in Eg5-independent spindle formation 
(Sturgill and Ohi, 2013).  We asked if kinetochore fiber microtubules are needed for 
Kif15 localization in LLC-Pk1 GFP-Kif15 cells. In cells depleted of Nuf2, a treatment 
that prevents kinetochore fiber formation (Fig. 3.6), GFP-Kif15 remained associated with 
the spindle (Fig. 3.3C, left) despite the loss of kinetochore fibers and concomitant failure 
of chromosome congression (Fig. 3.3C, right).  We also tested the requirement for 
kinetochore fibers for Kif15 localization in parental cells by depleting Nuf2 and staining 
for Kif15; in these cells the spindle localization of Kif15 is reduced, but not completely 
abolished, consistent with previous observations (Vanneste et al., 2009). Together these 
results show that overexpressed GFP-Kif15 is distributed in a manner similar to that of 
the endogenous protein and that TPX2, but not kinetochore fibers, is required for spindle 
localization.   
To examine Kif15-dependent spindle formation in LLC-Pk1 GFP-Kif15 cells we 
first treated parental and GFP-Kif15 cells with 1 M STLC (DeBonis et al., 2004) for 18 
hours and quantified spindle morphology (Fig. 3.3D). In parental cells treated with 
STLC, 96% of spindles were monopolar.  In STLC treated GFP-Kif15 cells, the majority 
of spindles were bipolar (87%), demonstrating that GFP-Kif15 can support bipolar 
spindle formation in these cells, consistent with results in other mammalian cells either 
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overexpressing Kif15 or treated to develop resistance to STLC (Raaijmakers et al., 2012; 
Sturgill et al., 2016; Sturgill and Ohi, 2013; Vanneste et al., 2009).  Next, we assessed the 
ability of STLC treated GFP-Kif15 expressing cells to form bipolar spindles following 
siRNA mediated depletion of TPX2.  As shown in Figure 3D, 97% of spindles were 
monopolar, indicating that TPX2 is required for Kif15 dependent bipolar spindle 
formation (Tanenbaum et al., 2009).  It should be noted, however, that depletion of TPX2 
in control cells also leads to defects in spindle formation, resulting in short bipolar 
spindles, multipolar spindles and monopolar spindles (Gruss and Vernos, 2004) 
Because our data showed that the C-terminal 37 amino acids of TPX2 are important for 
spindle localization of Kif15 and inhibition of Kif15 motility in vitro, we next used cell 
lines expressing full-length or truncated TPX2 from a BAC to determine if the C-terminal 
region is important for force generation by Kif15 in vivo.  Cells were co-nucleofected 
with siRNA to deplete endogenous TPX2 and with a plasmid encoding mCherry-Kif15.  
40 hours post nucleofection cells were treated with STLC and spindle morphology 
scored.  As shown in Figure 3D, bipolar spindles were present in the majority of cells 
expressing full-length TPX2, but not in cells expressing TPX2-710.  This result 
demonstrates that the C-terminal region of TPX2 is necessary for Eg5-independent 
bipolar spindle formation in cells overexpressing Kif15.   
 The mechanism by which Kif15 promotes spindle bipolarity in the absence of Eg5 
activity is not known, but has been proposed to result from Kif15 action on parallel, 
bundled microtubules (Sturgill and Ohi, 2013).  Consistent with this, recent work shows 
that some Kinesin-5 inhibitor-resistant cell lines express low levels of a rigor mutant of 
Eg5 that promotes microtubule bundle formation (Sturgill et al., 2016). To determine if 
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microtubule bundles are sufficient for Kif15 localization in the absence of TPX2, we 
depleted cells of TPX2 and added FCPT, which induces microtubule bundle formation by 
promoting rigor binding of Eg5 to microtubules (Groen et al., 2008).  Treatment of 
parental cells with FCPT alone promoted microtubule bundle formation as expected; 
however, very few bundles were observed in the absence of TPX2 (Fig. 3.3E).  
Immunostaining showed that Eg5 bound to microtubule bundles in FCPT treated cells, 
was reduced in siTPX2 treated cells, and bound to residual bundles in cells treated with 
both FCPT and siRNA to TPX2 (Fig. 3.3E).  Although Kif15 was detected on bundles in 
FCPT treated cells, it was not detected in cells treated with siRNA targeting TPX2, even 
when FCPT was added to promote bundle formation (Fig. 3.3E). These results show that 
Eg5 can bind  to spindle microtubules in the absence of TPX2 when rigor binding of Eg5 
to microtubules is promoted by FCPT treatment.  However, in cells lacking TPX2, the 
formation of microtubule bundles using FCPT treatment alone may not be sufficient to 
localize Kif15 properly to the spindle.  
 
3.2.4 Dynamic microtubules contribute to Kif15 behavior in vivo 
Although Kif15 motility in vitro has been characterized (Drechsler et al., 2014; 
Sturgill et al., 2014), the motile behavior of Kif15 in vivo has not been reported.  To 
investigate this, we performed time-lapse confocal microscopy of GFP-Kif15 expressing 
LLC-Pk1 cells, which facilitate imaging due to their flat morphology throughout mitosis 
remain relatively flattened during mitosis, facilitating imaging.  We observed rapid 
motion of fluorescent particles of GFP-Kif15 toward the spindle equator, where 
microtubule plus-ends are located (Fig. 3.4A). Close inspection of the confocal image 
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sequences revealed some variation in the fluorescence intensity and morphology of the 
motile particles (Fig. 3.4A,D).  The larger or brighter particles may represent clusters of 
Kif15 tetramers, a possibility that is consistent with recent in vitro experiments that show 
accumulation of Kif15 at intersections of dynamic microtubules and at microtubule plus-
ends (Dreschler and McAinsh, 2016).  However, the fluorescent puncta move rapidly, 
and photobleach quickly, so variation in morphology of individual puncta could not be 
quantified. When cells progressed into anaphase, GFP-Kif15 was enriched along 
kinetochore fibers and in some cases showed an accumulation near kinetochore fiber 
plus-ends (Fig. 3.4B, Fig. 3.7B). 
We also performed TIRF microscopy of live cells to visualize motors on 
microtubules that extended to the peripheral regions of the cell (Gable et al., 2012).  In 
accord with results from confocal microscopy, GFP-Kif15 motors appeared to move in a 
directed manner, away from the centrosome, consistent with predominantly plus-end 
directed motion (Fig. 3.7A).  
To determine if the fluorescent particles of GFP-Kif15 are walking along the 
lattice of spindle microtubules or moving with the tips of growing microtubules, we 
measured the velocity of GFP-Kif15 in vivo, from kymographs (Fig. 3.4C) of fluorescent 
particles in the image sequences taken of metaphase and anaphase cells (Methods).  We 
also imaged LLC-Pk1 cells expressing GFP-EB1, using identical imaging parameters, to 
determine the rate of microtubule growth (Piehl et al., 2004). This analysis showed that 
particles of GFP-Kif15 moved in a processive manner at a velocity of 133  43 nm/sec 
This value was not different from the rate of microtubule growth determined from the 
GFP-EB1 movies, 119  26 nm/sec (P = 0.09) suggesting that Kif15 motility results from 
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association with growing microtubule ends.  We also imaged both GFP-Kif15 and GFP-
EB1 at room temperature, which reduced photobleaching, and again found that the 
velocities were not different (data not shown).  The relatively wide distribution in the 
velocities of GFP-Kif15 puncta could reflect different rates for single or multiple motors, 
for motors walking on one microtubule with a second microtubule as cargo, or because 
some motors are moving on microtubule growing ends and others are walking along the 
microtubule lattice (Dreschler and McAinsh, 2016). To determine if this motile behavior 
is unique to GFP-Kif15, we overexpressed Eg5-Emerald from a plasmid, and imaged the 
cells.  In this case, plus-end directed motile behavior was not observed (data not shown), 
consistent with previous work demonstrating that Eg5, expressed from a BAC, bound and 
unbound rapidly from mitotic microtubules and showed dynein-dependent minus-end 
motion (Gable et al., 2012; Uteng et al., 2008).       
To determine if GFP-Kif15 motility results from motors associating with dynamic 
microtubule plus-ends (Dreschler and McAinsh, 2016), we treated GFP-Kif15 cells with 
nanomolar concentrations of Paclitaxel, to suppress microtubule dynamics (Yvon et al., 
1999).  Under these conditions (Methods), the velocity and number of growing 
microtubule plus-ends, measured in GFP-EB1 expressing LLC-Pk1 cells was reduced, 
confirming a suppression of microtubule dynamics (Fig. 3.7C,D).  Time-lapse movies of 
Paclitaxel treated GFP-Kif15 cells showed a dramatic reduction of Kif15 motility on the 
spindle, which precluded tracking.  This result shows that microtubule dynamics 
contribute to GFP-Kif15 behavior in vivo (Fig. 3.4D).  Because of the high density of 
microtubules in the spindle, and the fact that the Kif15 antibody is only compatible with 
methanol fixed cells, we were not able to document co-localization of Kif15 and GFP-
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EB1 in fixed cells, and in live cells expression of both GFP-Kif15 and mCherry-EB1 
resulted in aberrant spindle morphology.  
  To determine if the distribution of Kif15 and TPX2 was altered in Paclitaxel 
treated cells, as might be expected if the motors preferentially associate with dynamic 
microtubules, parental cells were fixed and stained for microtubules and TPX2 or Kif15.  
The results show that suppression of dynamics with Paclitaxel resulted in an increase in 
TPX2 and Kif15 near the spindle poles and a reduction along spindle microtubules (Fig. 
3.4E).  To quantify this, TPX2 and Kif15 levels were normalized to tubulin, and the ratio 
of each protein in the half-spindle and at the pole was determined; the results show that 
Paclitaxel treatment reduced this ratio for both Kif15 and TPX2 (Fig. 3.4E’). This result 
shows that the distribution of TPX2 and Kif15 is impacted by microtubule dynamics, 
consistent with the enrichment of TPX2 and Kif15 at plus-ends of dynamic microtubules 
in vitro (Dreschler and McAinsh, 2016; Reid et al., 2016; Roostalu et al., 2015).  Kif15 
and TPX2 lack a short amino acid motif, composed of Serine, any amino acid, Isoleucine 
and Proline and abbreviated SxIP, that is commonly found in proteins that localize to 
microtubule plus-ends in a EB-1–dependent manner (Honnappa et al., 2009).  This 
suggests that the association of TPX2 and Kif15 with microtubules is direct rather than 
mediated by EB1. TPX2 has been reported to associate with dynamic microtubule ends in 
vitro at low concentrations (Reid et al., 2016; Roostalu et al., 2015) but has not been 
reported to tip track in vivo, where it is present at higher concentrations (~20 nM in a 
mitotic cell extract).  One possibility is that TPX2 is required to load Kif15 onto 
microtubules but not required for it to remain at the growing plus-end (Fig. 3.4Fa); 
alternatively TPX2 may remain at the plus-end with Kif15 (Fig. 3.4Fb), but may not be 
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detectable in vivo (Dreschler and McAinsh, 2016; Reid et al., 2016; Roostalu et al., 
2015). 
3.3 Discussion 
The results of these experiments demonstrate that the C-terminal region of TPX2, 
which was shown previously to contribute to the regulation of the Kinesin-5, Eg5, also 
contributes to the regulation of the Kinesin-12, Kif15.  Specifically, the C-terminal 37 
amino acids of TPX2 contribute to the spindle localization of each motor and inhibition 
of motor walking in vitro.  In the case of Eg5, both TPX2-710 and full length TPX2 had 
an inhibitory effect on motor stepping in vitro, although full-length TPX2 was a more 
effective inhibitor (Balchand et al., 2015). This is in contrast to Kif15, which was only 
inhibited when the full-length protein was added. The reason for these differences is not 
clear; one possibility is that Eg5 is more susceptible to inhibition because of differences 
in the neck linker and stalk which are unique to Eg5 (Waitzman and Rice, 2014).  
Our results showing that the C-terminal region of TPX2 contributes to the spindle 
localization of both Eg5 and Kif15, two kinesins that contribute to spindle bipolarity, 
raises the question of how bipolarity is achieved in cells expressing truncated TPX2.  
First, for both motors, spindle localization is reduced but not eliminated when TPX2-710 
is expressed, which is consistent with the observation that the Eg5-TPX2 interaction is 
not completely abolished when the C-terminal region is removed from the protein 
(Eckerdt et al., 2008; Ma et al., 2011); the residual binding may be sufficient to generate 
bipolar spindles. In addition, incomplete knockdown of TPX2 may contribute to motor 
binding to spindle microtubules.  Second, in LLC-Pk1 cells centrosome separation 
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typically occurs during prophase when most of TPX2 is in the nucleus and thus before 
complete inhibition of Eg5 by TPX2 can occur (Raaijmakers et al., 2012).  Finally, it is 
possible that TPX2 also impacts minus-end directed motility (Wittmann et al., 1998), and 
that the reduction of both inward and outward force generators enables spindle 
bipolarization via microtubule pushing forces (Ferenz et al., 2009b; Toso et al., 2009; 
Wittmann et al., 1998). 
In Kif15 overexpressing cells treated with STLC, spindle formation is thought to 
occur when a monopolar spindle breaks symmetry, driven by Kif15 acting on parallel, 
bundled microtubules (Sturgill et al., 2014; Sturgill and Ohi, 2013). When TPX2 is 
depleted from these cells, bipolar spindles are not observed (this report and (Tanenbaum 
et al., 2009)).  One possibility is that TPX2 is needed to generate microtubule bundles to 
which Kif15 binds (Sturgill et al., 2014); alternatively, TPX2 may play a more direct role 
in promoting force generation by Kif15 (Drechsler et al., 2014).  It should be noted that 
depletion of TPX2 results in a dramatic alteration of spindle morphology resulting in 
short spindles with extensive astral arrays and few or no spindle microtubules (Gruss et 
al., 2002), and these changes impact spindle formation.  However, in Kif15 
overexpressing cells expressing TPX2-710, microtubule formation in the chromosome 
pathway can proceed (Ma et al., 2011), and these cells also fail to generate bipolar 
spindles.  This suggests that TPX2 is needed not only to promote microtubule formation 
but to also regulate motor activity, which is consistent with in vitro experiments showing 
that the C-terminus of TPX2 is required for motor regulation on individual, unbundled, 
microtubules (this report) and experiments showing that Kif15 can generate greater force 
in the presence of TPX2 (Drechsler et al., 2014).       
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Our analysis is the first report of the motile behavior of GFP-Kif15 on spindle 
microtubules in vivo.  We observed plus-end directed motion of Kif15 puncta in 
prometaphase, metaphase and anaphase cells. In live cells, Kif15 puncta moved at a rate 
(133 nm/sec) that was indistinguishable from microtubule plus-end growth in these cells 
(119 nm/sec) and was suppressed in cells treated with Paclitaxel to reduce microtubule 
dynamics.  These observations support the idea that motion of Kif15 is due, at least in 
part, to tracking with microtubule plus-ends.  This possibility is also consistent with in 
vitro experiments showing that Kif15 tracks, and accumulates at the plus-ends of 
dynamic microtubules, in the absence of other microtubule-associated proteins (Dreschler 
and McAinsh, 2016).  The velocity of GFP-Kif15 puncta in live cells overlaps with the 
velocity of GFP-Kif15 measured in vitro on stable microtubules (~130 nm/sec) but is 
slower than the velocity on dynamic microtubules (~500 nm/sec) (Dreschler and 
McAinsh, 2016).  Because microtubules in vivo are highly dynamic, the velocity of Kif15 
in vivo would be predicted to be ~500 nm/sec (Verhey et al., 2011). The similarity of the 
velocities of microtubule growth and Kif15 puncta motility is thus consistent with motors 
tracking plus-ends, but we cannot eliminate the possibility that Kif15 walking on spindle 
microtubules in vivo also contributes to the observed motility.  Because puncta composed 
of multiple tetramers of GFP-Kif15 are easier to detect in live cells, our imaging 
experiments may preferentially capture the brighter puncta at microtubule ends and 
individual motors on the microtubule lattice may be insufficiently bright to track.  It 
should be noted that measuring the rate that a mitotic motor walks in vivo is challenging.  
In the case of Eg5, prior work showed that motors bound and unbound rapidly to spindle 
microtubules (Gable et al., 2012).  In the interzonal region, short excursions were 
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measured with a rate of ~6.5 nm/sec, similar to the rate that Eg5 walks in vitro (Balchand 
et al., 2015; Weinger et al., 2011).  In contrast, in the half-spindle, Eg5 moved toward the 
spindle poles in a dynein dependent manner (Gable et al., 2012; Uteng et al., 2008).  To 
our knowledge, the in vivo motile behavior of individual molecules of other mammalian 
mitotic motors has not been reported.  Therefore, additional experiments will be required 
to establish if Kif15 walks on the microtubule lattice, tracks the microtubule plus-end, or 
both, in vivo (Dreschler and McAinsh, 2016).      
We observed Kif15 puncta on kinetochore fibers, in fixed and live cells, 
consistent with the fact that Kif15 can crosslink parallel microtubules in vitro (Drechsler 
et al., 2014; Sturgill et al., 2014). One appealing possibility is that Kif15 can aid in the 
formation of parallel microtubule bundles in the spindle by walking along a kinetochore 
microtubule while associated with a dynamic growing microtubule. In late anaphase and 
telophase cells, Kif15 was not detected on interzonal microtubules, consistent with 
preferential binding to parallel microtubules. 
  Mitotic motors, including Eg5 and Kif15, and TPX2 are all subject to mitotic 
regulation (Blangy et al., 1997; Fu et al., 2015a; Nousiainen et al., 2006; vanHeesbeen et 
al., 2016), but how these modifications impact motor behavior in vitro and in vivo 
remains incompletely understood.  For example, modifications of mitotic motors regulate 
their binding to spindle microtubules as cells enter mitosis, but if these modifications also 
impact their interaction with TPX2 is not known.  Additionally, if there is competition 
between these motors for interaction with TPX2 has not been determined.  Enrichment of 
GFP-Kif15 on kinetochore fibers was observed as cells progressed into anaphase 
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suggesting that Kif15 distribution and function may change not only as cells enter 
mitosis, but also as cells progress into anaphase.   
In conclusion, the results of these in vitro experiments show that Kif15 is a 
processive, track-switching motor and that a fraction of the motors exist as tetramers in 
both interphase and mitotic extracts, supporting the view that Kif15, like Eg5, functions 
as a tetramer. The results presented here demonstrate that the C-terminal 37 amino acids 
of TPX2 regulates in vitro motility of Kif15, contributes to the spindle localization of 
Kif15 and to Eg5-independent force generation in vivo.  Our live cell imaging shows that 
Kif15 moves in a manner consistent with tracking microtubule plus-ends in vivo, a 
property that likely aids the motor aligning microtubules into kinetochore fibers and 
generating force for bipolarization.  Together with other recent work, our results highlight 
the essential role of microtubule-associated proteins in regulating of the cellular activity 
of kinesin motors (Barlan et al., 2013; Dixit et al., 2008; Li et al., 2016; Wignall and 
Villeneuve, 2009). 
3.4 Materials and Methods 
3.4.1 Materials 
All chemicals, unless otherwise specified, were purchased from Sigma-Aldrich. 
 
3.4.2 Cell Culture, nucleofection and inhibitor treatments 
LLC-Pk1 cells were cultured in a 1:1 mixture of F10 Hams and Opti-MEM 
containing 7.5% fetal bovine serum and antibiotics and maintained at 37 C and 5% CO2.  
LLC-Pk1 cells were nucleofected using an Amaxa nucleofector (Lonza) using program 
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X-001 and Mirus nucleofection reagent (Mirus Bio LLC, Madison, WI) according to the 
manufacturers recommendations.  The following siRNAs were used:  TPX2, 
GGACAAAACUCCUCUGAGA; Nuf2, AAGCAUGCCGUGAAACGUAUA; Kif15, 
UGACAUCACUUGCAAAUAC. siRNAs were purchased from Dharmacon (GE 
Healthcare Life Sciences, Pittsburgh, PA).  
LLC-Pk1 cells expressing full-length TPX2 or TPX2-710 from a bacterial 
artificial chromosome (BAC) were grown as previously described (Ma et al., 2011).  To 
generate cells expressing GFP-Kif15, parental cells were nucleofected with GFP-Kif15 
and selected using the appropriate antibiotic; cells were subcloned to enrich for GFP-
Kif15 expressing cells.  For some experiments, GFP-Kif15 cells that had been further 
selected for fluorescence using cell sorting were used. mCherry-Kif15 was prepared by 
subcloning of GFP-Kif15 into the appropriate vector. 
Paclitaxol, FCPT and STLC were prepared as stock solutions in DMSO, stored at 
-20 °C and diluted with culture medium prior to use.  FCPT was used at 200 M, 
Paclitaxol at 330 nM and STLC at 1 M.  
 
3.4.3 Preparation of cell extracts 
Cell extracts for TIRF experiments were prepared from LLC-Pk1 cells expressing 
GFP-Kif15.  A confluent 100 mm diameter cell culture dish was washed twice with 
calcium and magnesium free PBS and then 300 l extraction buffer (40 mM 
HEPES/KOH pH 7.6, 100 mM NaCl, 1 mM EDTA, 1 mM PMSF, 10 μg/ml Leupeptin, 1 
mg/ml pepstatin, 0.5% Triton X 100 and 1 mM ATP) was added drop wise to the dish 
and incubated with gentle rotation for approximately 2 min (Balchand et al., 2015; Cai et 
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al., 2007).  The extract was transferred to a microcentrifuge tube on ice and centrifuged at 
15,000 RPM at 4 C for 10 min in a tabletop centrifuge. The supernatant was recovered 
and used immediately or stored in aliquots in liquid nitrogen; protein concentration was 
determined using the method of Lowry (Lowry et al., 1951).  For quantification of the 
fluorescence intensity of individual puncta using TIRF microscopy, the cells were treated 
with siRNA targeting endogenous Kif15 72 hours prior to preparation of the extract.   
To prepare mitotic extracts, GFP-Kif15 cells were treated with siRNA targeting 
endogenous Kif15, and were synchronized using 330nM Nocodazole for the final 18 
hours of the 72 hr siRNA treatment. Extracts were prepared as described above with the 
addition of Simple Stop 1 Phosphatase Inhibitor Cocktail (1X)(Gold Biotechnology Inc., 
St. Louis, MO) to the extract buffer. 
 
3.4.4 Protein purification 
Full-length and truncated TPX2 were expressed and purified from bacteria as 
previously described (Balchand et al., 2015). Kinesin-1-GFP was prepared using the 
dimeric construct as previously described (Balchand et al., 2015). To generate TPX2-657, 
a stop codon was introduced at amino acid 657 in the bacterially expressed Full-length 
TPX2 construct.  To generate TPX2 Δ PFAM, PCR was used to remove amino acids 662 
to 719 from full-length TPX2.  Proteins were run on 8% polyacrylamide gels using 
appropriate MW standards, and stained with Commassie brilliant blue. 
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3.4.5 Single molecule experiments 
For the single molecule experiments, perfusion chambers (~10 l volume) were 
made from glass slides, silanized coverslips and double stick tape (Balchand et al., 2015).  
First, 10 l  of 10% Rat YL ½ anti-tubulin antibody (Accurate Chemical and Scientific, 
Corp) was flowed into the chamber and incubated for 3 min. Next, the chamber was 
blocked by flowing in 5% pluronic F127 for 3 min.  Diluted rhodamine labeled 
microtubules, composed of 10% rhodamine tubulin (Cytoskeleton, Inc.) and unlabeled 
porcine brain tubulin, were flowed into the chamber and incubated for 3 min followed by 
a second block of 5% pluronic F127.  Cell extract containing GFP-Kif15 was diluted in 
PEM 20 motility buffer (20 mM Pipes pH 6.9, 2 mM EGTA, 2 mM MgSO4), containing 
0.25% F127, 100 μM ATP, 1 mM DTT, 25 μM Paclitaxel and supplemented with oxygen 
scavenging system (15 mg/ml glucose, 1.23 mg/ml glucose oxidase and 0.375 mg/ml 
catalase), flowed into the chamber and imaged.  To determine the directionality of Kif15, 
polarity marked microtubules were used and confirmed that Kif15 walked toward the 
plus-end for the majority of excursions. For pre-incubation experiments with TPX2, the 
indicated concentrations of TPX2 were added to the motility buffer containing GFP-
Kif15 and incubated on ice for 2 min before flowing into the chamber.  Single molecule 
imaging of Kinesin-1-GFP was performed as described previously (Balchand et al., 
2015). 
 
3.4.6 Microscope Imaging and Analysis 
TIRF microscopy was performed using a Nikon Ti-E microscope with a 100X 
1.49 NA objective lens, and an Andor Zyla sCMOS camera; the system was run by 
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Nikon Elements software.  TIRF imaging was performed at room temperature; images 
were collected at 1 frame per second for a total of 300 seconds.  To measure motor 
velocity, individual puncta were tracked using the Particle Tracking function of Nikon 
Elements software and exported to Excel for analysis.  For the experiment with mitotic 
extract, a Nikon Ti-E microscope run by Metamorph software and with a Hammamatsu 
Flash 4.0 camera was used. 
Live and fixed cells were imaged using either spinning disc confocal microscopy 
or point scanning confocal microscopy.  For spinning disc confocal, two different 
systems were used, either a Nikon Ti-E microscope with a CSU-X1 Yokogawa spinning 
disc confocal scan head (PerkinElmer, Wellesley, MA), and an Andor iXon+ EMCCD 
camera (Andor, Belfast, Northern Ireland), and a 100X 1.4 NA objective lens or a CSU-
10 Yokogawa spinning disc confocal on a Nikon TE300 as previously described (Tulu et 
al., 2003). For live cell imaging, exposures were adjusted without saturating the camera's 
pixels; typical exposures were 50 - 800 msec.  For point scanning confocal, a Nikon A1R 
system with a 60X 1.4 N.A. objective lens was used.  Images of live cells were acquired 
every 2 sec at room temperature or every 3 sec at ~34 C; images were typically 
collected for 2-5 min.  For both fixed and live cell imaging, a laser power of 1-2 % was 
used.  For heating the cells during imaging, a Nicholson Precision Instruments (Bethesda, 
MD) Air Stream Stage Incubator was used; temperature was measured using a thermistor 
probe taped to the microscope stage outside of the cell chamber.  When the thermistor 
temperature is 37 C, the temperature inside the chamber is ~34 C. 
   To quantify the fluorescence intensity of tubulin and Kif15, a 1 X 1 micron box 
was placed midway between the spindle pole and the chromosomes, or at the spindle 
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pole, and the ratio of Kif15 to tubulin fluorescence was measured, after background 
subtraction. Statistical analysis was performed in Excel.  Velocity of GFP-EB1 dashes 
and Kif15 puncta were tracked in ImageJ using the M Track J plug-in.   
 
3.4.7 Immunofluorescence  
LLC-Pk1 cells were plated on #1.5 glass coverslips approximately 48 hours prior 
to experiments.  For Kif15 staining, cells were rinsed twice with room temperature PBS 
lacking calcium and magnesium, and fixed in -20 C methanol for 5-10 minutes, and 
rehydrated in PBS containing 0.1 %Tween and 0.02 % sodium azide (PBS-Tw-Az).  
Kif15 primary antibodies (Cytoskeleton, Inc.) were used following the manufacturers’ 
recommendation and subsequently stained with fluorescent secondary anti-rabbit 
antibodies (Ma et al., 2011). For TPX2 staining, cells were fixed in 2% 
paraformaldehyde, 0.25% glutaraldehype, 0.5% Triton X 100, made fresh daily in PBS 
lacking calcium and magnesium.  TPX2 antibodies were obtained from Novus 
Biologicals; Hec1 antibodies (Abcam) were the kind gift of T. Maresca.  Microtubules 
were stained with either DM1a mouse anti-tubulin (Sigma Chemical Co.) or YL1/2 rat 
anti-tubulin (Accurate Chemical and Scientific Corporation) and appropriate secondary 
antibodies as previously described (Ma et al., 2011). Stained cells were mounted on glass 
slides using Fluomount G (Southern Biotech) to which DAPI was added to stain DNA. 
 
3.4.8 Western blotting and detection  
Whole cell extracts of control or siRNA treated cells were prepared by adding 
SDS sample buffer to 35mm dishes of cells, followed by sonication.  Extracts were run 
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on 8% SDS polyacrylamide gels using the formulation of Laemmli (Laemmli, 1970).  
Gels were transferred onto Amersham Hybond-P membrane (GE Healthcare, Waukesha, 
WI).  Blots were probed with Kif15 or TPX2 antibodies used at 1:1,000 for 1 h at room 
temperature in 5% non-fat dry milk dissolved in Tris buffered saline containing 0.02% 
Tween-20 (TBS-Tween).  The blots were then probed with goat anti-rabbit HRP 
conjugated secondary antibody (Jackson Immunoresearch Laboratories, Inc.) (1:5,000) 
for 1 hr at room temperature in 5% non-fat dry milk dissolved in TBS-Tween and were 
detected using chemiluminescence. 
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Figure 3.1 The C-terminal region of TPX2 contributes to spindle localization of 
Kif15.  (A).  Immunofluorescence staining for microtubules (left) and Kif15 (right). Top 
row, parental cells; bottom three rows show cells depleted of TPX2 and expressing: no 
transgene (parental); transgene encoding full length TPX2 (middle) or TPX2-710 
(bottom). (B). Spindle morphology for parental cells and cells expressing full-length or 
truncated TPX2; cells on the right were additionally treated with siRNA targeting TPX2. 
(C). Quantification of fluorescence ratio of Kif15 to tubulin at pole and in the half 
spindle.  Error bars are standard deviation. Parental cells depleted of TPX2 were only 
measured at spindle pole due to loss of spindle microtubules. Scale bar in (A) is 2 μm. 
 92 
 
 
Figure 3.2 Inhibition of Kif15 motor stepping requires full-length TPX2.  (A) 
Schematic diagram of experiment.  (B) Histograms of GFP-Kif15 velocity (left) and run 
length (right) for plus-end and minus-end directed motion, n = 261 and 43 motors, 
respectively. Data from 2 independent experiments. (C) GFP-Kif15 switches microtubule 
tracks; arrow marks moving GFP-Kif15 puncta. Time in min:sec. (D) Histogram of 
fluorescence intensity of Kinesin-1-GFP (top) and GFP-Kif15 (bottom); fluorescence in 
arbritary units (AU). For Kinesin-1-GFP, n = 295 and for GFP-Kif15, n = 652, from 2 
independent experiments.  (E) Photobleaching of microtubule bound GFP-Kif15 from 
interphase and mitotic extracts.  Horizontal pink lines show bleach steps. For interphase, 
n = 11 particles, 5 >3 steps and 6 <3 steps; data from 2 independent experiments; for 
mitotic extracts n = 15 particles, 10 > 3 steps and 5 < 3 steps. (F) Schematic diagram of 
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constructs used for inhibition experiments (top) and bar graph (lower) showing ratio of 
velocity without and with added proteins; error bars SEM. (G) Kymographs showing 
motility of GFP-Kif15; added TPX2 construct indicated at top; vertical axis marker bar = 
15 sec; horizontal axis marker bar = 1 μm. Bar in C = 1 μm. 
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Figure 3.3 TPX2 is required for bipolar spindle formation in cells overexpressing 
Kif15. (A) LLC-Pk1 cells expressing GFP-Kif15 (left) and parental cells fixed and 
stained for Kif15 (right).  (B) Western blot of extracts from parental and GFP-Kif15 
expressing cells; blot stained for Kif15 (top) and tubulin as loading control (bottom). (C) 
Images of GFP-Kif15 expressing cells treated with siRNA targeting TPX2 (top) or Nuf2 
(bottom); GFP-Kif15 (left) and co-nucleofected mCherry-H2B to label chromosomes 
(right). (D) Bar graphs showing percent of bipolar, monopolar and multipolar spindles for 
each treatment condition. Error bars show standard deviation.  (E) Parental cells treated 
with FCPT, with siRNA targeting TPX2, or with both. Cells were stained for 
microtubules (lower panels) and either Kif15 or Eg5 (upper panels). Marker bar, A, C, E 
= 2 μm. 
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Figure 3.4 Dynamics of GFP-Kif15 in vivo. (A) Selected frames from a movie of GFP-
Kif15 expressing cells; red and yellow arrowheads mark fluorescent particles traveling 
toward the chromosome region (spindle equator to right; dark ovals are chromosomes).  
(B) Live cell expressing GFP-Kif15 progressing from prometaphase (0:00) to metaphase 
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(3:30) and anaphase (9:00); arrows show accumulation of fluorescence near the 
kinetochores. (C) Kymographs from movie sequences of GFP-Kif15 expressing 
metaphase and anaphase cells; distance, horizontal axis; time, vertical axis; dark regions 
are chromosomes; spindle midzone to right. (D) Sequential frames (2 sec interval) from 
movies of GFP-Kif15 expressing control and Paclitaxel treated cells (inverted contrast); 
motion of fluorescent particles toward the kinetochore region (right in all panels) in 
control but not Paclitaxel treated cells. Green arrowheads mark moving puncta. (E) LLC-
Pk1 parental cells fixed and stained for microtubules and Kif15 (top) or TPX2 (bottom); 
control and Paclitaxel as indicated; merged images to the right. (E’) Bar graph showing 
quantification of images in E. (F) Cartoon showing GFP-Kif15 cells in the presence of 
STLC; bipolar spindle formation requires TPX2.  TPX2 could load Kif15 onto the 
microtubule, followed by motor motion to the microtubule + end (a) or TPX2 and Kif15 
could both localize to microtubule ends (b). Marker bars in A,B,C,D,E  =  2 μm; time 
scale in C, 30sec. 
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Figure 3.5 TPX2 constructs purified from bacteria and binding to microtubules in 
vivo. Western blot showing protein depletion following siRNA treatment. (A) TPX2, (B) 
Kif15. Tubulin was used as a loading control (lower).  For the blots shown, TPX2 was 
depleted 95% and Kif15 75.5%.  (C’, C’’) Polyacrylamide gel showing the truncated and 
full length TPX2 proteins used in in vitro experiments.  (D) Images of truncated TPX2-
mCherry constructs bound to microtubules in LLC-Pk1 cells depleted of full length TPX2 
using siRNA. Molecular weight of markers in kilodaltons.  Marker bar = 5 μm. 
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Figure 3.6 Depletion of Nuf2 reduces cold-stable kinetochore fibers.  LLC-Pk1 cells 
were treated with siRNA targeting Nuf2, treated with 5 M MG132 to arrest cells in 
metaphase, and then in ice-cold medium for 10 min, fixed and stained for microtubules 
and DNA. Bar = 2 μm.    
 99 
 
Figure 3.7 Tracking GFP-Kif15 and EB1 puncta in vivo. (A) TIRF microscopy of 
GFP-Kif15 expressing cells; region marked with red box is shown enlarged in lower 
panels; red arrowhead shows initial position of puncta (contrast inverted); yellow arrow 
marks puncta.  Time in seconds. Kymograph of an individual puncta of GFP-Kif15 
(upper right); time: vertical axis; distance: horizontal axis.  (B) GFP-Kif15 associates 
with kinetochore fibers in anaphase.  Image of GFP-Kif15 expressing cell fixed and 
stained with antibodies to Hec1 to mark kinetochores.  GFP-Kif15 (left) associates with 
fibers that end at Hec1 positive dots (middle). (C,D) Microtubule dynamics in LLC-Pk1 
cells treated with Paclitaxel.  (C) Live cells expressing GFP-EB1; control (left) and 
Paclitaxel treated (right). (D) Velocity of GFP-EB1 dashes in control and Paclitaxel 
treated.  Bar = 2 μm; error bars show Std. Dev. 
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CHAPTER 4 
 
SRC FAMILY KINASE PHOSPHORYLATION OF THE MOTOR DOMAIN OF 
THE HUMAN KINESIN-5, EG5 
This chapter is adapted from Bickel et al. 2017 and was completed with the guidance of 
Patricia Wadsworth. This project was performed in collaboration with Kathleen G. Bickel 
(Northwestern Medical School), Joshua S. Waitzman (Northwestern Medical School) and 
Taylor A. Poor (Northwestern Medical School) under the guidance of Dr. Sarah E. Rice 
(Northwestern Medical School). KGB performed in vitro phosphorylation assays, 
immunoprecipitations, and bacterial protein purifications. JSW performed initial in silico 
and in vitro work, ITC experiments and assisted KGB with microtubule gliding assays. 
JSW and TAP performed Mass Spectrometry and analysis (data not shown).  
4.1 Introduction 
Chromosome segregation during mitosis requires the mitotic spindle, a dynamic 
structure composed of microtubules (MTs), motor proteins, and non-motor MT-
associated proteins.  All spindles are bipolar and in most cell types, spindle bipolarity 
relies on the activity of kinesin-5 motor proteins (Blangy et al., 1995; Enos and Morris, 
1990; Goshima and Vale, 2003; Hagan and Yanagida, 1990; Hoyt et al., 1992; Kapitein 
et al., 2005; Scholey et al., 2014). The bipolar arrangement of tetrameric kinesin-5 family 
members allows them to crosslink and slide MTs originating from each of the two 
centrosomes, thus establishing the bipolar spindle (Kapitein et al., 2005).  Inhibition of 
the mammalian kinesin-5, Eg5, early in mitosis induces the formation of monopolar 
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spindles that are incapable of proper chromosome segregation (Goshima and Vale, 2003; 
Maliga et al., 2002). 
  During spindle formation, outward forces generated by kinesin-5 and other 
motors are opposed by motor-dependent inward forces.  How these forces are balanced 
and regulated remains incompletely understood (Brust-Mascher et al., 2009; Ferenz et al., 
2010; Saunders et al., 1997; Tanenbaum et al., 2008).  Past studies have shown that 
phosphorylation of the kinesin-5 tail domain and interaction with binding partners such as 
TPX2 are important for motor localization to the spindle (Blangy et al., 1997; Blangy et 
al., 1995; Ma et al., 2011; Ma et al., 2010).  Phosphatase and tensin homolog (PTEN) 
activity has also been shown to contribute to Eg5 localization (He et al., 2016).  Other 
work demonstrated that phosphorylation of the motor domain contributes to kinesin-5 
regulation in yeast and Drosophila (Avunie-Masala et al., 2011; Garcia et al., 2009; 
Shapira and Gheber, 2016; Shapira et al., 2017); whether similar modifications affect Eg5 
is not yet established.  
  Although Eg5 is mostly degraded as cells exit mitosis (Uzbekov et al., 1999; 
Venere et al., 2015), some studies show an interphase function for the motor in neurons, 
where it contributes to neuronal migration and growth cone behavior (Falnikar et al., 
2011; Myers and Baas, 2007; Nadar et al., 2008; Venere et al., 2015).  Eg5 fails to 
undergo cell-cycle regulated degradation in patient-derived glioblastoma cells and 
contributes to the invasive behavior of these cells (Venere et al., 2015). These data 
suggest that Eg5 function is precisely regulated by a variety of mechanisms, and that 
dysregulation of Eg5 function can contribute to human disease.   
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 Here we present evidence that Eg5 is phosphorylated at three sites in its motor 
domain by Src family kinases (SFKs) in mammalian cells. This phosphorylation 
modulates Eg5 activity in vitro and spindle morphology in vivo.  Several SFKs, 
particularly those that are activated and upregulated in mitosis (c-Src, Fyn, c-Yes, and 
Lyn; (Kuga et al., 2007) overlap in substrate and inhibitor specificity (Thomas and 
Brugge, 1997).  Therefore, in this work we refer to the SFKs as kinases collectively 
acting on Eg5, except when discussing experiments that specifically use c-Src.  SFKs are 
best known for activating cell proliferation, migration, and cytoskeletal reorganization 
(Sen and Johnson, 2011). Their dysregulation also contributes to oncogenesis (Kim et al., 
2009) and recent data points to a new role for SFKs in regulating spindle establishment 
and orientation (Nakayama et al., 2012).  Other recent work suggests that 
phosphotyrosine (pTyr) modifications are more prevalent than previously appreciated, 
particularly in the kinetochore/spindle region and particularly by SFKs (Caron et al., 
2016).  To date, however, few mitotic SFK targets have been identified and none of them 
are known to regulate the MT cytoskeleton (Bhatt et al., 2005; Fumagalli et al., 1994; 
Wang et al., 2008).  SFK phosphorylation of the Eg5 motor domain is potentially a novel 
regulatory mode that links SFK activity to the MT cytoskeleton during spindle 
establishment and may provide insight into how Eg5 becomes dysregulated in the context 
of cancer.  
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4.2 Results and Discussion 
4.2.1 Endogenous Eg5 is phosphorylated on motor domain tyrosines in mammalian 
cells  
To test whether Eg5 is phosphorylated on tyrosine residues, we 
immunoprecipitated Eg5 from HEK293T cells and used a two-color Western blot to 
probe for tyrosine phosphorylation (Fig. 4.1 A; signals from red (Eg5) and green (pTyr) 
channels are displayed separately).  We observed co-localization of pTyr and Eg5 signals, 
suggesting that human Eg5 is phosphorylated on tyrosines.  Additionally, we observed 
tyrosine phosphorylation of Eg5 immunoprecipitated from pig-derived LLC-Pk1 cells 
(Fig. 4.1 A).  Treatment of immunoprecipitated Eg5 with lambda phosphatase diminished 
pTyr signal (Fig. 4.4 A), confirming that the anti-pTyr antibody binds specifically to 
phosphorylated protein.  These data and previous work showing that Eg5 is 
phosphorylated at multiple tyrosines in the motor domain (Fig. 4.1 B, 4.4 B; (Han et al., 
2010; Hornbeck et al., 2015; Iliuk et al., 2010; Kim et al., 2010; Li et al., 2009; Luo et al., 
2008) establish that mammalian Eg5 is phosphorylated on tyrosines. 
 
4.2.2 Src kinase phosphorylates Eg5 more efficiently than Wee1 in vitro 
Previous data reported that the mitotic kinase Wee1 phosphorylates the 
Drosophila kinesin-5, KLP61F, at three tyrosines in the motor head, including the 
tyrosine homologous to mammalian Y211 (Garcia et al., 2009).  However, querying the 
complete Eg5 peptide sequence in the Scansite 3 kinase predictor site (Methods; 
(Obenauer et al., 2003) suggested SFKs as potential kinases targeting Y211.  In addition, 
a Src homology domain 3 (SH3) targeting sequence (–PXXP−) is located in the MT 
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binding face of several kinesin-5s, including Eg5 (Fig. 4.1 B, inset, Fig. 4.1 C and Fig. 
4.4 C-D; (Kim et al., 2010).  Furthermore, post-translational modification databases 
recorded Y125, Y211, and Y231 as phosphorylation sites in the motor domain (Fig. 4.4 
B; (Hornbeck et al., 2015; Li et al., 2009).  We performed in vitro kinase assays to test 
whether Eg5 motor heads could be phosphorylated on these residues and to compare the 
ability of c-Src and Wee1 to phosphorylate Eg5 motor heads in vitro (Fig. 4.2 A, B).   
For all in vitro kinase assays we used a previously well-characterized 367-amino 
acid monomeric Eg5 motor head construct (Eg5-367; (Cochran and Gilbert, 2005; 
Cochran et al., 2004; Maliga et al., 2002) that additionally harbored an E270A mutation 
in the active site (termed Eg5-367 E270A; in KLP61F-364, E266A was mutated, Fig. 4.4 
E, F).  This mutation served to abolish the basal ATPase activity of Eg5 and thus to 
prevent motor heads from depleting the kinase’s supply of ATP during the assay 
(Methods; (Kull et al., 1996).  We incubated either human c-Src or human Wee1 (Fig. 4.2 
A, B) with the indicated kinesin-5 substrates and radiolabeled ATP.  In addition to Eg5-
367 E270A and KLP61F E266A, we also tested a non-phosphorylatable Eg5 mutant with 
phenylalanines at the three putative sites (Eg5-367-3Y->F E270A), and a -PXXP-null 
mutant (Eg5-367-GSTY E270A) as kinase substrates (Methods; Fig. 4.4 E).  c-Src 
robustly phosphorylated Eg5-367 E270A and KLP61F E266A motor heads under these 
conditions (Fig. 4.2 A). c-Src phosphorylated the -PXXP-null construct Eg5-367-GSTY 
E270A in vitro, albeit markedly less efficiently than wild-type (Fig. 4.2 A), suggesting a 
role for the –PXXP- targeting motif in Eg5 phosphorylation.   In contrast to c-Src, Wee1 
showed minimal phosphorylation of all motor head constructs, including Drosophila 
KLP61F E266A, despite robust autophosphorylation (Fig. 4.2 B). 
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To identify the residues phosphorylated by c-Src, we performed an in vitro 
phosphorylation assay with purified Eg5 motor heads and c-Src kinase, and performed 
liquid chromatography-mass spectrometry (LC-MS) on the trypsinized protein products.  
The LC-MS data confirmed that c-Src phosphorylated Y211 and Y231 (data not shown; 
provided by KGB). We generated a construct harboring Y211F and Y231F mutations as 
well as the E270A mutation and showed that it was still robustly phosphorylated by c-
Src.  However, an additional Y125F mutation diminished c-Src phosphorylation of Eg5 
to near background levels (data not shown).  Notably, c-Src showed no phosphorylation 
of Eg5-367-3Y->F E270A (Fig. 4.2 A), despite the presence of 7 other tyrosines in the 
motor head, confirming c-Src phosphorylates Y125.  These data show that c-Src 
phosphorylates Eg5 on Y125, Y211, and Y231, and that this effect is aided by the 
presence of the SH3-targeting –PXXP- motif in the Eg5 MT binding domain.   
 
4.2.3 SFKs phosphorylate Eg5 in mammalian cells 
To examine the ability of c-Src to phosphorylate Eg5 motor heads on Y125, 
Y211, and Y231 in the cellular environment, we transfected HEK293T cells with either a 
constitutively active human c-Src construct (c-Src-Active, Fig. 4.4 F), a C-terminal myc-
tagged Eg5 motor head construct (Eg5-367myc), or both.  We then immunoprecipitated 
Eg5-367myc from the cells and analyzed the motor heads for phosphorylation by two-
color Western blot (Fig. 4.2 C, Methods).  In cells co-transfected with c-Src-Active and 
either Eg5-367myc-WT or Eg5-367myc-GSTY, robust phosphorylation was observed.  
However, c-Src-Active did not phosphorylate Eg5-367myc-3Y->F.  This result shows 
that c-Src is capable of phosphorylating Eg5 motor heads in a cellular environment and 
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that it likely phosphorylates Eg5 on the Y125, Y211, and Y231 residues.  We did not 
detect phosphorylation of transfected Eg5-367myc by endogenous SFKs in cells lacking 
a transfected c-Src-Active construct, as we did for endogenous Eg5.  This apparent 
difference may be because the expressed motor heads lack the tail domain, which is 
required for localization of Eg5 to spindles (Blangy et al., 1995; Rapley et al., 2008), 
where a subset of SFKs is known to localize during mitosis (David-Pfeuty et al., 1993; 
Levi et al., 2010; Ley et al., 1994).  Phosphorylation was not observed in cells co-
transfected with c-Src-Active and Eg5 motor heads and treated with the SFK-specific 
inhibitor, A-419259 (Fig. 4.2C; (Calderwood et al., 2002).  This confirms that 
phosphorylation of Eg5-WT and Eg5-GSTY motor heads was due to c-Src-Active.   
Finally, we used a chemical genetics approach to determine whether SFKs 
phosphorylated endogenous Eg5 in cells.  We transfected HEK293Ts with either an 
empty vector control, cSrc-Active, or a constitutively active point mutant of c-Src that is 
resistant to A-419259 (cSrc-IR, Fig. 4.4 F), with or without treatment with A-419259, 
and measured endogenous Eg5 phosphorylation (Fig. 4.2 D).  Phosphorylation of 
endogenous Eg5 was detected even in the absence of transfected c-Src but was 
significantly enhanced following transfection of cSrc-Active. In both cases treatment 
with A-419259 abrogated Eg5 phosphorylation.  In contrast, Eg5 from cells transfected 
with the resistant cSrc-IR showed robust phosphorylation regardless of whether they 
were treated with A-419259.  These results strongly suggest that Eg5 tyrosine 
phosphorylation in cells is dependent on SFK activity.   
In summary, these data show Eg5 is phosphorylated in an SFK-dependent manner 
at the same three residues both in vitro and in cells.  Also, since the A-419259 inhibitor 
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that blocked Eg5 phosphorylation in cells is relatively specific for SFKs (Calderwood et 
al., 2002; Wilson et al., 2002), these results give us confidence that SFKs phosphorylate 
Eg5.   
 
4.2.4 Tyrosine phosphomimetic mutants alter Eg5 activity in vitro 
Since Eg5 motor domains are phosphorylated in an SFK-dependent manner, we 
tested how phosphomimetic mutations at Y125, Y211, and Y231 affect Eg5 motor 
activity. For these experiments we generated phosphomimetic (E) and non-
phosphorylatable (F) mutants of Eg5-367, as well as the -PXXP-null mutant, Eg5-367-
GSTY (Fig. 4.4 E). We measured both the MT-stimulated ATPase rate and MT-sliding 
motility velocities (Methods) for each mutant and compared these rates to both wild-type 
monomeric Eg5 motor heads and an Eg5-367 construct lacking the eight residues 
125YTWEEDPL132 from loop L5 (Eg5-367-DL5, Fig. 4.4 E; (Maliga et al., 2002). L5 
includes Y125 and lies near Y211.  The Eg5-Y211E phosphomimetic mutant exhibited 
the greatest changes in activity, with an ATPase rate and sliding velocity that were two-
fold and three-fold decreased compared to wild-type, respectively (Table 4.1).  In fact, 
Eg5-367-Y211E motor properties were quite similar to those of Eg5-367-DL5 (Table 
4.1), consistent with the idea that SFK-dependent phosphorylation may regulate Eg5 by 
directly altering its motor characteristics, although other mechanisms are possible.   
L5 is the binding site for many small molecule inhibitors of Eg5 (Maliga et al., 
2002) some of which are in clinical trials for use as cancer therapy (Sarli and Giannis, 
2008).  One could speculate based on our results that Eg5 phosphorylation may affect 
inhibitor efficacy, and vice-versa (Smith et al., 2015).  As a preliminary test of this, we 
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conducted isothermal calorimetry (ITC) experiments (methods and data provided by 
KGB) to measure the binding affinity of the Eg5-367 phosphomimetic and non-
phosphorylatable mutants for the inhibitor s-trityl-L-cysteine (STLC), which binds near 
L5 in human Eg5 (Kim et al., 2010; Skoufias et al., 2006a).  The ITC data showed that 
each of the phosphomimetic mutations significantly diminished STLC binding to Eg-367, 
and the largest effect was observed for the Y211 E mutant (Table 4.1).  Binding of STLC 
to the non-phosphorylatable mutants was similar to wild-type (Table 4.1).  
Phosphomimetic mutations give only a first approximation of the effects of a 
uniformly phosphorylated protein sample, but the latter is nearly impossible to generate.  
Corroborating our results, L5 is a major conformational regulator of the Eg5 
mechanochemical cycle, and several mutations and deletions in this region diminish 
motor activity (Behnke-Parks et al., 2011; Kaan et al., 2009; Maliga and Mitchison, 2006; 
Maliga et al., 2006; Muretta et al., 2013; Waitzman et al., 2011).  Furthermore, key 
structural transitions during the Eg5 mechanochemical cycle require pi-stacking and 
hydrophobic interactions between Y211 and residues in L5, specifically W127; L5 
inhibitors bind through similar interactions (Muretta et al., 2015).  By introducing a 
negatively-charged glutamate residue at position 211 we are most likely abolishing those 
interactions. It is worth noting that phosphate groups have double the negative charge and 
increased bulk relative to glutamate (Waksman et al., 1992).  In summary, the available 
structural data suggest that any substantial modification in the L5 region, including 
phosphomimetic mutation or phosphorylation, is likely to affect Eg5 motor properties, 
and that phosphorylating Y211 would be at least as disruptive to the mechanochemical 
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cycle as a glutamate phosphomimetic mutation.  Based on these results and our ITC data, 
we would expect that phosphorylation would similarly disrupt L5 inhibitor binding.   
 
4.2.5 SFK phosphorylation of Eg5 regulates spindle morphology 
Because Eg5 plays a critical role in mitotic spindle assembly and maintenance, we 
next assessed the effects of SFK phosphorylation of Eg5 on mitotic spindle morphology. 
LLC-Pk1 cells were used for these studies because they remain relatively flat during 
mitosis, facilitating imaging.  In initial experiments, we transfected cells with plasmids 
encoding Emerald-tagged Eg5 with mutations at Y125, Y211, and Y231, to generate 
stable cell lines for use in experiments.  Despite multiple attempts, we were unable to 
achieve this, suggesting that these mutants have deleterious effects on cell division.  Next 
we adapted and optimized a previously described protein replacement strategy (Gable et 
al., 2012; Zaytsev et al., 2014), in which we expressed Emerald-tagged Eg5 wild-type, 
phosphomimetic, and non-phosphorylatable mutants, while simultaneously inhibiting 
endogenous Eg5 expression using siRNA (Methods).  For these experiments, we targeted 
Y211, which has been shown to alter mitosis in Drosophila (Garcia et al., 2009) and 
resulted in the most pronounced defects in Eg5 motor behavior in vitro (Table 4.1).  
Using this protocol, endogenous Eg5 protein levels decreased to approximately 50% of 
wild-type (Fig. 4.5) which caused cells to exhibit a large percentage of monopolar 
spindles (56% of cells), consistent with previous work (Goshima and Vale, 2003; Ma et 
al., 2010; Mayer et al., 1999; Skoufias et al., 2006a). Spindle bipolarity was rescued 
(81%) when LLC-Pk1 cells were co-transfected with Eg5 siRNA and an siRNA-resistant 
Eg5-WT-Emerald construct (Eg5-WT-Em, Fig. 4.3 A).  In contrast, co-transfection of 
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cells with siRNA and siRNA-resistant phosphomimetic Eg5-Y211E-Em resulted in a 
significant increase in monopolar spindles as compared to the wild-type rescue construct 
(p < 0.01), suggesting that modification of this site inhibits Eg5 activity in mitosis (Fig. 
4.3 A). When this site was made non-phosphorylatable (Y211F) there was also a 
significant increase in spindle defects, specifically disorganized spindles (p<0.01).  
Aberrant spindles that could not be designated as monopoles or multipoles and included 
spindles with extra foci, fragmented poles, shorter length, and bent morphology were 
classified as disorganized (Fig. 4.3 A).  In addition to these phosphomimetic and non-
phosphorylatable mutants, we also tested the -PXXP-null mutant (GSTY) which alters 
the MT binding site. As expected, since the GSTY mutation weakens MT binding by Eg5 
(Table 4.1), there was a significant increase in monopolar spindles as compared to the 
wild-type rescue construct (p<0.01). 
To determine whether the monopolar spindle phenotype resulted from spindle 
collapse or from failure of centrosome separation we performed live cell imaging of 
mCherry-tubulin-expressing LLC-Pk1 cells.  Cells co-transfected with siRNA targeting 
Eg5 and rescued with Eg5-WT-Em progressed through mitosis (Fig. 4.3 B). In contrast, 
cells rescued with Eg5-Y211E-Em initially formed a bipolar spindle that eventually 
collapsed into a monopolar spindle. Residual endogenous Eg5 in the siRNA treated cells, 
or the presence of Kif15, which functions redundantly with Eg5, could support the initial 
bipolarization in these cells (Tanenbaum et al., 2009; Vanneste et al., 2009).  Distinct 
from the monopolar spindles observed in cells rescued with Eg5-Y211E-Em, cells 
rescued with Eg5-Y211F-Em formed disorganized spindles, consistent with the 
disorganized phenotype observed in fixed cells (Fig. 4.3 B). 
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While phosphomimetic Eg5 is an imperfect substitution for phosphorylated 
protein, generating cells with hyper-phosphorylated Eg5 is not trivial.  Mitosis involves a 
complicated and inter-connected network of kinase signaling that is highly regulated 
(Caron et al., 2016).  Simply over-expressing c-Src kinase would not guarantee that Eg5 
is hyper-phosphorylated at Y211 and the interpretation of spindle phenotypes would be 
complicated by the effect of c-Src overactivation on other mitotic targets, potentially 
including other mitotic kinases.  Thus, the use of phosphomimetics allows us to examine 
the effects in cells of introducing a negative charge at position 211 directly. 
In addition to evaluating spindle phenotypes using cells expressing non-
phosphorylatable and phosphomimetic mutants of Eg5, we treated non-synchronized 
LLC-Pk1 cells with the SFK inhibitor SU6656.  Similar to our observations in LLC-Pk1 
cells expressing the non-phosphorylatable Eg5-Y211F-Em, we observed that LLC-Pk1 
cells treated with SU6656 (Methods) displayed high percentages of disorganized mitotic 
spindles (Fig. 4.3 C, D).  Consistent with this, Nakayama et al. observed mis-oriented 
spindles in HeLa cells treated with the SFK inhibitor PP2 (Nakayama et al., 2012).  The 
SU6656 inhibitor we used has been reported to have some activity on other kinases that 
contribute to spindle formation, for example, Aurora kinases (Bain et al., 2007). To 
determine if treatment with SU6656 inhibits Aurora A, we stained LLC-Pk1 cells for 
phosphorylated Aurora A after treatment with SU6656 (Fig. 4.3 E).  Phosphorylated 
Aurora A was detected at spindle poles/centrosomes, similar to controls.  Additionally, 
cells treated with BI-2536, an inhibitor of the mitotic kinase Plk1, showed a phenotype 
distinct from cells treated with SU6656, with pronounced bundling of interzonal 
microtubules in anaphase (Fig. 4.3 F; (Brennan et al., 2007).  Under these conditions 
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(Methods), we did not observe a statistically significant increase in disorganized spindles 
as with SU6656 or monopolar spindles as had been previously reported (Lenart et al., 
2007). These results suggest that SFK inhibition alters spindle phenotypes in a manner 
distinct from inhibition of other mitotic kinases indicating that the phenotype of cells 
treated with SU6656 is not due to off-target effects.   
Distinct spindle phenotypes were observed in LLC-Pk1 cells transfected with 
either Eg5-Y211E-Em or Eg5-Y211F-Em mutants suggesting that the optimal properties 
of Eg5 are tuned by phosphorylation such that abnormal mitotic phenotypes can occur 
when Eg5 is either hyperphosphorylated or hypophosphorylated at this site. The simple 
model is that Eg5 phosphorylation at Y211 alters spindle phenotypes by inhibiting its 
motor activity, because of the inhibitory effects seen in Table 4.1 and the monopolar 
phenotype in cells expressing Eg5-Y211-E-Em (Goshima and Vale, 2003; Ma et al., 
2010; Mayer et al., 1999; Skoufias et al., 2006a).  Furthermore, the largely monopolar 
spindle phenotype of cells expressing the phosphomimetic Y211E mutant is consistent 
with the decrease in Eg5 motor activity that is observed when cells are treated with L5 
inhibitors, which are thought to act by a similar mechanism (Maliga et al., 2002; Muretta 
et al., 2015).  Finally, it is worth noting that in many systems, Eg5 plays an important role 
in centrosome separation (Tanenbaum et al., 2008; van Ree et al., 2016; Whalley et al., 
2015) and the monopolar phenotype observed in cells expressing Eg5-Y211E-Em could 
be due to abnormal Eg5 activity during this earlier phase of mitosis. 
It is less simple to speculate about how overactive Eg5 would cause the 
multipolar/disorganized spindle phenotype observed in the Eg5-Y211F-Em transfected 
LLC-Pk1 cells.  One possibility is that excessive force from Eg5 in the spindle midzone 
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could lead to disorganized spindles.  A second possibility is that phosphorylation of Eg5 
Y211 could also modulate Eg5 localization, protein turnover rates, or its ability to bind 
MTs, as was observed for the yeast kinesin 5, Cin8p (Shapira and Gheber, 2016).  
Regardless of how the multipolar/disorganized spindle phenotype arises, its physiological 
relevance is reinforced by its similarity to the spindle phenotype observed in cells in 
which SFKs are inhibited, which has both been observed by other groups and is distinct 
from the phenotypes observed when other mitotic kinases are inhibited (Bain et al., 2007; 
Brennan et al., 2007; Nakayama et al., 2012).  
Given that endogenous Eg5 is homotetrameric (Kapitein et al., 2005; Scholey et 
al., 2014; van den Wildenberg et al., 2008), it is likely that not all of the Eg5 motor heads 
in a homotetramer are phosphorylated. Eg5 motor heads are highly cooperative when 
assembled into dimers (Krzysiak and Gilbert, 2006; Krzysiak et al., 2008), with dimers 
having distinct kinetic properties from monomers (Cochran et al., 2006; Krzysiak and 
Gilbert, 2006).  Additionally, recent structural studies of the Eg5 coiled-coil domain 
responsible for the assembly of Eg5 into homotetramers suggests that instead of being a 
dimer of dimers, each subunit in an Eg5 homotetramer directly contacts every other 
subunit in a highly intertwined and unique coiled-coil structure (Scholey et al., 2014).  
These data suggest that phosphorylation of even one motor head within the Eg5 
homotetramer could alter the function of the molecule. There is also a substantial body of 
evidence that mitotic spindle establishment and maintenance involves a balance of forces 
(Brust-Mascher et al., 2009; Saunders et al., 1997; Tanenbaum et al., 2008), making it 
feasible that even small changes to Eg5 motor activity could disrupt this balance. In 
support of this possibility, we observed that endogenous Eg5 was only reduced to 50% of 
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wild-type levels in our experiments using LLC-Pk1 cells, so one can imagine that many 
Eg5 homotetramers in our experiments had both mutant and wild-type subunits.  Despite 
this, nearly 90% of cells in those experiments had monopolar spindles (Fig. 4.3 A).  The 
severity of this defect supports the view that either not all of the motors in a 
heterotetrameric motor are simultaneously modified, or that Eg5 undergoes a cycle of 
phosphorylation and dephosphorylation in vivo.  
In summary, these experiments revealed a significant mitotic phenotype in LLC-
Pk1 cells expressing Eg5 with phosphomimetic and non-phosphorylatable mutations at 
Y211, the same site that was shown to impact spindle assembly in Drosophila (Garcia et 
al., 2009). Y211 is a particularly interesting site because it is conserved in both insects 
and vertebrates, coinciding almost without exception with the presence of a –PXXP− 
SH3-targeting domain (Fig. 4.1 B, Fig. 4.4 D). Conversely, neither Y211 nor the -PXXP− 
motif is found in worms, which are viable with diminished levels of kinesin-5, suggesting 
that this organism has evolved alternative pathways for establishing bipolar spindles 
(Bishop et al., 2005).   
Motor domain phosphorylation has also been described for the yeast kinesin-5, 
Cin8p (Avunie-Masala et al., 2011; Shapira and Gheber, 2016; Shapira et al., 2017).  
Only one of these sites, S337 (H. sapiens numbering) is in a region of the motor that is 
conserved in Eg5.  Phosphorylation of each of these sites has unique effects on motor 
behavior including Cin8p microtubule binding, motor directionality, and velocity 
(Shapira and Gheber, 2016; Shapira et al., 2017).  Although the precise locations of these 
modifications are not conserved from yeast to humans, one notable similarity amongst 
these modifications is that the changes to Cin8p motor behavior are primarily mediated 
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by electrostatic interactions, which we find to be a compelling hypothesis for the effects 
of Eg5 Y211 phosphorylation given the available structural data.  Future experiments 
examining phosphorylation of kinesin-5 motors could illuminate the extent of their 
modifications and could reveal a potential mechanism by which kinesin-5s are 
differentially regulated to play similar, but non-identical, roles in varying cell types and 
species. 
Our results support a growing body of data identifying phosphoregulatory 
mechanisms governing the activity of several different kinesin motors (for example: 
(Chee and Haase, 2010; DeBerg et al., 2013; Garcia et al., 2009). Previously identified 
Eg5 phosphoregulatory mechanisms target serine or threonine residues in the motor stalk 
and tail, and have been reported to affect Eg5 localization to the spindle or centrosome 
during mitosis (Blangy et al., 1995; Rapley et al., 2008).  Our results showing 
phosphorylation of Eg5 in its motor domain at Y125, Y211, and Y231 suggest that in 
addition to altering motor localization, phosphoregulatory mechanisms can tune Eg5 
enzymatic activity for optimal spindle morphology (Avunie-Masala et al., 2011; Garcia et 
al., 2009).  Furthermore, our data suggest this post-translational modification could affect 
the efficacy of small molecule inhibitors that bind to L5, although further study is 
required to gauge whether this has any practical implications for use of Eg5 inhibitors as 
cancer therapy. 
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4.3 Materials and Methods 
4.3.1 In silico prediction of phosphorylated residues in Eg5 and targeting kinases 
There are several databases summarizing the results of large-scale proteomics 
experiments that provide evidence for the post-translational modification of specific 
residues in thousands of proteins.  We searched PhosphositePlus (Hornbeck et al., 2015) 
and SysPTM (Li et al., 2009) for modifications entered for human Eg5 and narrowed the 
list of modifications down to tyrosine phosphorylations.  We also did a manual search of 
PubMed articles for entries presenting phosphoproteomics experiments that included 
human Eg5 in their results.  These searches generated a list of putative tyrosine 
phosphorylation sites in Eg5 (summarized in Fig. 4.4 B).   
 To generate hypotheses regarding possible kinases targeting human Eg5, we 
entered its full sequence as found in the UniProt database (accession number P52732, 
(UniProt, 2015) into the search engine found in the Scansite3 kinase predictor site 
(Obenauer et al., 2003).  We used the “medium stringency” setting, which returns kinases 
for which the queried protein sequence is in the top percentile of sequences in the 
vertebrate subset of SWISS-PROT matching the optimal targeting motif (Obenauer et al., 
2003).  This search revealed three SFKs as possible kinases targeting the Y211 location.  
It also revealed a –PXXP− SH3 targeting site.   
 
4.3.2 Cloning  
Mutagenesis of the Eg5-367 monomer construct has been described previously 
(Larson et al., 2010). Briefly, Eg5-367 constructs for bacterial expression include the first 
367 amino acids of H. sapiens Eg5 immediately followed by a C-terminal 6X-histidine 
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tag in a pRSET plasmid.  KLP61F-364 constructs include the first 364 amino acids of the 
Drosophila kinesin-5, KLP61F, similarly followed by a 6X-histidine tag.  
Phosphomimetic (Y->E) and non-phosphorylatable (Y->F) point mutations were made 
using Quikchange site-directed mutagenesis (Agilent Technologies, Santa Clara, CA), as 
were enzymatically inactive mutations (E270A in Eg5-367 and E266A in KLP61F).  To 
generate an Eg5-367 mutant lacking the -PXXP- SH3-targeting motif in its MT-binding 
domain, site-directed mutagenesis was used to replace residues 305RTPH308 with the 
homologous residues in H. sapiens kinesin-1 heavy chain (GSTY).  This removes the 
initial proline from the SH3 targeting motif. The resulting motor can still hydrolyze ATP 
and bind MTs, albeit at reduced affinity (Table 4.1).  
For expression in mammalian cells, we replaced the C-terminal 6X-histidine tag 
of Eg5-367 constructs with a 10-residue Myc tag (EQKLISEEDL). Myc-tagged Eg5-367 
constructs were then cloned into the pcDNA3 vector (gift of Dr. Cara Gottardi, 
Northwestern University) between the Xho1 and HindIII restriction sites using Phusion 
polymerase (New England Biolabs, Ipswich, MA).  All constructs were verified by 
sequencing.  A mammalian c-Src construct in the pCMV-SPORT6 mammalian 
expression plasmid was a kind gift from Dr. Thomas Smithgall, University of Pittsburgh.  
This construct was mutated using Quikchange site-directed mutagenesis to generate a 
constitutively active c-Src construct (Y527F).  This constitutively active construct was 
then further mutated to render it resistant to treatment with A-419259 (T338M, (Meyn 
and Smithgall, 2009).  All c-Src construct numbering refers to the structure of human c-
Src (PDB: 1FMK).   
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The Eg5-Emerald wild-type (Eg5-WT-Em) construct consisted of full-length 
human Eg5 fused to pmEmerald with an 18 amino acid linker; expression is under the 
control of a pCMV promoter.  This construct was used to express fluorescent Eg5 in 
LLC-Pk1 cells, was a gift from the late Dr. Michael Davidson Florida State University 
and was made siRNA resistant using PCR site-directed mutagenesis (Forward primer: 
GTCACAAAAGCAATGTGGAAACCTAACTGAAGATCTCAAGACTATAAAGCAG
ACCC; reverse primer: 
CAAAGTTCCTGGGAATGGGTCTGCTTTATAGTCTTGAGATCTTCAGTTAGGTT
TCC) and verified by sequencing. Each mutant was then made in this backbone using 
PCR site-directed mutagenesis and verified by sequencing.   
 
4.3.3 Protein Expression and Purification 
Expression and purification of Eg5-367 constructs has been described previously 
(Larson et al., 2010).  Briefly, 6x-His-tagged Eg5-367 and KLP61F-364 constructs were 
transformed into E. coli BL21-CodonPlus(DE3)-RP cells for expression. Cells were 
grown in TPM media (2% tryptone, 1.5% yeast extract, 137 mM NaCl, 14 mM 
Na2HPO4) with in 50 µg/mL carbenicillin and 34 µg/mL chloramphenicol at 37  C while 
shaking at 200 rpm until cells reached an OD600 between 0.6 and 1.0. Plasmid expression 
was induced through the addition of 0.125 mM IPTG.  Cells were allowed to express at 
18  C overnight.  2 L cultures were then harvested by centrifugation (6,300 rpm for 10 
min at 4  C) and re-suspended in 20 mL Eg5 lysis buffer (10 mM HEPES, 2 mM MgCl2, 
1 mM EGTA, 5% sucrose, 0.02% polyoxyethylenesorbitan monolaurate (TWEEN-20), 
10 M ATP, leupeptin (1  g/mL), aprotinin (1 g/mL), pepstatin (1 g/mL), and 100 
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M PMSF, pH 8).  Cells were lysed by sonication and the clarified lysate was batch-
bound with pre-equlibrated nickel-nitrilotriacetic acid resin (Qiagen, Valencia, CA) for 2 
h at 4  C.   The resin was washed with nickel wash buffer (10 mM HEPES, 2 mM 
MgCl2, 1 mM EGTA, 5% sucrose, 0.02% TWEEN-20, 10 M ATP, 300 mM NaCl, and 
20 mM imidazole, pH 6) and bound protein eluted in 5 mLs using nickel elution buffer 
(10 mM HEPES, 2 mM MgCl2, 1 mM EGTA, 5% sucrose, 0.02% TWEEN-20, 10 M 
ATP, 300 mM NaCl, and 400 mM imidazole, pH 6).  Peak fractions were collected and 
diluted 20-fold in Buffer A (10 mM HEPES, 2 mM MgCl2, 1 mM EGTA, 5% sucrose, 
0.02% TWEEN-20, 10 M ATP, 1 mM DTT pH 6) to decrease the ionic strength of the 
buffer.  Diluted fractions were then purified further on a 5 mL HiTrap S-Sepharose cation 
exchange column (GE Healthcare, Little Chalfont, UK).  Protein was eluted using a linear 
0.05-1 M NaCl gradient.  Peak fractions were identified by SDS-PAGE and pooled.  
After adding an additional 15% sucrose, protein was flash-frozen in liquid nitrogen and 
stored at -80  C until use.   
 
4.3.4 In vitro kinase assay 
 E. coli-purified Eg5-367 E270A and KLP61F-364 E266A proteins were first 
dialyzed against Src kinase assay buffer (10 mM HEPES pH 6.8, 2 mM MgCl2, 1 mM 
EGTA, 2.0 mM DTT, 10% glycerol, 0.02% TWEEN-20). Each reaction contained 3 μM 
Eg5 protein, [32P]-ATP (Perkin-Elmer) to 50 nCi acitivity per reaction, and 200 μM 
ATP.  Src kinase (Invitrogen, Carlsbad, CA) was diluted to a concentration of 2 M in 
assay buffer with 0.2 mg/mL BSA (Sigma-Aldrich, St. Louis, MO), and 2 L of this 
solution was added to each 20 L reaction. Reactions were incubated at 30 º C for the 
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indicated reaction times, quenched with SDS sample buffer and run on an SDS-PAGE 
gels using the formulation of Laemmli (Laemmli, 1970). Gels were dried and exposed to 
film for 30 min.  
 Wee1 kinase assays were performed identically except for the buffer used.  A 
Wee1 kinase assay buffer based on conditions cited by Garcia et al. (Garcia et al., 2009) 
was used instead (50 mM HEPES ph 6.8, 15 mM MgCl2, 1 mM EGTA, 2 mM DTT, 10% 
glycerol).  
 
4.3.5 Coupled-enzyme ATPase assay 
 MTs were purified from porcine brains according to published protocol 
(Mitchison and Kirschner, 1984).  A subset were labeled with tetramethylrhodamine (as 
described in (Hyman et al., 1991a). For use in coupled-enzyme ATPase assays, MTs 
were prepared exactly as described in (Woehlke et al., 1997).  ATPase assays were 
performed as described previously, with 10-60 nM Eg5 protein (Huang and Hackney, 
1994; Woehlke et al., 1997). Briefly, reactions were conducted in ATPase assay buffer 
(10 mM HEPES, 2 mM MgCl2, 1 mM EGTA, 5% sucrose, 50 mM KCl, 500 nM ATP).  
Eg5-367 protein and MTs were incubated with a coupled NADH oxidation system (0.3 
M phosphoenolpyruvate, 0.5 M NADH, pyruvate kinase (11 U/mL), and lactate 
dehydrogenase (10 U/mL)).  We calculated the decrease in absorbance at 340 nm over 
time to determine the ATPase rate. ATPase rates were determined at MT concentrations 
from 60 nM - 4 μM, and data were fit to a Michaelis-Menten shown below (R2 > 0.8) 
with kcat and K0.5, MTs as the only two fit parameters using KaleidaGraph software 
(Synergy Software, Reading, PA). Errors shown are errors in fit parameters. 
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𝜈 =
𝑘𝑐𝑎𝑡[𝑡𝑢𝑏𝑢𝑙𝑖𝑛]
𝐾0.5𝑀𝑇𝑠 + [𝑡𝑢𝑏𝑢𝑙𝑖𝑛]
 
 
4.3.6 Motility assay 
 For use in motility assays, a mixture of tetramethylrhodamine-labeled tubulin 
(Cytoskeleton, Inc., Denver, CO) and unlabeled tubulin was combined 1:1 with a 2X 
polymerization mix (80 mM Pipes buffer, 1 mM MgCl2, 1 mM EGTA, 2 mM GTP, 20% 
DMSO, pH 6.8) and incubated at 37  C for 45 min.  Paclitaxel (50 M) was then added 
to stabilize MTs.  For motility assays flow chambers were created using glass coverslips, 
microscopy slides, and double-sided tape. Anti-His H8 antibody (ab18184, Abcam, 
Cambridge, MA) in motility buffer (80 mM PIPES, pH 6.8, 2 mM MgCl2, 1 mM EGTA, 
0.2 mg/mL BSA, 150 mM sucrose and 1 mM ATP) was incubated in the flow chamber 
for two minutes. The flow chamber was then washed three times with motility buffer.  
Next, the flow chamber was incubated with motility buffer containing Eg5-367 proteins 
for two minutes, before being washed three times with motility buffer.  Finally, motility 
buffer containing an oxygen scavenging system (glucose oxidase (0.432 mg/mL), 
catalase (0.072 mg/mL), glucose (45 mM), and -mercaptoethanol (61 mM), an ATP 
regenerating system (2 mM creatine phosphate and 810 U/mL creatine phosphate), and 
tetramethlyrhodamine-labeled polymerized MTs stabilized with GTP (1 mM) and 
paclitaxel (100 M) was flowed into the cell, which was then sealed with vacuum grease.  
MT sliding was visualized on a Nikon TE-2000 E microscope fitted with a X60 objective 
(N. A. 1.4) using epifluorescence.  Images were captured using a Photometrics CoolSnap 
EZ camera (1392 x 1040 imaging pixels, 6.45 x 6.45 m/pixel) and Metamorph software.  
The concentration of MTs and Eg5-367 construct was adjusted to promote sliding 
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populations suitable for tracking and quantification.  For Eg5-367, Eg5-367 non-
phosphorylatable, and Eg5-367 GSTY mutants, movies were 30 minutes long with a 20 
second interval between frames.  For Eg5-367 DL5 and Eg5-367 phosphomimetic 
mutants, movies were one hour long with a 40 second interval between frames to 
accommodate slower sliding velocities while minimizing photobleaching of MTs.  We 
reported the mean non-zero sliding velocity calculated in the following manner.  We 
tracked the ends of individual fluorescent MTs using the ImageJ plug-in MTrackJ.  This 
plug-in calculates a step velocity based on the difference in location between consecutive 
frames in a movie.  For each movie we tracked 3-7 MTs for a total of  190 step velocity 
measurements per slide.  The non-zero mean velocity and standard deviation of these 
measurements for each individual slide were calculated using Microsoft Excel.  For each 
Eg5-367 we calculated the weighted average and standard deviation for all step velocity 
measurements from three different movies to generate the final average velocity and 
standard deviation reported in Table 4.1.   
 
4.3.7 Transient Transfection and Nucleofection of Mammalian Cell Lines 
HEK293T cells, the kind gift from Dr. Cara Gottardi, Northwestern University, 
were  cultured in 100 mm dishes containing DMEM medium (Corning Life Sciences, 
Tewksbury, MA) supplemented with 10% fetal bovine serum (FBS, Atlanta Biologicals, 
Flowery Branch, GA) and penicillin/streptomycin (200 U/mL, Life Technologies, 
Carlsbad, CA) in 5% carbon dioxide (CO2) at 37  C. LLC-Pk1 cells were cultured in 1:1 
Ham’s F-10 medium and Opti-MEM (Life Technologies, Carlsbad, CA) supplemented 
with 7.5% FBS and 1X antibiotic/antimycotic solution (final concentrations 100 U/mL 
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penicillin, 0.1 mg/mL streptomycin, 0.25 g/mL amphotericin B; Sigma-Aldrich, St. 
Louis, MO) at 37  C and 5% CO2.   
To transfect HEK293T cells, 100 mm plates at 70-80% confluence were 
transfected with 2 μg of DNA using the Effectene transfection reagent (Qiagen, Redwood 
City, CA), and allowed to express for 24 h.   
LLC-Pk1 cells (parental or expressing mCherry- Tubulin) were transfected 
using an Amaxa nucleofector (Lonza, Portsmouth, NH) using program X-001 and Mirus 
nucleofection reagent (Mirus Bio LLC, Madison, WI) according to the manufacturers 
recommendations. siRNA used to target endogenous Eg5 
(CUGAAGACCUGAAGACAAU) was obtained from Dharmacon (GE Healthcare Life 
Sciences, Pittsburgh, PA). Following nucleofection, cells were plated on #1.5 coverslips 
or Mattek glass bottom dishes (Mattek Corporation, Ashland, MA).  Cells were used at 
72 hours following nucleofection.   
 
4.3.8 Inhibitors 
For treatment of cells with the SFK inhibitor A-419259 (Sigma Aldrich, St. Louis, 
MO), the protocol developed and verified by the Smithgall lab was followed (Meyn and 
Smithgall, 2009).  Specifically, A-419259 was dissolved in water (100 M stock 
solution), aliquoted, and stored at -20  C.  Twenty-four hours prior to harvest, cell 
culture media was aspirated from plates and carefully replaced with warmed media 
containing A-419259 (1  M final concentration).  Cells incubated at 37  C and 5% CO2 
until harvest. In cases where cells were both transiently transfected and treated with A-
419259, the SFK inhibitor was added to cell media during the transfection procedure.  
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Stock solutions of SU6656 and BI-2536 were prepared in DMSO, stored at -20°C 
and diluted into culture medium before use. SU6656 was used at a final concentration of 
500 nM and BI-2536 was used at 2 M. Each was incubated on cells for 15-30 min prior 
to fixation. 
 
4.3.9 Immunoprecipitation and 2-color Western Blot 
Before harvesting, mammalian cells were first treated with pervanadate to inhibit 
phosphatase activity.  Briefly, hydrogen peroxide (1.7%) was added to PBS containing 5 
mM sodium orthovanadate to convert it to pervanadate, after which exposure to light was 
limited.  Next, 0.5 mL of this solution was added to warmed DMEM to generate a final 
media concentration of 0.25 mM pervanadate.  Existing media was then aspirated off 
each plate of cells and gently replaced with DMEM containing pervanadate.  Cells were 
then incubated at 37  C and 5% CO2 for 30 minutes.  Next, cells were dislodged from 
the plate with a cell scraper and pelleted at 1000 x g for 5 minutes.  The media was then 
aspirated off and pellets were re-suspended in PBS containing calcium (0.9 mM) and 
magnesium (0.49 mM) and washed 3 times.  Finally, cells were re-suspended in 1% 
Triton lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM EDTA, 5% glycerol, 1% 
Triton X-100, plus COmplete protease and PhosStop phosphatase inhibitor tablets 
(Roche, Mannheim, Germany)) and incubated on ice for one hour. Total protein 
concentration of lysate samples was determined using a standard Bradford assay.  All 
samples were normalized to the same protein concentration.  
To immunoprecipitate endogenous Eg5, 5 L of the polyclonal rabbit anti-Eg5 
antibody NB500-181 (Novus Biologicals, Littleton, CO) was added to 2.0 mg total 
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protein lysate in the case of HEK293T lysates or 2.5 mg total protein lysate in the case of 
LLC-Pk1 lysates and incubated while rotating for 2 h at 4  C.  To create IgG isotype 
controls, 1 L of rabbit IgG (EMD Millipore, Billerica, MA) was added to 2.0 mg of total 
protein lysate and incubated similarly.  Then, 60 L of pre-equilibrated 50% Pierce 
Protein A agarose resin slurry (ThermoFisher Scientific, Rockford, IL) was added to each 
sample, which were then incubated while rotating for another 2 h at 4  C.  To 
immunoprecipitate transfected myc-tagged Eg5-367 constructs, 25 μL of pre-equilibrated 
goat anti-myc beads, epitope EQKLISEEDL (Bethyl, Montgomery, TX), were tumbled 
with 2.0 mg of cell lysate for 3 h at 4  C.  After 3 washes with 1% Triton lysis buffer and 
one wash with 0.1% Triton lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM 
EDTA, 5% glycerol, 0.1% Triton X-100, plus COmplete protease and PhosStop (Roche, 
Mannheim, Germany) inhibitor tablets), beads were re-suspended in 30 L of 2X SDS-
PAGE sample buffer (200 mM Tris-Cl, 0. 130 mM SDS, 33 mM DTT, 3 mM 
bromophenol blue, 20% glycerol, pH 6.8), boiled for 20 minutes, and run on a 6% SDS-
PAGE gel overnight.  For loading controls and verification of transfection, prior to 
immunoprecipitation we retained 2.5% of each 2.0 mg total protein lysate sample, to 
which we added an equal volume of hot 6X SDS-PAGE sample buffer (300 mM Tris-Cl, 
0.4 M SDS, 0.1 M DTT, 9 mM bromophenol blue, and 60% glycerol).  Each input 
sample was then boiled for 20 min and run on a 9% SDS-PAGE gel overnight.   
 After transfer to nitrocellulose (0.45 m, Thermo Fisher Scientific, Waltham, 
MA), and blocking with 5% non-fat dehydrated milk in PBS at room temperature for one 
hour and washing three times with TBS containing 0.1% TWEEN-20 (TBS-T), we 
probed with primary antibodies in 5% BSA in TBS while rocking at 4  C overnight.  For 
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detection of endogenous Eg5 we used 1:5000 polyclonal rabbit anti-Eg5 NB500-181 
antibody (Novus Biologicals, Littleton, CO).  For detection of myc-tagged Eg5 constructs 
we used 1:5000 rabbit anti-myc ab9106 antibody (Abcam, Cambridge, MA).  To probe 
for pTyr we used 1:200 mouse anti-pTyr PY20 antibody (sc-508, Santa Cruz 
Biotechnology, Dallas, TX).  To detect  -catenin and -tubulin as loading controls, we 
used 1:250 mouse anti--catenin BD160154 antibody (BD Biosciences, San Jose, CA) 
and 1:5000 mouse anti--tubulin AA2 antibody (Sigma-Aldrich, St. Louis, MO), 
respectively.  To probe for c-Src, we used 1:200 rabbit anti-c-Src SRC2 antibody (sc-18, 
Santa Cruz, Dallas, TX).  After briefly washing blots three times with TBS containing 
0.1% TWEEN-20, we incubated them in secondary antibodies diluted in 5% non-fat 
dehydrated milk in TBS at room temperature for one hour while rocking.  For detection 
of all rabbit antibodies, we used a 1:5000 dilution of the donkey anti-rabbit IRDye 
680RD fluorescent antibody (LI-COR, Lincoln, NE).  For detection of all mouse 
antibodies, except for the anti-pTyr PY20 antibody, we used a 1:5000 dilution of the 
donkey anti-mouse IRDye 800CW (LI-COR, Lincoln, NE).  The pTyr antibody signal 
was below the minimum detection limit of fluorescent secondary antibodies.  Instead, we 
used a 1:5000 dilution of a goat anti-mouse IgG-HRP conjugate secondary antibody (Bio-
Rad, Hercules, CA) for detection by chemiluminescence, which amplifies the signal.  
After incubation in secondary antibodies, blots were washed three times with TBS-T.  
Blots exposed only to fluorescent secondary antibodies were then dried for 20 min 
sandwiched between paper towels in a drawer.  Blots exposed to the HRP-conjugate 
secondary antibody were instead developed for 20 min using the Pierce ECL2 Western 
Blotting substrate (Thermo Fisher Scientific, Rockford, IL) and imaged while wet. All 
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blots were imaged on a LI-COR Odyssey Fc imaging system (Lincoln, NE).  Fluorescent 
antibody exposure times were 2 min; chemiluminescent detection occurred over 10 min.  
Entire images were contrast-adjusted using LI-COR Image Studio software without 
altering gamma settings before being exported to Adobe Illustrator for preparation for 
publication.   
 
4.3.10 Phosphatase Assay 
To verify that signal from the anti-pTyr antibody was specific to phosphorylated 
protein and not due to non-specific binding, we submitted our immunoprecipitated 
endogenous Eg5 to a lambda protein phosphatase assay according to the commercial 
protocol that came with the lambda protein phosphatase used (New England Biolabs, 
Ipswich, MA).  Briefly, we immunoprecipitated Eg5 from 4.0 mg of HEK293T cell 
lysate by doubling reagents in the preceding protocol.  After incubation with Pierce 
Protein A agarose resin (Thermo Fisher Scientific, Rockford, IL), we washed the beads 3 
times with 1% Triton lysis buffer lacking protease and phosphatase inhibitor tablets, and 
once with 0.1% Triton lysis buffer lacking protease and phosphatase inhibitors.  After the 
final wash the beads were re-suspended in an equal volume of 0.1% Triton lysis buffer 
lacking inhibitors, divided into two separate and equal samples.  Both samples were spun 
down briefly in a tabletop microcentrifuge and the supernatants removed by aspiration.  
The resin in one sample was re-suspended in lambda protein phosphatase assay buffer 
(50 mM Hepes, 100 nM NaCl, 2 mM DTT, 0.01% Brij 35, 1 mM MnCl2) containing 
lambda protein phosphatase (8000 U/mL).  The resin in the other sample was re-
suspended in lambda protein phosphatase buffer without the enzyme as a negative 
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control.  Both samples were incubated at 30  C for an hour while agitating.  Lambda 
protein phosphatase reactions were quenched by the addition of 50  L of 2X SDS-PAGE 
sample buffer, boiled for 20 min, and run on an SDS-PAGE gel overnight.  They were 
blotted for endogenous Eg5 and pTyr as described above. 
 
4.3.11 Mammalian Cell Fixation and Immunofluorescence 
LLC-Pk1 cells were rinsed twice with room temperature PBS lacking calcium and 
magnesium and were then fixed for 10 minutes in 2% paraformaldehyde, 0.25% 
glutaraldehyde, and 0.5% Triton X 100, made fresh daily in PBS lacking calcium and 
magnesium. Fixed cells were rinsed in PBS containing 0.02% TWEEN-20 and 0.02% 
sodium azide (PBS-Tw-Az), treated with sodium borohydride (10mg/10mL H2O) for 10 
minutes and then rehydrated in PBS-Tw-Az. The following antibodies were used: 
Phospho Aurora-A/B/C (Cell Signaling Technology, Danvers, MA); tubulin, DM1α 
mouse anti-tubulin (Sigma-Aldrich) or YL1/2 rat anti-tubulin (Accurate Chemical and 
Scientific Corporation, Westbury, NY) and appropriate secondary antibodies as 
previously described (Ma et al., 2011). Primary antibodies were mixed with 2% BSA in 
PBS-Tw-Az to block non-specific binding and used at the following final dilutions: 
Phosoho Aurora-A/B/C 1:1,000, DM1α and YL1/2 1:100; cells were incubated in 
primary antibodies for 1 hour at 37°C. Stained cells were mounted on glass slides using 
DAPI Fluomount G (Southern Biotech, Birmingham, AL) to stain DNA. 
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4.3.12 Immunofluorescence Microscopy/Imaging 
To quantify mitotic phenotypes of fixed cells, a Nikon Eclipse Ti with an X-Cite 
series 120Q excitation light source, and a 100 X, 1.3 N.A., objective lens, was used. 
Images of fixed cells were acquired using a CSU-10 Yokogawa spinning-disk confocal 
scan head on a Nikon TE300 as previously described (Tulu et al., 2003).  Transfected 
cells (identified by the Eg5-Emerald signal) were classified by spindle morphology based 
on microtubule staining as bipole, multipole, monopole, or disorganized. Disorganized 
spindles included spindles with extra foci, fragmented poles, short spindles, no pole, and 
bent spindles. For live cell imaging, a Nikon Ti-E microscope with a CSU-X1 Yokogawa 
spinning-disk confocal scan head (PerkinElmer, Wellesley, MA), an Andor iXon+ 
electron-multiplying charge-coupled device camera (Andor), and a 100×/1.4 NA 
objective lens was used. For live-cell imaging, exposures were adjusted without 
saturating the camera’s pixels; typical exposures were 50–800 ms. 
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Table 4.1 Effects of phosphomimetic and non-phosphorylatable mutations on Eg5 
motor characteristics and STLC binding.  
Construct Velocity 
(nm/s) 
kcat (s-1) K0.5(MT) (μM) KD - STLC  
(nm) 
N (STLC) 
WT 11.7 ± 3.4 7.01 ± 0.15 0.073 ± 0.008 86±21 1.07 
DL5 4.2 ± 1.3 2.09 ± 0.07 0.181 ± 0.023 -- -- 
GSTY 12.3 ± 3.2 7.60 ± 0.38 0.261 ± 0.047 -- -- 
Y125E 4.9 ± 1.2 6.47 ± 0.25 0.128 ± 0.022 540±150 0.95 
Y211E 4.4 ± 1.2 2.95 ± 0.15 0.336 ± 0.053 1600±250 0.74 
Y231E 11.0 ± 3.0 8.68 ± 0.28 0.231 ± 0.024 304±32 0.89 
Y125F 12.5 ± 3.5 5.42 ± 0.11  0.63 ± 0.008 42±18 1.03 
Y211F 12.5 ± 3.4 4.94 ± 0.07 0.089 ± 0.009 45±6.0 0.62 
Y231F 14.9 ± 3.8 7.33 ± 0.25 0.086 ± 0.017 55±19 1.09 
 
Steady-state ATPase rates and MT sliding velocities of Eg5 phosphomimetic (E) and 
non-phosphorylatable (F) mutants were measured and compared to those of Eg5-367-WT 
and Eg5-367-DL5 mutants using standard in vitro assays (Methods).  Dissociation 
constants of the L5 inhibitor STLC to Eg5-367 phosphomimetic and non-
phosphorylatable mutants (KD) was calculated from ITC titrations. Errors in KD were 
estimated based on the nonlinear least-squares fits to raw ITC data. Stoichiometries (N) 
show some variability reflecting protein concentration determination, but are generally 
consistent with single-site binding. 
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Figure 4.1 Human Eg5 is phosphorylated on tyrosine residues. (A) Two-color 
Western blot showing endogenous Eg5 immunoprecipitated from HEK293T or LLC-Pk1 
cell lysates, with each channel displayed separately in black and white.  A-419259 was 
added as indicated; the lower panel shows a β-tubulin loading control (green). (B) The 
structure of Eg5 bound to S-trityl-L-cysteine (STLC) is marked with tyrosines Y125, 
Y211, and Y231 (orange space fill, PDB: 3KEN). A predicted SH3 binding site in the 
MT-binding site of the Eg5 motor domain is shown in the inset. L5 is shown in dark blue; 
Loop 12 within the MT binding domain is shown in red. (C) Sequence alignment 
comparing the putative phosphorylation sites and the –PXXP− SH3 targeting domain. 
Putative phosphorylated tyrosines and the –PXXP− SH3 targeting motifs are shown in 
red. The accession numbers for each protein are listed in Fig. 4.4 C. 
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Figure 4.2 SFK dependent phosphorylation of Eg5 in vitro and in mammalian cells.  
Kinesin-5 constructs (denoted across the top) were incubated with human c-Src (A) or 
human Wee1 kinase (B) and radiolabeled ATP for the times indicated.  Reactions were 
quenched and run on an SDS-PAGE (top) that was then dried and exposed to film 
(bottom). Position of c-Src, Eg5, and Wee1 marked on the left side.  (C) 
Immunoprecipitation of Eg5 from HEK293T cells co-transfected with myc-tagged Eg5 
motor head and c-Src constructs; A-419259 added as indicated. Western blot stained 
using anti-myc and anti-pTyr antibodies which here are displayed separately in black and 
white. The lower panel shows inputs and β-tubulin level as a loading control.  (D) 
Endogenous Eg5 was immunoprecipitated from HEK293T cells transfected with the 
indicated constructs; A-419259 was added as indicated.  pTyr was detected using a two-
color Western blot.  Each channel is displayed separately in black and white.  
Transfection efficacy was verified by detection of c-Src in the lysates from transfected 
cells.   -catenin level is shown as a loading control.   
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Figure 4.3 Mitotic spindle defects in cells expressing phosphomimetic and non-
phosphorylatable mutants of Eg5. (A) Percent of mitotic phenotypes in LLC-Pk1 cells 
transfected with siRNA targeting endogenous Eg5 alone or co-transfected with an siRNA 
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resistant Eg5 Emerald construct (WT, Y211E, Y211F, GSTY). Monopole (yellow), 
bipole (red), muitipole (blue), disorganized (green). Examples of each phenotype are 
shown on right. (B) Time-lapse imaging of LLC-Pk1 cells expressing mCherry-α-tubulin 
(right panels) co-transfected with Eg5 siRNA and siRNA resistant Eg5 Emerald 
constructs (WT, Y211E, and Y211F left panels).  (C) Immunofluorescence staining for 
MTs in control (left) and SU6656-treated (right) parental LLC-Pk1 cells.  (D) 
Quantification of mitotic spindle phenotypes shown in C.  (E) Immunofluorescence 
staining for MTs (top) and phospho-Aurora (bottom) for control and SU6656 treated 
cells. (F) Immunofluorescence staining of -tubulin in anaphase LLC-Pk1 cells: control 
(top), BI-2536 (middle), SU6656 (bottom). ** = p ≤ 0.01. Scale bars in A, B, C, E, F = 5 
μm. Time in B (min:sec). Error Bars = St Dev.   
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Figure 4.4 Eg5 is phosphorylated on a conserved tyrosine in its motor head.  (A) A 
single immunoprecipitation reaction from HEK293Ts (3.5 mg total lysate) was divided in 
two. Half was incubated with λ-phosphatase (right); the other was incubated with 
phosphatase buffer alone (left). (B) Table summarizing Eg5 tyrosine phosphorylations as 
reported in databases collecting results from phosphoproteomics experiments, including 
PhosphositePlus (Hornbeck et al., 2015). (C) Table showing the UniProt Accession 
numbers used to generate the alignment of kinesin-5 family members in Figure 4.1 C.  
(D) Alignment of kinesins from families 1-7, highlighting the MT binding region.  The –
PXXP- SH3 targeting motif, when present, is highlighted in red.  Residues that are 
identical across the alignment are marked in dark grey, while similar residues are marked 
in light grey. While there is extensive conservation of sequence in this region across 
kinesin family members, the PXXP motif is only seen in kinesin-5s of higher order 
organisms. (E) List of the sequence mutations made in Eg5 constructs and (F) other 
constructs for experiments using Eg5 mutants. 
 
 
 
 
 
Figure 4.5 Eg5-targeting siRNA decreases endogenous Eg5 levels. Western blot 
showing the efficiency of Eg5 knockdown using siRNA in LLC-Pk1 cells. Treatment 
with siRNA led to an approximately 50% reduction in Eg5 signal as measured by 
densitometry.
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CHAPTER 5 
 
PROTEIN TAGGING AT THE ENDOGENOUS LOCUS AS A TOOL FOR 
STUDYING MITOTIC PROTEIN DYNAMICS AND LEVELS 
5.1 Introduction 
Cell division is a carefully controlled, dynamic process, which ensures that 
genetic material is equally segregated between daughter cells. Mitosis requires precise 
spatial and temporal regulation of proteins to guarantee proper division. Understanding 
where and when these proteins localize and their local concentrations would help us gain 
insight into this basic, dynamic biological process.   
Kinesin-5 is an essential motor protein that has been extensively studied 
(reviewed (Ferenz et al., 2010; Singh et al., 2018; Waitzman and Rice, 2014)). The 
human kinesin-5, HsEg5, is a homotetrameric, bipolar, protein that crosslinks parallel and 
antiparallel microtubules generating force between microtubules (Kapitein et al., 2005; 
Shimamoto et al., 2015). When these microtubules are antiparallel, outward forces are 
generated that antagonize inward forces caused by the minus-end directed activity of 
Dynein (Ferenz et al., 2009a; Mitchison et al., 2005; Sharp et al., 2000a; Tanenbaum et 
al., 2008). Cells depleted of Eg5 or treated with Eg5 specific inhibitors fail to establish 
bipolar mitotic spindles (Ferenz et al., 2010; Kapoor et al., 2000; Mayer et al., 1999). 
Despite decades of study, how Eg5 is regulated to achieve spindle bipolarity remains 
incompletely understood. 
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 TPX2 is a multifunctional, microtubule associated protein first identified for its 
role in dynein-dependent targeting of the Xenopus kinesin-12, Xklp2, to spindle poles 
(Wittmann et al., 1998). During interphase, TPX2 resides in the nucleus due to   
importin-α/β binding to a nuclear localization signal. Following nuclear envelope 
breakdown, RanGTP binds importin-α/β releasing active TPX2 (Gruss et al., 2001; Gruss 
and Vernos, 2004; Schatz et al., 2003).  Reduction in TPX2 by siRNA results in short 
bipolar or multipolar spindles that fail to progress through mitosis due to the essential 
roles TPX2 plays in spindle formation (Garrett et al., 2002; Gruss et al., 2002).  The N-
terminus of TPX2 activates and targets the mitotic kinase Aurora A to spindle 
microtubules, which then phosphorylates TPX2 contributing to spindle flux (Fu et al., 
2015b; Kufer et al., 2002). TPX2 also nucleates microtubules around chromosomes, 
stabilizes microtubules, regulates motor proteins, and is involved in microtubule branch 
formation in vitro (Alfaro-Aco et al., 2017; Drechsler et al., 2014; Mann et al., 2017; 
Petry et al., 2013; Reid et al., 2016; Tulu et al., 2006; Vanneste et al., 2009).  
 TPX2 has been reported to show a distribution on the spindle that overlaps with 
Eg5 (Ma et al., 2011). The C-terminal 37 amino acids of TPX2 facilitate localization of 
both Eg5 in vivo and inhibit motor walking on microtubules in vitro (Balchand et al., 
2015; Eckerdt et al., 2008; Ma et al., 2011; Ma et al., 2010). In cells, active Eg5 is needed 
on microtubules to separate centrosomes and form a bipolar spindle (Kashina et al., 
1997). Eg5 also plays a role on interpolar microtubules in anaphase to facilitate spindle 
elongation (Scholey et al., 2016), suggesting that TPX2 may not globally inhibit Eg5.  
Identifying when and where these proteins localize to specific spindle regions 
may provide clues as to where Eg5 is actively sliding microtubules and generating forces 
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and where TPX2 regulates its activity in vivo. Knowing the relative levels of these 
proteins will also provide insight into how TPX2 is able to perform all of its mitotic 
functions. Further, Eg5 has been shown in vitro to produce both pushing and braking 
forces that scale with motor number and microtubule length (Shimamoto et al., 2015) but 
how this relates in vivo remains unclear. Quantification of protein concentrarion in 
mammalian cells may help address these questions. 
We therefore wanted a reliable system for protein quantification in vivo. In yeast, 
fluorescent protein tagging at endogenous loci has allowed researchers to ask questions 
about protein copy numbers and stoichiometry both globally and locally 
(Dhatchinamoorthy et al., 2017; Joglekar et al., 2006; Lawrimore et al., 2011; Wu and 
Pollard, 2005). Although some labs have attempted to quantify proteins in mammalian 
cells, protein overexpression was used (Johnston et al., 2010; Suzuki et al., 2015).  
Recent advances in genetic engineering in mammalian cells have made it possible 
to tag proteins at the endogenous locus (Dambournet et al., 2014; Mali et al., 2013; Ran 
et al., 2013). With these approaches, it has also come to light that our understanding of 
dynamic processes may be incomplete or incorrect due to the technical limitations of 
previously used methods (Dambournet et al., 2014).  For example, when the distribution 
of clathrin tagged at the endogenous locus was compared to the same protein expressed 
from a plasmid, differences in both the abundance and distribution were observed (Doyon 
et al., 2011).  
To understand how pervasive this situation might be we tagged TPX2 and Eg5 
using CRISPR/Cas9 and examined the distribution along the spindle throughout mitosis. 
The results obtained with CRISPR tagging differ from either expression from a BAC 
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(Gable et al., 2012) or via antibody staining, suggesting that novel insight can be gained 
by tagging proteins at the endogenous locus. Further, through quantitative imaging we 
found that TPX2 and Eg5 display distinct patterns of localization throughout mitosis; 
TPX2 is absent in areas where Eg5 activity is required. These results not only further 
strengthen the evidence that endogenous tagging may provide new understanding of 
dynamic processes, such as mitosis, but also be used for protein quantification by 
fluorescence in vivo. 
5.2 Results 
5.2.1 Knock-sideways is functional and rapidly moves motor proteins 
Determining when proteins are specifically needed in mitosis requires a method to 
control protein localization and function with better temporal control than siRNA. Cells 
use compensatory pathways when proteins are depleted by methods such as siRNA; it 
can take days to reach desired depletion levels and other pathways can mask the effect of 
protein loss (Wordeman et al., 2016). Small molecule inhibitors provide temporal control 
that allows for rapid inactivation, however, only a small percentage of proteins have 
specific inhibitors. Alternately, researchers can inject single cells with antibodies that 
specifically target a protein rendering it inactive, though this also has its disadvantages 
(i.e. low number and time consuming). Recently, several novel approaches have been 
developed to inactivate proteins with improved temporal resolution.  For example, 
proteins can be tagged with an Auxin-inducible degron, which induces rapid degradation 
by the proteasome following addition of Auxin or, Rapamycin-induced dimerization in 
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which fusion proteins with dimerization tags are used (Holland et al., 2012; Robinson et 
al., 2010; Wordeman et al., 2016). 
We decided to adapt the “knock-sideways” approach for our system. To establish 
the functionality of knock-sideways, we chose to re-localize Eg5. There are specific small 
molecule inhibitors of Eg5 (STLC/Monastrol), which prevent ATP hydrolysis and 
ultimately the ability to bind microtubules (Kapoor et al., 2000; Mayer et al., 1999). 
When Eg5 is not bound to microtubules early in mitosis, outward forces cannot be 
generated resulting in spindles collapsing into monopoles. Therefore, if we knock Eg5 
sideways, then we would expect to see monopolar spindles indicating that we can re-
localize proteins to produce physiologically relevant phenotypes. 
We therefore generated an LLC-Pk1 cell line expressing an siRNA resistant Eg5-
FKBP-GFP and mCherry-Tubulin (Fig. 5.1A; Methods). To these cells we co-
nucleofected siRNA, to knock down endogenous Eg5, and the FRB “trap” (LDR-FRB-
BFP) (Wordeman et al., 2016). Cells containing Eg5-FKBP-GFP, mCherry-Tubulin, and 
FRB-BFP were bipolar in the absence of Rapamycin (Fig. 5.1B). Upon addition of 
200nM Rapamycin for ~30 min, Eg5-FKBP-GFP re-localized to the membrane and 
spindles collapsed into monopoles (Fig. 5.1B) and this was specific to cells expressing 
both the trap and Eg5; cells with no FRB-BFP remained bipolar even in the presence of 
Rapamycin (Fig. 5.1B).  
These results not only highlighted the functionality of Knock-sideways but how 
quickly it could produce a phenotype. We therefore wanted to determine how fast re-
localization occurs. For this, we used a CRISPR modified cell line where we C-
terminally tagged Dynein Heavy Chain (DHC) with FKBP-GFP (Fig. 5.1C; methods). 
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We chose Dynein (DHC) because it is expressed and functional in both interphase and 
mitosis (reviewed (Roberts et al., 2013)) allowing us to observe its movement in any cell 
that was expressing both the FKBP and FRB. We nucleofected the FRB-BFP membrane 
targeted trap and added the Rapamycin during time-lapse image acquisition. Within 2-3 
minutes, the diffusive GFP observed in the cytoplasm of interphase cells began to re-
localize to the membrane (Fig. 5.1D). Taken together, these results indicate that knock-
sideways has physiological functionality and provides high temporal control. Due to the 
success of our knock-sideways initial experiments, we decided to tag other mitotic 
proteins at the endogenous locus using CRISPR/Cas9 but unfortunately only yielded 
heterozygotes (see section xxx; Discussion) and thus prohibited further knock-sideways 
experiments. 
 
5.2.2 Generating CRISPR cells for protein localization 
In order to generate mammalian cells expressing proteins that were fluorescently 
tagged at the endogenous locus, we added a C-terminal EGFP tag using CRISPR/Cas9 in 
HeLa cells (Methods; Fig. 5.2A; Fig. 5.3A).  To do this a cassette containing the coding 
sequence for EGFP and a selectable marker was inserted downstream of each gene.  After 
introduction of Cas9 and the repair cassette by nucleofection, only those cells that had 
undergone homologous recombination survive in antibiotic containing medium 
(Methods).  Genotyping of clonal populations revealed that approximately half of all 
selected clones (6/10 Eg5 and 2/5 TPX2) were modified; of the clones that were 
genotyped (3 and 2 Eg5 and TPX2 respectively), all were heterozygous, with one allele 
tagged with the EGFP and the other wild-type (Fig. 5.3A, B).  Western Blotting of total 
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cell extracts of cell clones, using Eg5 or TPX2 specific antibodies also verified genotypes 
(Fig. 5.3C, D).  Quantification of Western blots showed that Eg5 clones expressed ~50% 
(55 ± 3.7%) EGFP tagged and ~50% (44.9 ± 3.7%) untagged protein.  In contrast, TPX2 
clones expressed ~20% (20.7 ± 2.4%) tagged vs. ~80% (79.3 ± 2.4%) untagged protein.  
Because we used HeLa cells for tagging and these cells are known to have irregular 
karyotypes (Landry et al., 2013; Macville et al., 1999) we wanted to ensure that 
expression in our TPX2 tagged cells was stable over time.  In order to test this, we 
passaged the cells for >30 passages and compared the protein expression levels to the 
earlier passage number (Fig. 5.3C).  No difference in the expression levels was observed 
indicating that this clone was stable over the period of our analysis (see Discussion).  
Finally, both the TPX2 and Eg5 CRISPR modified cells display mitotic morphology 
indistinguishable from the parental HeLa cells (Fig. 5.3E) and progressed through mitosis 
without any abnormalities, suggesting that the tag does not interfere with mitosis in these 
cells.   In summary, this approach is a straightforward method to generate clonal cell 
populations with fluorescent tags at the endogenous locus.  Because large numbers of 
cells are present following selection, testing additional clones is likely to yield 
homozygous lines.  For the present experiments, having a fluorescent tag at both alleles is 
not required, so the heterozygous cells were used for the following experiments. 
 
5.2.3 TPX2 but not Eg5 is enriched relative to microtubules at spindle poles 
The CRISPR modified cells were used to quantify protein distribution throughout 
mitosis.  This is important because knowing the distribution and relative levels of 
proteins in the mitotic spindle can provide information about the mechanisms by which 
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the proteins might interact and function.  In previous work, enrichment of mitotic 
proteins, including Eg5 and TPX2, at spindle poles has been reported; however, the 
extent of enrichment, and if a given protein is enriched relative to microtubules, which 
are also more condensed at spindle poles, has not been established.     
To measure protein distribution along the spindle axis, cells were arrested in 
metaphase using MG132 and Z-stacks of metaphase cells were acquired using spinning 
disc confocal microscopy (Methods).  The distribution of Eg5 and TPX2 was measured 
using line scans along the pole-to-pole axis and additionally by quantifying fluorescence 
in selected regions: near the pole, in front of kinetochores and at the spindle midzone 
(Methods; Fig. 5.2). The results show that each protein is enriched at spindle poles 
relative to the midzone, consistent with earlier work. TPX2 was nearly 2-fold more 
enriched at poles compared to Eg5 (5 ± 1.12X vs. 2.6 ± 0.63X respectively) in cells with 
and without microtubule labels (Fig. 5.2D, Fig. 5.6A).  When the level of each tagged 
protein was compared near the pole and just in front of kinetochores, however, there was 
a more similar enrichment for Eg5 and TPX2 (1.27 ± 0.22X vs. 1.48 ± 0.2X respectively) 
however they were still significantly different (p=0.01) (Fig. 5.6B).  In summary, these 
results demonstrate that Eg5 and TPX2 have distinct distributions on the spindle, 
suggesting independent mechanisms for localization.   
To determine if Eg5 and TPX2 were enriched relative to microtubules, we 
additionally imaged microtubules in the CRISPR cells. This was done in two different 
ways.  First, Eg5-EGFP cells were transfected with mCherry tubulin, selected, and sorted 
using flow cytometry.  The second way microtubules were labeled was using SiR Tubulin 
(Methods) (Hueschen et al., 2017) under conditions that had no detectable effect on 
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mitotic spindle morphology.  In either case, similar ratios of tubulin at the pole compared 
to the midzone (2.3X for both) were obtained, and thus data from both approaches were 
averaged.  When the enrichment level of each protein was compared to that of tubulin, 
the results show that Eg5 is not significantly enriched at spindle poles relative to 
microtubules, with a ratio of ~1 (1.2 ± 0.36X).  In contrast, TPX2 was ~2 fold (2.2 ± 
0.41X) enriched relative to microtubules. When the levels of Eg5 and TPX2 were 
compared to the microtubules near the pole and just in front of kinetochores, Eg5 was not 
enriched relative to microtubules while TPX2 was still slightly enriched (1.00 ± 0.13X, 
Eg5; 1.28 ± 0.16X, TPX2) (Fig. 5.4B). 
As a control for our analysis method, cells expressing CRISPR tagged HURP 
were used.  Unlike Eg5 and TPX2, HURP has been shown to be enriched towards 
kinetochores not poles (Koffa et al., 2006; Sillje et al., 2006).  HURP indeed shows a 
distinct distribution from Eg5 and TPX2, and quantification shows that it is not enriched 
at the poles either alone or relative to tubulin (Fig. 5.2 B, C, D).     
Because these data suggest that Eg5 and TPX2 are distributed differently along a 
metaphase spindle we were curious what their relative protein levels were on the spindle. 
On average, there was ~4 fold (3.9X) more TPX2 on a metaphase spindle than Eg5 (Fig. 
5.2E), and this relationship was constant throughout all stages of mitosis (Fig. 5.8A). 
Additionally, by measuring the total cellular fluorescence and spindle-associated 
fluorescence for both Eg5 and TPX2, the fraction of each protein that is spindle 
associated can be determined. The data show that on average only a fraction of the total 
fluorescence (19.8% Eg5 and 33.9% TPX2) was associated with the spindle, regardless 
of mitotic stage (Fig. 5.8B, C). 
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5.2.4 Immunofluorescence quantification of metaphase spindles  
Next we wished to compare the distribution of Eg5-EGFP and TPX2-EGFP 
obtained using CRISPR tagged cells with the distribution obtained using conventional 
immunofluorescence.  To do this, parental HeLa cells were arrested at metaphase using 
MG132, fixed and stained for microtubules and either TPX2 or Eg5 and Z-stacks of 
metaphase cells were acquired using spinning disc confocal microscopy as with the live 
cells.  Analysis was performed identically to the live cells (Fig. 5.6).  In the case of 
TPX2, protein distribution on the spindle was similar to that obtained using the CRISPR 
EGFP tagged cells, although there is increased spindle-to-spindle variability using 
immunofluorescence (Fig. 5.6 A, B, C).  In the case of Eg5, however, the results obtained 
with immunofluorescence suggest that Eg5 is concentrated relative to microtubules at 
spindle poles (1.76 ± 0.55X) which was not observed using CRISPR tagging (Fig. 5.6 C, 
D).   The results obtained from the fixed and stained cells are more similar to cells 
overexpressing Eg5 (Gable et al., 2012). We then wondered if these differences might be 
a result of the method used and therefore looked for differences in spindles between the 2 
techniques. On average spindles were significantly shorter (9.96 ± 0.87 μm; CRISPR vs. 
5.91 ± 0.98 μm; IF) and they were shorter in Z (Fig. 5.4C). These differences might be 
attributed to the differences we observe between the two methods.  
 
5.2.5 Redistribution of Eg5 and TPX2 are distinct in anaphase 
Next, we quantified the dynamics and distribution of Eg5 and TPX2 as cells 
progressed through mitosis using time lapse imaging of cells expressing either Eg5-EGFP 
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or TPX2-EGFP.  Cells were observed starting at anaphase onset when fluorescence of 
both proteins appears to decrease in the spindle midzone (Fig. 5.7). Analysis of the 
fluorescence intensity within the spindle midzone as anaphase progresses revealed that 
Eg5 redistributes to the midzone before TPX2 (Fig. 5.7 B, D). In fact, TPX2 remains 
accumulated at spindle poles throughout anaphase and showed only minimal 
redistribution to the midzone compared to Eg5 (Fig. 5.7C). This distinct distribution 
further suggested that Eg5 and TPX2 have different regulation and function in anaphase.  
 
5.2.6 Eg5 but not TPX2 is found on overlapping microtubules 
Eg5 generates outward force on overlapping antiparallel microtubules (Kapitein et 
al., 2005; Shimamoto et al., 2015), and this action is thought to be critical to maintain 
spindle length and bipolarity (Ferenz et al., 2009a).  In vitro, TPX2 regulates Eg5 activity 
by acting as a brake, causing motors to slow on microtubules (Balchand et al., 2015).  
Because both proteins localize to spindle microtubules, the data suggest that Eg5’s 
activity would be inhibited by TPX2 on spindle microtubules, preventing the generation 
of outward forces.    
To understand how TPX2 regulates Eg5, the distribution of Eg5 and TPX2 in the 
region of the spindle where overlapping microtubules are present was examined 
(Mastronarde et al., 1993; McIntosh and Landis, 1971; Polak et al., 2017).  To do this we 
took advantage of cells with spindles oriented perpendicular (90°) to the coverslip 
surface. We acquired Z-stacks of these perpendicular spindles and asked if Eg5 and/or 
TPX2 co-localized with microtubules in the mid-region of the spindle (between sets of K- 
fibers) (Fig. 5.8A).  As expected, discrete puncta of microtubules in both metaphase and 
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anaphase cells (Fig. 5.8 B, C, Fig. 5.9) were detected in the 1.32 μm region in the spindle 
midplane. These microtubule puncta were generally organized in a circle consistent with 
the distribution of chromosomes on the periphery of the spindle at metaphase (Magidson 
et al., 2011).  Z-planes away from the midplane contained microtubule bundles that were 
considerably brighter, consistent with kinetochore fibers which contain on average 17 
microtubules (Simunic and Tolic, 2016; Tolic, 2017; Wendell et al., 1993). 
Imaging of Eg5-EGFP CRISPR modified cells revealed that Eg5-EGFP was also 
present in the mid-region of both metaphase and early anaphase spindles (Fig. 5.8 B, C, 
Fig. 5.9 A, B) and further that these Eg5 puncta were present in a distribution that 
overlapped with the microtubule distribution (Fig. 5.8 B, C, Fig. 5.9 A, B). In the 
midplane of TPX2-EGFP CRISPR modified cells, however, fluorescent puncta above 
background fluorescence levels were rare for both metaphase and later anaphase cells.  
Moreover, TPX2 puncta that could be detected did not match the microtubule distribution 
except at the cell periphery (Fig. 5.8 B, C, Fig. 5.9 A, B). These few visible puncta at the 
cell periphery are likely part of long microtubules originating from the poles or K-fibers 
where TPX2 and Eg5 were both detected (Fig. 5.8 B, C). These results suggest that TPX2 
is not significantly localized to regions of microtubule overlap.  This result supports the 
hypothesis that Eg5 is active on overlapping antiparallel microtubules in the midzone and 
is not subject to inhibition by TPX2 in this location.  
 
5.2.7 Absolute Protein Concentrations using Quantitative Fluorescence Microscopy 
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One of the advantages of endogenous tagging is that we can address relative 
protein accumulation as well as measure protein concentration both locally and globally 
in vivo (Wu and Pollard, 2005).  
A major function of Eg5 is to drive centrosome separation during prophase; 
consistent with this function, Eg5 is detected at the centrosome (Blangy et al., 1995; 
Eibes et al., 2017; Gable et al., 2012; Rapley et al., 2008). Z-stacks of prophase Eg5-
EGFP CRISPR modified cells were collected using spinning disc confocal microscopy 
and fluorescence of the whole cell vs. the centrosomes was determined (methods). For 
centrosome measurements, we chose an area ~2 μm (2.08 μm) in diameter centered on 
each centrosome (Area = 3.4 μm2) with a height between 2-5 μm based on the number of 
z-steps needed to encompass all the centrosome fluorescence. This volume was similar in 
dimensions to the size of the total functioning centrosome which includes centrioles, and 
pericentriolar material (Alieva and Uzbekov, 2016). On average, the fluorescence of the 
centrosome, as defined here, is only ~2% (2.25 ± 1.18%) of the total cell fluorescence. 
We therefore determined the relative accumulation at the centrosomes and compared it to 
the entire cell by calculating their fluorescence per area (μm2) (Fig. 5.5D).  On 
centrosomes, Eg5 is ~7.5X (7.6 ± 1.94X) concentrated relative to the whole cell (Fig. 
5.5D).   
We then determined the local concentration of Eg5 at the centrosome. For this, we 
used cells with a known number of GFP molecules in a defined structure. We therefore 
imaged HeLa cells stably expressing Hec1-EGFP using identical conditions as our 
CRISPR modified cells. Knowing that there are 244 Hec1-EGFP molecules per 
kinetochore (Suzuki et al., 2015) we were able to measure the average total fluorescence 
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for Hec1-EGFP spots and convert fluorescence intensities to number of molecules (Fig. 
5.10 A, B). We found that the concentration of Eg5 at a prophase centrosome to be ~4 
μM (4.08 ± 1.93 μM) (Fig. 5.10C; methods). This is significantly concentrated compared 
to the whole cell Eg5 concentration of ~2 μM (1.97 ± 0.45 μM) (Fig. 5.10C).  Similar 
calculations can be performed for other sub-regions of the mitotic cell to gain insight into 
local concentrations of mitotic proteins. 
TPX2 is also detected at prophase centrosomes in animal cells (Eibes et al., 2017; 
Ma et al., 2011) and at the nuclear periphery in plant cells.  Recent work shows that this 
pool of TPX2 contributes to Eg5 localization to prophase centrosomes (Eibes et al., 
2017).  However, given the bright nuclear signal of TPX2, which typically overlaps the 
centrosome signal, the enrichment of TPX2 at prophase centrosomes was not measured.  
Regulation of Eg5 is only one of the many functions of TPX2 in mitosis and 
therefore one would expect that it is more abundant than Eg5 but this has never been 
quantified. Using our Hec1-EGFP standard, and the volume of an average HeLa cell 
(methods) we determined that TPX2 is significantly more concentrated in mitosis 
compared to Eg5 (3.14 μM vs. 1.97 μM respectively).  
Finally, we asked how much Eg5 and TPX2 were on the spindle itself. We 
therefore measured the relative local accumulation of TPX2 and Eg5 on the spindle by 
comparing their respective fluorescence intensities (Figure 5.11). On average, there is 
~3.5X more TPX2 than Eg5 on the spindle (Figure 5.11A). However, our live cell data 
suggest that the localization of these proteins change throughout mitosis. Therefore, we 
measured the relative local accumulation of TPX2 and Eg5 throughout mitosis and found 
that while Eg5 levels remain relatively constant early in mitosis (Figure 5.11 B,C), TPX2 
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is significantly higher early in mitosis compared to later stages (Figure 5.11 B,C) and 
remains significantly higher than Eg5 by the spindle poles. Taken together this suggests 
that there is spatial regulation of Eg5 by TPX2. 
5.3 Discussion 
5.3.1 Advantages and Disadvantages of CRISPR Tagging 
Our data show that using CRISPR tagging provides insight into protein 
distribution in mitosis and that the values obtained differ from prior work using either 
BACs or immunofluorescence (Figures 5.2, 5.6) (Gable et al., 2012).  These data 
highlight the differences in information gathered due to technical limitations.  As others 
have argued, CRISPR and other endogenous tagging methods prevent overexpression 
artifacts (Dambournet et al., 2014; Doyon et al., 2011). More specifically, overexpression 
of TPX2 is a marker for many cancers as well as results in abnormal spindle phenotypes 
(Gruss et al., 2002; Neumayer et al., 2014). Additionally, because CRISPR modifications 
are permanent and specific, the chances of a plasmid integrating into unwanted places in 
the genome or being lost as cells divide is reduced. 
Despite the value of using endogenous tagging, it may not be feasible to use this 
approach in all cases.  For example, despite the fact that generating CRISPR tagged cells 
is becoming more straightforward, it is time consuming, and making cells with multiple 
tags could be limited by the availability of selectable markers.  Additionally, examining 
the distribution of several different proteins following deletion, or deletion/replacement 
approaches would be more complicated. For example, many essential mitotic proteins 
were discovered using screens for defective phenotypes when they were absent or 
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inhibited (Goshima et al., 2007; Neumann et al., 2010; Zhu et al., 2005). For these and 
other essential proteins, CRISPR cannot be used for permanent knock-outs otherwise the 
cells would have irregularities that would ultimately affect their survival. Inducible 
knock-outs could be used as an alternative strategy to permanent deletion in a cell line 
(McKinley and Cheeseman, 2017); however, these too have their limitations. Therefore, 
testing the effects of specific perturbations regarding essential proteins would require a 
variety of different CRISPR lines with appropriate modifications.  
In our experiments we used CRISPR modified cell lines that were heterozygotes 
(Fig. 5.3B).  One drawback of this approach is the possibility that the tagged and 
untagged versions of the protein are not equivalent and thus not present in equal amounts 
in cellular structures. In addition, differential allele expression has been seen in human 
cells (Knight, 2004) and appears to be the case in our CRISPR modified TPX2 clones 
(Fig. 5.3C) where the amount of tagged and untagged protein are not equivalent.  We 
assumed that even though there appears to be differential allele expression that both the 
tagged and untagged versions were present in cellular structures without any bias. 
However, this assumption needs to be validated by additional experimentation.   
Alternatively, having all copies of the protein tagged could also be deleterious due 
to potential interference by the tag, and this could impact cellular processes.  Prior work 
in genetically tractable systems has shown that proteins with GFP tags can complement 
deletion of the endogenous protein suggesting that the tag has little or no effect on cells.  
However, there are cases where the tag can affect a cellular process. Perhaps the best 
example is tubulin, in which cells that express high levels of GFP-tubulin are not viable 
or have shortened spindles.  In yeast, GFP-TUB1 tagged cells display normal dynamics 
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and growth but only if there is a mixture of tagged and untagged TUB1 (Maddox et al., 
1999; Straight et al., 1997). The same is seen in mammalian cells where tubulin 
translation is regulated by the cytoplasmic level of tubulin (Yen et al., 1988); thus when 
tubulin is expressed from a plasmid, the total level of tubulin is regulated by the cell 
(Goodson et al., 2010; Rusan et al., 2001). These examples provide strong evidence that a 
tag can affect cellular processes and therefore limiting the amount may be necessary in 
some cases, supporting the use of heterozygotes. In order to test this hypothesis, 
homozygous CRISPR modified clones would need to be made, characterized and 
compared to heterozygotes.  
 
5.3.2 TPX2 is not present at sites where Eg5 is acting 
Using cells with tags at the endogenous locus, our results provide new insight into 
the regulation of Eg5 by TPX2.  Prior work demonstrated that TPX2 reduces the motility 
of Eg5 on microtubules in vitro (Balchand et al., 2015; Ma et al., 2011).  This result has 
been difficult to reconcile with the requirement for active Eg5 during spindle assembly 
and maintenance (Kapoor et al., 2000; Mayer et al., 1999; Sawin and Mitchison, 1995). 
Our results show that Eg5 is present on regions of the spindle where overlapping 
antiparallel microtubules are located, consistent with the active force generation at this 
location (Shimamoto et al., 2015).  In contrast, TPX2 was barely detected above 
background in this region, even though the protein was 4X more enriched on the spindle 
than Eg5.  Thus the data suggest at sites where Eg5 is active, TPX2 is not detectable.   
Consistent with this idea comes from or prophase data.  As mentioned, in most 
cells, kinesin-5 activity is required for bipolar spindle formation; therefore, it was not 
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surprising to find a high local concentration of Eg5 at spindle poles (Fig. 5.10C; Fig. 
5.5D). Though TPX2 has been shown to localize to the centrosomes in prophase (Eibes et 
al., 2017; Ma et al., 2011) it is potentially not as concentrated or has a different 
distribution allowing Eg5 to accumulate and be active. 
In contrast to these regions where we observed a difference in localization of 
these proteins, both TPX2 and Eg5 were prominently localized to the half spindle, 
between the kinetochores and spindle pole, consistent with numerous reports 
(Cheerambathur et al., 2008; Gable et al., 2012; Garrett et al., 2002; Gruss et al., 2002; 
Sawin et al., 1992; Sawin and Mitchison, 1995; Wittmann et al., 2000).  By measuring 
the fluorescence of microtubules the data show that TPX2, but not Eg5 is enriched 
relative to microtubules near spindle poles.  The relatively uniform distribution of Eg5 is 
somewhat unexpected, as other work has reported that it is enriched at spindle poles and 
further, Eg5 has been reported to be transported poleward by dynein (Gable et al., 2012; 
Uteng et al., 2008).  In yeast, kinesin-5 family members move toward the minus ends, 
and accumulate in the region between kinetochores and spindle poles (Goldstein et al., 
2017; Roostalu et al., 2011; Tytell and Sorger, 2006). Eg5 is highly dynamic with a short 
dwell time on microtubules (Gable et al., 2012).  This rapid binding and unbinding 
behavior may counteract poleward transport or plus end directed motility, resulting in this 
even distribution.   
 
5.3.3 In vivo quantification of Eg5 and TPX2 levels in mitosis 
Eg5 and TPX2 are both cell cycle regulated with levels increasing in S and G2, 
remaining high in M, and dropping in G1 (Gruss et al., 2002; Uzbekov et al., 1999; 
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Venere et al., 2015). Previous work showed that Eg5 and TPX2 are specifically 
ubiquitinated and degraded by the anaphase-promoting complex as cells exit mitosis 
(Stewart and Fang, 2005; Venere et al., 2015). Our data show that the levels do not 
appear to significantly decrease as cells progress through mitosis, but rather remain 
constant even through late anaphase (Fig. 5.5 A, B, C). It is possible that the methods 
used account for these differences and because we are imaging single cells live we are 
better able to detect subtle differences that a bulk assay cannot.  
The ability to observe single cells live provided us the ability to correlate 
fluorescence to protein amount (Wu and Pollard, 2005). Knowing the concentrations and 
stoichiometries of proteins helps provide insight into how biological processes form and 
change as well as form the basis for modeling. Given that TPX2 is a multifunctional 
microtubule associated protein it is perhaps not surprising that it is present at a ~4x 
higher relative level than Eg5 on the spindle and ~1.5x more concentrated as a whole 
(Fig. 5.2E, Fig. 5.10D).  Additionally, the fraction of each EGFP tagged protein is not 
particularly high on the spindle (Fig. 5.5B), which was also not unexpected, given that 
these are dynamic proteins in vivo (Gable et al., 2012; Ma et al., 2010). 
Mammalian cells are more complex than yeast making them more challenging to 
quantify. Additionally, unlike yeast which have a reliable, endogenously tagged EGFP 
standard for comparison (Joglekar et al., 2006; Lawrimore et al., 2011), the mammalian 
cell standard does not have an endogenous tag (Suzuki et al., 2015). Therefore, it is 
subject to potential cellular problems like those mentioned above (section 5.3.1). Despite 
these potential problems, determining the protein amount in vivo both locally and 
globally is needed in the mammalian field. Our cells are potentially an improvement on 
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the mammalian standard due to the endogenous tag. In the future, this technique could be 
useful not only for quantifying other mitotic proteins but for analyzing targeting 
mechanisms and asking how specific proteins change after perturbations. 
5.4 Materials and Methods 
5.4.1 Materials 
All chemicals, unless otherwise specified, were purchased from Sigma-Aldrich. 
 
5.4.2 CRISPR gene editing 
EGFP or FKBP-EGFP tags were added to the C-terminus of human TPX2, Eg5, 
and HURP using methods described previously (Sheridan and Bentley, 2016; Stewart-
Ornstein and Lahav, 2016).  In brief, repair cassettes containing either EGFP or FKBP-
EGFP linked to a cleavable peptide (T2A) followed by a selectable marker (Neomycin) 
were cloned and used for PCR reactions. Each also encoded for Glycine-Alanine linkers 
between proteins. Guide sequences were selected using the CRISPR design tool 
(http://crispr.mit.edu/) from the Zhang lab at MIT (Ran et al., 2013). The parameters used 
were: “other regions” and the human target genome (hg19). We then had the tool search 
for guides close to the C-terminus of the protein of interest (~100nt surrounding and 
including the stop codon). Top and bottom oligos were obtained for each guide (Table 
5.1) with the bases 5’-CACC -3’added to the top oligo and 5’-AAAC-3’ added to the 
complement of the bottom oligo.  
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Table 5.1 Guide RNAs (PAM) 
Target Protein Guide RNAs 5’-3’ 
TPX2 TGCGGATACCGCCCGGCAAT(GGG) 
Eg5 AGGTTGATCTGGGCTCGCAG(AGG) 
HURP ACTTTTTCACCTCTACAACC(AGG) 
 
Guides were cloned into a Cas9 containing plasmid (PX459) obtained from 
Addgene (Cambridge, MA) (#62988) following methods previously outlined (Moyer and 
Holland, 2015). Briefly, top and bottom oligos were annealed and then phosphorylated by 
T4 PNK (NEB, Ipswich, MA). Guides were then cloned into PX459 that was cut using 
BbsI (NEB, Ipswich, MA) and ligated using T4 ligase (NEB Ipswich, MA). Guide-Cas9 
containing plamids were then sequenced using the U6 promotor primer (Ran et al., 2013) 
and purified using either endotoxin free mini-preps or midi-preps according to 
manufacturer protocol (Promega, Madison, WI). 
Repair cassettes were amplified using primers designed to be homologous to the 
C-terminal genomic DNA surrounding the STOP codon (Table 5.2). In all cases, the 
guide target sequence was mutated to prevent Cas9 from recognizing the repair cassette 
and described previously (Moyer and Holland, 2015).  
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Table 5.2 Oligonucleotides Used 
Protein Repair Cassette PCR Primers 5’-3’ 
TPX2 F 
GTACCAGGGTCTGGAGATAAAGTCAAGTGACCAGCCTCTGACTGTGCCTGT
ATCTCCCAAATTCTCCACTCGATTCCACTGCGGAGCTGGTGCAGGCG 
TPX2 R 
CTATCGCCTTCTTGACGAGTTCTTCTAAACTCAGCTGTGAGCTGCGGATA
CCGCCCGGCAATGCGACCTGCTCTTAACCTCAAACCTAGGACCGTCTTG 
Eg5 F 
CACTGGAGAGGTCTAAAGTGGAAGAAACTACAGAGCACTTGGTTACAAAG
AGCAGATTACCACTCCGTGCGCAGATTAACCTTGGAGCTGGTGCAGGCG 
Eg5 R 
CTATCGCCTTCTTGACGAGTTCTTCTAATTCACTTGGGGGTTGGCAATTT
TATTTTTAAAGAAAACTTAAAAATAAAACCTGAAACCCCAGAACTTGAGC 
HURP F 
GACATCAAGAACATGCCAGACACATTTCTTTTGGTGGTAACCTGATTACTT
TTTCTCCTCTTCAGCCTGGTGAATTTGGAGCTGGTGCAGGCG 
HURP R 
CTATCGCCTTCTTGACGAGTTCTTCTGAATTTAAAAATAAATCCAAACA
TTTTCCTTCATATTATCAATGCTTATATATTCCTTAGACTATTGAAATTT 
Protein Genomic DNA PCR Primers 5’-3’ 
TPX2 F GTGACTGGGACCTGTAAAACTC 
TPX2 R CTACCCGTGCCTGAGAAAG 
Eg5 F GAAGGCATTTGGCGCTAC 
Eg5 R CTTGAGCCCAGGAGTTTG 
GFP R CTACAACAGCCACAACGTC 
Primer Knock-Sideways, Gibson Assembly Primers 5’-3’ 
Eg5 F CTTATGGCCATGGAGGCCCGAATTCGGATGGCGTCGCAGCCAAATTC 
Eg5 R CGCCTGCACCAGCTCCAAGGTTGATCTGGGCTCG 
Cassette F CGAGCCCAGATCAACCTTGGAGCTGGTGCAGGCG 
Cassette R CATGTCTGGATCCCCGCGGCCGCTCAGAAGAACTCGTCAAGAAGGC 
Protein siRNA 5’-3’ 
Eg5 CUGAAGACCUGAAGACAAU 
 
Cells were grown in DMEM medium (ThermoFisher Scientific) with 10% Fetal 
bovine serum (FBS, Atlanta Biologicals, Flowery Branch, GA) and 0.5X 
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antibiotic/antimycotic solution (final concentrations 50 U/mL penicillin, 0.05 mg/mL 
streptomycin, 0.125 ug/mL amphotericin B; Sigma-Aldrich, St. Louis, MO) at 37 C and 
5% carbon dioxide (CO2).  For long term storage cells were frozen in DMEM medium 
with 5% FBS and 0.5X antibiotic/antimycotic solution and held at -80C for 1-2 days 
before moving to liquid nitrogen.   
Parental HeLa Cells were nucleofected using an Amaxa Nucleofector (Lonza,  
Portsmouth, NH) program I-013 and Mirus nucleofection reagent (Mirus Bio LLC, 
Madison, WI) according to the manufacturers recommendations. Plasmids and Repair 
cassettes were used at ratio of 1:1 at a concentration of 1 μg DNA each. Following 
nucleofection, cells were grown in regular growth media in 100mm dishes for 48-72 Hrs 
and then 0.2g/L Neomycin/G418 (InvivoGen, San Diego, CA) selection media was 
added. Media was then changed daily for 10-14 days and then colonies of green, CRISPR 
positive, cells were picked using cloning rings and returned to regular media for further 
screening and experiments. 
 
5.4.3 Genotyping 
Genomic DNA was isolated from clonal CRISPR tagged cells using the DNeasy 
Blood and Tissue Kit (Qiagen, Valencia, CA) according to manufacturers 
recommendations. DNA was then amplified by PCR using genomic primers (Table 5.2) 
targeting the C-terminus of each protein, the GFP tag, and downstream of the Stop codon 
(Fig. 5.3). KOD polymerase (MilliporeSigma, St. Louis, MO) was used to amplify 2 μL 
of isolated genomic DNA in a 20 μL reaction for 35 cycles. Extension times were varied 
based on primer combinations and products were analyzed using 1% agarose gel 
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electrophoresis. PCR Products of clones that produced bands of expected sizes were 
purified using a PrepEase DNA clean-up kit (USB Corporation, Cleveland, OH) and 
sequenced to verify proper integration of the tag. 
 
5.4.4 Western Blotting and Quantification 
Cell extracts of clonal CRISPR tagged cells were prepared by adding 1X SDS 
Sample buffer to cells grown to confluency in 35 mm dishes. Samples were boiled for 5 
minutes and run on either an 8 or 10% SDS polyacrylamide gels using the formulation of 
Laemmli (Laemmli, 1970). Gels were transferred onto Amersham Hybond-P membrane 
(GE Healthcare, Waukesha, WI). Blots were probed with Eg5, TPX2 or Hec1 antibodies 
(Novus Biologicals, Littleton, CO) used at 1:1000 (Eg5 and TPX2) and 1:200 (Hec1) for 
1 h at room temperature in 5% non-fat dry milk dissolved in Tris buffered saline 
containing 0.02% Tween-20 (TBS-Tween). Blots were then probed using goat anti-rabbit 
HRP conjugated secondary antibody (Eg5 and TPX2) and goat anti-mouse HRP 
conjugated secondary antibody (Hec1) (Jackson Immunoresearch Laboratories, Inc.) 
(1:5000) for 1 hr at room temperature in 5% non-fat dry milk dissolved in TBS-Tween 
and blots were imaged using chemiluminescence. 
To quantify the levels of tagged and untagged protein in each sample from clonal 
cell populations, densitometry was used (Fiji). The total protein level was determined by 
adding the total fluorescence in each lane. The amount of tagged and untagged protein 
was calculated as a percentage of this total amount. 
 
5.4.5 Knock-Sideways (Rapamycin-induced Dimerization) 
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Proteins were tagged on the C-terminus with an FKBP and an EGFP tag in either 
a plasmid (Eg5) or at the endogenous locus (DHC; see CRISPR gene editing methods). 
Cloning Eg5, FKBP, and EGFP into a Clonetech Laboratories (Mountain View, CA) 
expression vector (pCMV-Myc) was done using Gibson Assembly. Cloning was 
designed to mimic the endogenous tag in CRISPR modified cells (CRISPR gene editing 
methods) including a 10AA (Gly-Ala) linker between the C-terminus of Eg5 and FKBP. 
Eg5 and FKBP-EGFP-T2A-Neomycin cassette were amplified by PCR (Table 5.2). The 
Eg5 was made resistant to siRNA as described previously (Bickel et al., 2017). 
The siRNA resistant pCMV-Myc-Eg5-FKBP-EGFP construct was nucleofected 
into mCherry-Tubulin expressing LLC-Pk1 cells as previously described (Bickel et al., 
2017). With the help of Dr. Amy Burnside, GFP and mCherry positive cells were sorted 
by flow cytometry. These cells were then maintained as described previously (Bickel et 
al., 2017). Cells were then co-nucleofected with Eg5 siRNA (Table 5.2) obtained from 
Dharmacon (GE Healthcare Life Sciences, Pittsburgh, PA) and a membrane targeted 
FRB-BFP construct that was provided by Dr. Linda Wordeman and used previously for 
knock-sideways experiment (Wordeman et al., 2016). For knock-sideways experiments 
with DHC-FKBP-EGFP CRISPR modified HeLa cells, only the FRB-BFP construct was 
nucleofected as described above (CRISPR gene editing methods). Following 
nucleofection, cells were plated on mattek dishes and imaged ~24 hrs later. 
 
5.4.6 Cell Fixation and Immunofluorescence 
HeLa cells were rinsed twice with room temperature PBS lacking calcium and 
magnesium and were then fixed for 10 minutes in 3.2% paraformaldehyde, 0.1% 
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glutaraldehyde, and 0.5% Triton X 100, made fresh daily in PBS lacking calcium and 
magnesium. Fixed cells were rinsed in PBS containing 0.02% TWEEN-20 and 0.02% 
sodium azide (PBS-Tw-Az), treated with sodium borohydride (10mg/10mL H2O) for 10 
minutes and then rehydrated in PBS-Tw-Az.  
The following antibodies were used: tubulin, DM1α mouse anti-tubulin (Sigma-
Aldrich) or YL1/2 rat anti-tubulin (Accurate Chemical and Scientific Corporation, 
Westbury, NY), Eg5 rabbit polyclonal (Novus Biologicals, Littleton, CO), TPX2 rabbit 
polyclonal (Novus Biologicals, Littleton, CO) and appropriate secondary antibodies as 
previously described (Avunie-Masala et al., 2011). Primary antibodies were mixed with 
2% BSA in PBS-Tw-Az to block non-specific binding and used at the following final 
dilutions: Eg5 and TPX2 1:1,000, DM1α and YL1/2 1:100; cells were incubated in 
primary antibodies for 1 hour at 37°C. Stained cells were mounted on glass slides using 
DAPI Fluomount G (Southern Biotech, Birmingham, AL) to stain DNA. 
 
5.4.7 Microscopy 
1-2 days prior to imaging, cells were plated on Mattek glass bottom dishes 
(Mattek Corporation, Ashland, MA). Before imaging, cells were transferred to imaging 
(non CO2) media lacking phenol red (Collins et al., 2014) and maintained on the 
microscope in an Okolab UNO (Burlingame, CA) environmental chamber set to 37C. 
For z-stacks, cells were imaged on a Nikon Ti-E microscope with a CSU-X1 
Yokogawa spinning-disk confocal scan head (PerkinElmer, Wellesley, MA), an Andor 
iXon+ electron-multiplying charge-coupled device camera (Andor), and a 100×/1.4 NA 
objective lens. Z-step size was set at 0.33 μm to optimize signal collected but not 
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oversample. Z-steps were taken relative to the bottom of the cell for a total Z-stack of 25 
μm (77 steps) for live cells and 20 μm (62 steps) for fixed cells. In order to ensure cells 
did not photobleach prior to imaging, mitotics were identified using Phase Contrast and 
the focus was dropped below the cell before imaging began. 
Laser powers and exposures were chosen to ensure that the sum of the fluorescent 
signal would not be saturated. For cells expressing EGFP tags, images were acquired 
using a 488nm laser at 20% power and 750 msec exposure. For cells also expressing 
mCherry tags (Tubulin) images were taken using a 561 laser at 32% power with 500ms 
exposure. For cells with far-red tags (SiR Tubulin, DRAQ5), images were acquired using 
a 640 laser at 20% power and 750 msec exposure. When 2 colors were imaged, each 
color was acquired before moving up in z. In the case of DRAQ5 (DNA marker), a single 
image was acquired following the 488 z-stack of the corresponding cell. 
Timelapse images were acquired using a CSU-10 Yokogawa spinning-disk 
confocal scan head on a Nikon TE300 as previously described (Tulu et al., 2003). Images 
were acquired every minute with an exposure of 1000 msec and 4x4 binning.  
To quantify mitotic phenotypes of fixed cells, a Nikon Eclipse Ti with an X-Cite 
series 120Q excitation light source, and a 100 X, 1.3 N.A., objective lens, was used. 
Mitotic phenotypes were classified by spindle morphology based on microtubule staining 
as bipole, multipole, monopole, or disorganized. Disorganized spindles included spindles 
with extra foci, fragmented poles, short spindles, no pole, and bent spindles. 
For knock-sideways experiments, a Nikon A1R point scanning confocal 
microscopy with 60X/1.4 NA objective was used. Cells expressing the membrane bound 
FRB-BFP “trap” were found using epifluorescence and a Violet excitation block BFP 
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filter. Eg5-FKBP-GFP, mCherry Tubulin expressing LLC-Pk1 cells were then imaged for 
GFP and mCherry to determine spindle phenotypes following Rapamycin treatment. For 
time-lapse imaging of DHC-FKBP-GFP CRISPR modified HeLa cells, only the GFP 
signal was acquired and cell positions were marked using XY positioning in NIS 
elements.  
 
5.4.8 Image Analysis 
Analysis was performed in Fiji (Image J) (Schindelin et al., 2012). Sum intensity 
projections of z-stacks were created for single or double colors. For whole cell 
Fluorescence Intensity, images were background subtracted using a region of the same 
size from a z-stack of parental HeLa cells imaged using identical conditions. For 
background-corrected fluorescence intensity on the spindle, a region within a region 
background subtraction was used. This was done by manually drawing a region around 
the spindle and then a concentric larger region around the spindle, encompassing the 
spindle and surrounding cytoplasm. Then using the formulas: Background signal = 
(Integrated Fluorescence Intensity big area – Integrated Fluorescence Intensity small 
area)⁄(Area big – Area small). Total Intensity = Integrated Fluorescence Intensity small area – 
(Background signal × Area small) (Ye et al., 2015), fluorescence intensity was calculated. 
Cells were grouped according to cell stage (identified using DRAQ5 to label DNA). In 
order to account for untagged protein in the cell, following background subtraction, 
fluorescence values were adjusted based on the amount of tagged and untagged protein 
determined to be in the clonal population (Fig. 5.3).  
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For local accumulation, the fluorescence of the whole cell was measured by 
drawing a freehand shape around the cell and then background subtracted using the 
region within a region method described above. The total fluorescence was then divided 
by the area, which resulted in the total fluorescence per unit area (μm2). A smaller region 
was drawn around the centrosome within the cell and the same region was used for 
background subtraction. This total fluorescence was also divided by the area, which 
resulted in the total fluorescence per unit area (μm2). Finally, the ratio of the fluorescence 
per area of the centrosome to the fluorescence per area of the whole cell was calculated. 
For absolute levels, Hec1-EGFP expressing HeLa cells were imaged under the 
same conditions as the CRISPR modified Eg5 and TPX2 cells and served as a standard. 
Using a subset of the acquired z-slices that included all the fluorescence present in the 
kinetochores, circles were drawn around single kinetochores in a sum projection image, 
background subtracted and adjusted for untagged protein to determine the total 
fluorescence intensity. There are 244 molecules of Hec1 at the kinetochore (Suzuki et al., 
2015). Therefore, the number of molecules of either Eg5 or TPX2 could be calculated 
using a ratio comparing their fluorescence to Hec1. To further determine the 
concentrations of each, number of molecules was converted to Molarity using an 
approximate volume of a HeLa cell (3000 μm3) (Puck et al., 1956; Zhao et al., 2008) 
and/or the volume of a cylinder that contained all of the centrosome fluorescence.  
For relative levels, boxes of 5 x 5 pixels were drawn on the GFP Sum intensity 
projections; measured areas include the spindle pole, the spindle midzone, and a 
background area outside the spindle but in the cytoplasm. Boxes were drawn in the 
corresponding places on the Tubulin (mCherry or SiR) sum projection using the ROI 
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manager. Integrated Fluorescence Intensity was measured and background subtracted. 
Ratios were then made between regions (pole:midzone) in each color and then a ratio of 
the ratio was taken to compare the GFP-tagged proteins to Tubulin.  
These images were also used for line scans. Using the line tool, a line was drawn 
from pole-to-pole with a width of 50 pixels and 100 pixels for background subtraction. 
All of the spindle lengths were then normalized to the smallest spindle length and the 
fluorescence intensities were normalized to 1 to account for the difference in intensity 
between fluorescent channels. 
Line scans were also used to determine the dynamics of TPX2 and Eg5. Lines 
were drawn both perpendicular to and through the pole-to-pole axis of the spindle 
(through the spindle midzone) and at each time interval. The fluorescence intensities 
were normalized to 1 to account for differences in expression and corresponding 
fluorescence between Eg5 and TPX2-EGFP. 
 
5.4.9 Live Cell Labeling and Inhibitors 
SiR tubulin (Cytoskeleton, Denver, CO), used at a concentration of 50 nM in 
combination with 10 μM Verapamil, was added between 30-90 min prior to imaging. 
MG132 was used at a concentration of 10 μM for 90 minutes. In experiments with both 
MG132 and SiR Tubulin, they were added to cells at the same time and both were 
washed out after 90 min by transferring cells to non-CO2 media for imaging. DRAQ5 
(Thermo Fisher Scientific) was used at 1 μM and was added to cells just before imaging 
(~1-5 min). For knock-sideways, 200nM Rapamycin was added to imaging media. 
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Figure 5.1 Rapamycin re-localizes Eg5 producing monopolar spindles and re-
localizes Dynein to membranes in minutes. (A) Diagram of Knock-sideways method in 
LLC-Pk1 cells expressing siRNA-resistant Eg5-FKBP-GFP. (B) Images of Eg5-FKBP-
GFP (green), Microtubules (red), Membrane targeted FRB-BFP (Trap; Blue) in cells with 
and without 200nM Rapamycin after 30 minutes. (C) Diagram of Knock-sideways in 
HeLa DHC-FKBP-GFP CRISPR modified cells. (D) Time-lapse images of DHC-FKBP-
GFP before and after addition of 200nM Rapamycin. Time in min:sec:msec. Marker bar 
= 10 μm. 
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Figure 5.2 Eg5 and TPX2 are concentrated at spindle poles in metaphase, but only 
TPX2 is concentrated relative to microtubules.  (A) Diagram of CRISPR strategy. (B) 
Sum intensity projections of endogenous GFP-tagged proteins: Eg5 (top), TPX2 (middle) 
and HURP (bottom) in live cells arrested at metaphase using MG132. Cells were either 
expressing mCherry-Tubulin or labeled with 50nM SiR Tubulin ~30 min prior to imaging 
to stain microtubules. (C) Line scans of spindles; GFP-tagged protein (green) and tubulin 
(red) (see methods). (D) Ratio of spindle poles:midzone for each GFP-tagged protein 
(green) and tubulin (red); the ratio of poles:midzone of each protein:tubulin (yellow). (E) 
Relative, background subtracted (methods) Total Fluorescence Intensity for Eg5 (blue) 
and TPX2 (red) on a spindle in a cell arrested at metaphase using MG132. Amounts were 
adjusted to account for untagged protein. Error bars = St Dev. Marker bar = 10 μm. 
****p≤0.0001. n= 8 each. 
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Figure 5.3 Generation and characterization of CRISPR cell lines. (A) Schematic 
diagram of DNA modified by CRISPR (top) and unmodified (lower) for Eg5 (top) and 
TPX2 (lower).  (B) Genotyping of Eg5 (left) and TPX2 (right) CRISPR cell clones 
showing fragment size from genomic DNA and sequence analysis; yellow stars show 
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bands of correct size and the clones that were sequenced. (C) Quantification of EGFP-
tagged and untagged proteins for Eg5 (top) and TPX2 (bottom) clones by Western Blot; 
quantification of blots shown below.  Additional TPX2 blot showing tagged and 
untagged protein levels remain constant as passage number increases (bottom right) (D) 
Quantification of band intensity for Eg5 (blue) and TPX2 (red) from titration western 
blots. Linear trend lines, equations, and R2 shown. (E) Eg5 (blue) and TPX2 (red) 
CRISPR modified cells display normal mitotic phenotypes compared to parental HeLa 
cells (gray). 
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Figure 5.4 Only TPX2 is enriched relative to microtubules along K-fibers (A) Eg5-
EGFP and TPX2-EGFP are enriched to the same extent at poles relative to the midzone 
in cells with and without Tubulin labeling. (B)  Ratio of spindle poles:K-fiber for each 
GFP-tagged protein (green) and tubulin (red); the ratio of poles:K-fiber of each 
protein:tubulin (yellow). (C) Fixation for immunofluorescence results in spindle 
shrinking. Bar graph of length from pole-pole for live CRISPR cells compared to 
Immuofluorescence (left). Example images of Z distance from live CRISPR cells and 
Immunofluorescence (right). Error bars = St Dev.  ****p≤0.0001. 
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Figure 5.5 Relative amounts of Eg5 and TPX2 throughout mitosis. (A) Comparison 
of Eg5 (blue) and TPX2 (red) total Fluorescence levels on the spindle through mitosis. 
(B) Total Fluorescence Levels of TPX2 (top) and Eg5 (bottom) of the whole cell (dark 
colors) relative to the spindle (light colors) through mitosis; stages were identified using 
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DRAQ5. (C) As length increases the total fluorescence of TPX2 (red, top) and Eg5 (blue, 
bottom) on the spindle remain constant. Diagrams in A, B and C show region of the cell 
(whole cell or spindle) that was used for measuring fluorescence; all images were 
background subtracted. (D) Relative local concentration of Centrosomes vs. Whole cell. 
Box plot of the ratio of the Integrated Fluorescence Intensity per unit area. 
Whiskers define the range, boxes encompass the 25th to 75th quartiles, and lines depict 
the medians. Diagram representing Eg5 fluorescence distribution in a Prophase cell 
(right). Note that on average Eg5 is ~7.6X concentrated on centrosomes relative to the 
whole cell. Marker bars = 10 μm. Error Bars = St Dev. 
 
 
Figure 5.6 Immunofluorescence and CRISPR quantification differ. (A) Sum Intensity 
Projections of Parental cells arrested at metaphase using MG132, fixed and stained for α-
Tubulin (green) and either Eg5 (top) or TPX2 (bottom) (red). (B) Line scans of immuno-
stained spindles; Eg5 (top) a TPX2 (bottom) (green) and tubulin (red). (C) Ratio of 
spindle poles:midzone for Eg5 and TPX2 (green) and tubulin (red); the ratio of 
poles:midzone of Eg5/TPX2:Tubulin (yellow). (D) Comparison of the ratio of 
poles:midzone of Eg5:Tubulin for CRISPR and Immunofluorescently labeled cells. Error 
bars = St Dev. Marker bar = 10 μm. *p≤0.05 (p=0.025). n=8 Eg5, n=6 TPX2. 
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Figure 5.7 Distinct distribution of Eg5 and TPX2 throughout mitosis. (A) Time-lapse 
images of Eg5 and TPX2 from metaphase (0:00) through anaphase. (B) Schematic 
diagram and representative line scans perpendicular to pole-to-pole axis of Eg5 (blue) 
and TPX2 (red). Vertical lines indicate when protein begins to repopulate the midzone. 
(C) Box plot of spindle poles:midzone ratios for Eg5 (blue) and TPX2 (red) through 
different stages of mitosis. Whiskers define the range, boxes encompass the 25th to 75th 
quartiles, and lines depict the medians. (D) Line scans through the pole-to-pole spindle 
axis at indicated timepoints for Eg5 (blue) and TPX2 (red); schematic diagram of 
spindles. Note that Eg5 accumulates on interzonal microtubules before TPX2. Time in 
min:sec. Marker bar = 10 μm. 
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Figure 5.8 Eg5, but not TPX2, localizes to the spindle midzone in metaphase and 
anaphase. (A) Schematic diagram of image acquisition and images of slices (0.33 μm) 
through metaphase (left) and anaphase (right) spindles oriented at 90° relative to the 
coverslip surface. (B) Sum projections of 1.32 μm total through the midzone (top) and 
kinetochore fibers (bottom) of metaphase spindles in CRISPR modified cells. Top rows 
Eg5, lower rows TPX2. SiR Tubulin was used as a microtubule marker. Right images 
show zoomed in area in the middle of the spindle. Schematic diagrams (left) show where 
sum projections were made. (C) Anaphase cells, imaged as in A. Top rows Eg5, lower 
rows TPX2. Marker bars = 10 μm and 2 μm (zoom). 
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Figure 5.9 Eg5 is enriched in the spindle midzone relative to TPX2 at metaphase 
and anaphase. (A) Series of Z-slices through the middle of MG132 arrested metaphase 
spindles in GFP-tagged CRISPR cells oriented 90° from the surface of the coverslip; Eg5 
(top) and TPX2 (bottom). Tubulin was stained using SiR Tubulin (methods). (B) Series 
of Z-slices through the middle of Anaphase cells imaged as in A. YZ images (right) show 
microtubules and length of spndle. Z-slices = 0.33μm. Marker bar = 10 μm. 
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Figure 5.10 In vivo concentration of Eg5 and TPX2. (A) Sum projection image of 
Hec1-EGFP expressing cell using a subset of planes from a z-stack (left); cartoon shows 
location of Hec1 spots in a spindle. Western Blot showing expression level of GFP 
tagged vs. untagged Hec1 in cells (right). (B) Box plot of total fluorescence of Eg5 at the 
prophase centrosome (purple) compared to Hec1-EGFP (pink); left. Box plot of the 
number of GFP molecules of Eg5 at the prophase centrosome (purple) compared to 1 
GFP molecule (pink), calculated based on 244 Hec1 molecules in a kinetochore (Suzuki 
et al., 2015); right. (C) Box plot of the Eg5 concentration (μM) at the prophase 
centrosome (purple) vs. the whole cell (blue). (D) Box plot of the whole cell 
concentrations (μM) of Eg5 (blue) and TPX2 (red). Whiskers define the 
range, boxes encompass the 25th to 75th quartiles, and lines depict the medians. Marker 
bar in A = 10 μm. ****p≤0.0001. 
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Figure 5.11 Relative amounts of Eg5 and TPX2 on the mitotic spindle. (A) Average, 
background subtracted (methods) Total Fluorescence Intensity per μm3 for Eg5 (blue) 
and TPX2 (red) on a spindle close to the pole. (B) Max projection examples of Eg5 and 
TPX2 EGFP cells at different stages of mitosis (left); Quantification of the relative, 
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background subtracted Total Fluorescence intensity per μm3 for Eg5 (blue) and TPX2 
(red) on a spindle close to the pole at different mitotic stages (right). (C) Cartoon 
demonstrating the change in relative fluorescence on the spindle as mitosis progresses. 
The scale is shown bottom right. Amounts were adjusted to account for untagged protein. 
Marker bar in B = 10 μm. ****p≤0.0001. 
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